
<html lang="en"     class="pb-page"  data-request-id="c3b6883c-ede2-4c40-9638-a3eae4c18233"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-9;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b01896;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one)" /></meta><meta name="dc.Creator" content="Kurt G.  Pike" /></meta><meta name="dc.Creator" content="Bernard  Barlaam" /></meta><meta name="dc.Creator" content="Elaine  Cadogan" /></meta><meta name="dc.Creator" content="Andrew  Campbell" /></meta><meta name="dc.Creator" content="Yingxue  Chen" /></meta><meta name="dc.Creator" content="Nicola  Colclough" /></meta><meta name="dc.Creator" content="Nichola L.  Davies" /></meta><meta name="dc.Creator" content="Camila  de-Almeida" /></meta><meta name="dc.Creator" content="Sebastien L.  Degorce" /></meta><meta name="dc.Creator" content="Myriam  Didelot" /></meta><meta name="dc.Creator" content="Allan  Dishington" /></meta><meta name="dc.Creator" content="Richard  Ducray" /></meta><meta name="dc.Creator" content="Stephen T.  Durant" /></meta><meta name="dc.Creator" content="Lorraine A.  Hassall" /></meta><meta name="dc.Creator" content="Jane  Holmes" /></meta><meta name="dc.Creator" content="Gareth D.  Hughes" /></meta><meta name="dc.Creator" content="Philip A.  MacFaul" /></meta><meta name="dc.Creator" content="Keith R.  Mulholland" /></meta><meta name="dc.Creator" content="Thomas M.  McGuire" /></meta><meta name="dc.Creator" content="Gilles  Ouvry" /></meta><meta name="dc.Creator" content="Martin  Pass" /></meta><meta name="dc.Creator" content="Graeme  Robb" /></meta><meta name="dc.Creator" content="Natalie  Stratton" /></meta><meta name="dc.Creator" content="Zhenhua  Wang" /></meta><meta name="dc.Creator" content="Joanne  Wilson" /></meta><meta name="dc.Creator" content="Baochang  Zhai" /></meta><meta name="dc.Creator" content="Kang  Zhao" /></meta><meta name="dc.Creator" content="Nidal  Al-Huniti" /></meta><meta name="dc.Description" content="ATM inhibitors, such as 7, have demonstrated the antitumor potential of ATM inhibition when combined with DNA double-strand break-inducing agents in mouse xenograft models. However, the properties ..." /></meta><meta name="Description" content="ATM inhibitors, such as 7, have demonstrated the antitumor potential of ATM inhibition when combined with DNA double-strand break-inducing agents in mouse xenograft models. However, the properties ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 23, 2018" /></meta><meta name="dc.Type" content="news" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01896" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01896" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01896" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01896" /></link>
        
    
    

<title>The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01896" /></meta><meta property="og:title" content="The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0028.jpeg" /></meta><meta property="og:description" content="ATM inhibitors, such as 7, have demonstrated the antitumor potential of ATM inhibition when combined with DNA double-strand break-inducing agents in mouse xenograft models. However, the properties of 7 result in a relatively high predicted clinically efficacious dose. In an attempt to minimize attrition during clinical development, we sought to identify ATM inhibitors with a low predicted clinical dose (&lt;50 mg) and focused on strategies to increase both ATM potency and predicted human pharmacokinetic half-life (predominantly through the increase of volume of distribution). These efforts resulted in the discovery of 64 (AZD0156), an exceptionally potent and selective inhibitor of ATM based on an imidazo[4,5-c]quinolin-2-one core. 64 has good preclinical phamacokinetics, a low predicted clinical dose, and a high maximum absorbable dose. 64 has been shown to potentiate the efficacy of the approved drugs irinotecan and olaparib in disease relevant mouse models and is currently undergoing clinical evaluation with these agents." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01896"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01896">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01896&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01896&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01896&amp;href=/doi/10.1021/acs.jmedchem.7b01896" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 3823-3841</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00772" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Drug Annotation</span><a href="/doi/10.1021/acs.jmedchem.8b00522" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,3-dihydro-2<i>H</i>-imidazo[4,5-<i>c</i>]quinolin-2-one)</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Kurt G. Pike</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kurt G. Pike</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Building 310, Cambridge Science Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +44 (0)1223 223440. E-mail: <a href="/cdn-cgi/l/email-protection#e18a949395cf91888a84a180929593809b848f848280cf828e8c"><span class="__cf_email__" data-cfemail="ddb6a8afa9f3adb4b6b89dbcaea9afbca7b8b3b8bebcf3beb2b0">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kurt+G.++Pike">Kurt G. Pike</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9731-7500" title="Orcid link">http://orcid.org/0000-0002-9731-7500</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bernard Barlaam</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bernard Barlaam</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Building 310, Cambridge Science Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bernard++Barlaam">Bernard Barlaam</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elaine Cadogan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elaine Cadogan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Building 310, Cambridge Science Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elaine++Cadogan">Elaine Cadogan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrew Campbell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew Campbell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceutical Sciences, AstraZeneca, Silk Road Business Park, Macclesfield SK10 2NA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Campbell">Andrew Campbell</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yingxue Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yingxue Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yingxue++Chen">Yingxue Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nicola Colclough</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicola Colclough</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Building 310, Cambridge Science Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicola++Colclough">Nicola Colclough</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nichola L. Davies</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nichola L. Davies</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Building 310, Cambridge Science Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nichola+L.++Davies">Nichola L. Davies</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Camila de-Almeida</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Camila de-Almeida</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Building 310, Cambridge Science Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Camila++de-Almeida">Camila de-Almeida</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sebastien L. Degorce</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sebastien L. Degorce</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Building 310, Cambridge Science Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</div><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Centre de Recherches, Z. I. la Pompelle, BP 1050, 51689 Reims Cedex 2, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sebastien+L.++Degorce">Sebastien L. Degorce</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Myriam Didelot</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Myriam Didelot</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Centre de Recherches, Z. I. la Pompelle, BP 1050, 51689 Reims Cedex 2, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Myriam++Didelot">Myriam Didelot</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Allan Dishington</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Allan Dishington</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Allan++Dishington">Allan Dishington</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard Ducray</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard Ducray</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Centre de Recherches, Z. I. la Pompelle, BP 1050, 51689 Reims Cedex 2, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Ducray">Richard Ducray</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephen T. Durant</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephen T. Durant</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Building 310, Cambridge Science Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+T.++Durant">Stephen T. Durant</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lorraine A. Hassall</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lorraine A. Hassall</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lorraine+A.++Hassall">Lorraine A. Hassall</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jane Holmes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jane Holmes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jane++Holmes">Jane Holmes</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gareth D. Hughes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gareth D. Hughes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Building 310, Cambridge Science Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gareth+D.++Hughes">Gareth D. Hughes</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Philip A. MacFaul</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Philip A. MacFaul</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Philip+A.++MacFaul">Philip A. MacFaul</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Keith R. Mulholland</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Keith R. Mulholland</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Development, AstraZeneca, Silk Road Business Park, Macclesfield SK10 2NA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Keith+R.++Mulholland">Keith R. Mulholland</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thomas M. McGuire</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas M. McGuire</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Building 310, Cambridge Science Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+M.++McGuire">Thomas M. McGuire</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gilles Ouvry</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gilles Ouvry</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Centre de Recherches, Z. I. la Pompelle, BP 1050, 51689 Reims Cedex 2, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gilles++Ouvry">Gilles Ouvry</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0499-6055" title="Orcid link">http://orcid.org/0000-0003-0499-6055</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martin Pass</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin Pass</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Building 310, Cambridge Science Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Pass">Martin Pass</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Graeme Robb</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Graeme Robb</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Building 310, Cambridge Science Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Graeme++Robb">Graeme Robb</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Natalie Stratton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Natalie Stratton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Natalie++Stratton">Natalie Stratton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhenhua Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhenhua Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176, P.R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhenhua++Wang">Zhenhua Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joanne Wilson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joanne Wilson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, Building 310, Cambridge Science Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joanne++Wilson">Joanne Wilson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Baochang Zhai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Baochang Zhai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176, P.R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Baochang++Zhai">Baochang Zhai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kang Zhao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kang Zhao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176, P.R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kang++Zhao">Kang Zhao</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Nidal Al-Huniti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nidal Al-Huniti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology, IMED Biotech Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nidal++Al-Huniti">Nidal Al-Huniti</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01896&amp;href=/doi/10.1021%2Facs.jmedchem.7b01896" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 3823–3841</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 23, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 January 2018</li><li><span class="item_label"><b>Published</b> online</span>23 April 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 May 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01896" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01896</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3823%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKurt%2BG.%2BPike%252C%2BBernard%2BBarlaam%252C%2BElaine%2BCadogan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D9%26contentID%3Dacs.jmedchem.7b01896%26title%3DThe%2BIdentification%2Bof%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BAvailable%2BInhibitors%2Bof%2BAtaxia%2BTelangiectasia%2BMutated%2B%2528ATM%2529%2BKinase%253A%2BThe%2BDiscovery%2Bof%2BAZD0156%2B%25288-%257B6-%255B3-%2528Dimethylamino%2529propoxy%255Dpyridin-3-yl%257D-3-methyl-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C3-dihydro-2H-imidazo%255B4%252C5-c%255Dquinolin-2-one%2529%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3841%26publicationDate%3DMay%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01896"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">8155</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">33</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01896" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kurt&quot;,&quot;last_name&quot;:&quot;G. Pike&quot;},{&quot;first_name&quot;:&quot;Bernard&quot;,&quot;last_name&quot;:&quot;Barlaam&quot;},{&quot;first_name&quot;:&quot;Elaine&quot;,&quot;last_name&quot;:&quot;Cadogan&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Campbell&quot;},{&quot;first_name&quot;:&quot;Yingxue&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Nicola&quot;,&quot;last_name&quot;:&quot;Colclough&quot;},{&quot;first_name&quot;:&quot;Nichola&quot;,&quot;last_name&quot;:&quot;L. Davies&quot;},{&quot;first_name&quot;:&quot;Camila&quot;,&quot;last_name&quot;:&quot;de-Almeida&quot;},{&quot;first_name&quot;:&quot;Sebastien&quot;,&quot;last_name&quot;:&quot;L. Degorce&quot;},{&quot;first_name&quot;:&quot;Myriam&quot;,&quot;last_name&quot;:&quot;Didelot&quot;},{&quot;first_name&quot;:&quot;Allan&quot;,&quot;last_name&quot;:&quot;Dishington&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Ducray&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;T. Durant&quot;},{&quot;first_name&quot;:&quot;Lorraine&quot;,&quot;last_name&quot;:&quot;A. Hassall&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;Holmes&quot;},{&quot;first_name&quot;:&quot;Gareth&quot;,&quot;last_name&quot;:&quot;D. Hughes&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;A. MacFaul&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;R. Mulholland&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;M. McGuire&quot;},{&quot;first_name&quot;:&quot;Gilles&quot;,&quot;last_name&quot;:&quot;Ouvry&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Pass&quot;},{&quot;first_name&quot;:&quot;Graeme&quot;,&quot;last_name&quot;:&quot;Robb&quot;},{&quot;first_name&quot;:&quot;Natalie&quot;,&quot;last_name&quot;:&quot;Stratton&quot;},{&quot;first_name&quot;:&quot;Zhenhua&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Joanne&quot;,&quot;last_name&quot;:&quot;Wilson&quot;},{&quot;first_name&quot;:&quot;Baochang&quot;,&quot;last_name&quot;:&quot;Zhai&quot;},{&quot;first_name&quot;:&quot;Kang&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Nidal&quot;,&quot;last_name&quot;:&quot;Al-Huniti&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;3823-3841&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01896&quot;},&quot;abstract&quot;:&quot;ATM inhibitors, such as 7, have demonstrated the antitumor potential of ATM inhibition when combined with DNA double-strand break-inducing agents in mouse xenograft models. However, the properties of 7 result in a relatively high predicted clinically efficacious dose. In an attempt to minimize attrition during clinical development, we sought to identify ATM inhibitors with a low predicted clinical dose (&lt;50 mg) and focused on strategies to increase both ATM potency and predicted human pharmacokinetic half-life (predominantly through the increase of volume of distribution). These efforts resulted in the discovery of 64 (AZD0156), an exceptionally potent and selective inhibitor of ATM based on an imidazo[4,5-c]quinolin-2-one core. 64 has good preclinical phamacokinetics, a low predicted clinical dose, and a high maximum absorbable dose. 64 has been shown to potentiate the efficacy of the approved drugs irinotecan and olaparib in disease relevant mouse models and is currently undergoing clinical evaluation with &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01896&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01896" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01896&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01896" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01896&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01896" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01896&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01896&amp;href=/doi/10.1021/acs.jmedchem.7b01896" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01896" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01896" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01896%26sid%3Dliteratum%253Aachs%26pmid%3D29683659%26genre%3Darticle%26aulast%3DPike%26date%3D2018%26atitle%3DThe%2BIdentification%2Bof%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BAvailable%2BInhibitors%2Bof%2BAtaxia%2BTelangiectasia%2BMutated%2B%2528ATM%2529%2BKinase%253A%2BThe%2BDiscovery%2Bof%2BAZD0156%2B%25288-%257B6-%255B3-%2528Dimethylamino%2529propoxy%255Dpyridin-3-yl%257D-3-methyl-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C3-dihydro-2H-imidazo%255B4%252C5-c%255Dquinolin-2-one%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D9%26spage%3D3823%26epage%3D3841%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291411" title="Pharmacokinetics">Pharmacokinetics</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/jmcmar.2018.61.issue-9/20180510/jmcmar.2018.61.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0028.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">ATM inhibitors, such as <b>7</b>, have demonstrated the antitumor potential of ATM inhibition when combined with DNA double-strand break-inducing agents in mouse xenograft models. However, the properties of <b>7</b> result in a relatively high predicted clinically efficacious dose. In an attempt to minimize attrition during clinical development, we sought to identify ATM inhibitors with a low predicted clinical dose (<50 mg) and focused on strategies to increase both ATM potency and predicted human pharmacokinetic half-life (predominantly through the increase of volume of distribution). These efforts resulted in the discovery of <b>64</b> (AZD0156), an exceptionally potent and selective inhibitor of ATM based on an imidazo[4,5-<i>c</i>]quinolin-2-one core. <b>64</b> has good preclinical phamacokinetics, a low predicted clinical dose, and a high maximum absorbable dose. <b>64</b> has been shown to potentiate the efficacy of the approved drugs irinotecan and olaparib in disease relevant mouse models and is currently undergoing clinical evaluation with these agents.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01720" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01720" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The DNA within our cells is constantly under attack from endogenous sources, environmental mutagens, and carcinogens with tens of thousands of DNA damage events occurring every day.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> To effectively detect and repair the different types of DNA damage incurred, the body has developed a suite of different repair mechanisms and signaling pathways, collectively termed the DNA damage response (DDR).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Although not the most frequent form of DNA damage, DNA double-strand breaks (DSBs) are the most cytotoxic and are repaired by either the homologous recombination repair (HRR) pathway or the nonhomologous end-joining (NHEJ) pathway. The HRR pathway is a relatively efficient and accurate repair pathway for DNA DSBs but requires the presence of undamaged sister chromatid DNA, whereas the NHEJ is less accurate but is not dependent on the presence of replicated DNA.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Cancer cells typically have high levels of replication stress, defects in one or more DDR pathway, and a higher level of endogenous DNA damage resulting from a variety of factors associated with increased proliferation and loss of cell cycle checkpoints. The result of these differences mean that cancer cells are more sensitive to exogenous DNA damage than normal cells and supports the hypothesis that targeting DDR pathways may provide an effective avenue for cancer therapies.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The formation of DNA DSBs is the primary driver for the cytotoxicity for a number of approved cancer chemotherapies, such as topoisomerase I and II inhibitors (e.g., irinotecan), as well as for ionizing radiation (IR). In addition, DNA DSBs can be induced by targeting specific DDR pathways such as the inhibition of PARP with the approved drug olaparib. Opportunities to interfere with the repair of DNA DSBs may therefore offer the potential to enhance the cytotoxicity of DSB inducing agents.</div><div class="NLM_p">Ataxia telangiectasia mutated (ATM) derives its name from a rare human autosomal recessive disorder ataxia-telangiectasia (A-T) that results from mutations in the ATM gene which causes patients to suffer a variety of symptoms including immunodeficiency, extreme radiosensitivity, and a predisposition to cancer.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> ATM kinase is a member of the phosphatidylinositol 3-kinase (PI3K)-related kinase (PIKK) family of atypical serine/threonine protein kinases (also comprising ATR, DNA-PKcs, mTOR, SMG1, and the nonenzymatic TRRAP) and plays a central role in both the early signaling of, and the protection of cells against, DNA DSBs and reactive oxygen species (ROS) that radiotherapy and a wide range of chemotherapies induce.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8−10)</a> ATM is a large protein (350 kDa) comprising 3056 residues and containing a kinase domain with a relatively high degree of similarity to all isoforms of the lipid kinase PI3K.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> ATM, in its inactive dimeric form, is recruited to the site of a DNA DSB by the DNA-end tethering MRE11-RAD50-NBS1 (MRN) complex and results in the autophosphorylation of ATM on serine 1981 and subsequent dimer dissociation.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> The activated ATM monomer phosphorylates a broad range of downstream targets, including γH2AX, p53 Mdm2, and Chk2, thereby initiating a signaling network capable of activating both cell survival and cell death pathways.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18">(14−18)</a> Loss of ATM activity results in the sensitization of virtually all cells to IR, whereas upregulation of ATM signaling has been observed to result in both chemoresistance and radioresistance in cancer cells.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19−21)</a> The central role of ATM in coordinating both the HR and NHEJ repair pathways in response to induced DNA DSBs, and its noncanonical responses to cellular stress, highlights this protein as a highly attractive pharmacological target to sensitize tumor cells to both chemotherapy and radiotherapy.<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22−24)</a></div><div class="NLM_p">A number of selective inhibitors of ATM have been disclosed, the first of which, <b>2</b> (KU-55933), was developed by KuDOS Pharmaceuticals (now part of AstraZeneca) following the extensive structure–activity relationship (SAR) studies performed on chemical scaffolds related to the pan-PI3K and pan-PIKK inhibitor <b>1</b> (LY294002), <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> Compound <b>2</b> is a potent, ATP-competitive inhibitor of ATM enzyme (IC<sub>50</sub> = 0.013 μM) with high levels of selectivity over the closely related enzymes DNA-PK (IC<sub>50</sub> = 2.5 μM), ATR (IC<sub>50</sub> > 100 μM), mTOR (IC<sub>50</sub> = 9.3 μM), and PI3K (IC<sub>50</sub> = 17 μM) and has been shown to sensitize HeLa cells to the cytotoxic effects of topoisomerase I and II inhibitors and to IR.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The utility of <b>2</b> has been limited to in vitro assessment as a result of poor physicochemical properties, in particular, low aqueous solubility and low oral bioavailability. Subsequent optimization of the scaffold resulted in the discovery of second-generation ATM inhibitors, such as <b>3</b> (KU-59403), with improved potency and properties.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Compound <b>3</b> is a potent inhibitor of ATM enzyme (IC<sub>50</sub> = 0.003 μM) with >300-fold selectivity over ATR, DNA-PK, mTOR, and PI3K and showed effective chemosensitization in cells at 1 μM. Despite the improved solubility of <b>3</b>, the compound remains unsuited to oral administration (PO); however, intraperitoneal administration (IP) has allowed the study of <b>3</b> in tumor-bearing mice. Tumor growth delay was observed following administration of <b>3</b> (25 mg/kg IP BID) for 5 days when combined with either etoposide or irinotecan. More recently, the quinazoline <b>4</b> has been reported as a modest inhibitor of ATM in cell-based assays (IC<sub>50</sub> = 1.2 μM) but with good in vivo pharmacokinetics in mouse (<i>t</i><sub>1/2</sub> = 19 h).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Quinazoline <b>4</b> showed efficacy when evaluated at 10 μM in a clonogenic assay in which MCF7 cells were treated with compound and irradiated with increasing doses of IR (0, 2, and 4 Gy), but concerns about its selectivity remain (significant activity was observed against 41 out of 451 kinases when tested at 3 μM in a panel of diverse kinases).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of LY294002 (<b>1</b>), KU-55933 (<b>2</b>), KU-59403 (<b>3</b>), and quinazoline <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We have recently disclosed the optimization of a quinoline carboxamide scaffold from an initial screening hit <b>5</b>, a modestly potent inhibitor in cells with encouraging selectivity over closely related targets, to deliver potent and selective compounds with oral bioavailability, such as <b>6</b> (which has been given the external identifier AZ31) and <b>7</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Such compounds represent a significant advance allowing the more detailed investigation of ATM inhibition in vivo. Compound <b>6</b>, administered orally at 100 mg/kg QD, has been shown to potentiate the efficacy of IR in an HT29 mouse xenograft model and the efficacy of irinotecan, administered at 50 mg/kg IP Q7D, in an SW620 mouse xenograft model, resulting in tumor regressions.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> Compound <b>7</b>, administered orally at 50 mg/kg BID (on days 2–4 of a weekly schedule), has also been shown to potentiate the efficacy of irinotecan, administered at 50 mg/kg IP Q7D, and cause tumor regression in an SW620 mouse xenograft model.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> As anticipated, no significant activity in these models was observed for either <b>6</b> or <b>7</b> in the absence of a DNA DSB-inducing agent. The efficacious doses of <b>6</b> and <b>7</b> identified provide free plasma concentrations at, or above, the cellular IC<sub>50</sub> for ATM for approximately 24 h in mice on the days that the inhibitors were dosed. This level and duration of target engagement has subsequently been used to define the likely efficacious clinical exposure. The increased separation between ATM potency and potency against the hERG (human ether-a-go-go gene related gene) ion channel suggested a reduced risk of adverse cardiovascular events for compound <b>7</b> compared to <b>6</b>, and its potential as a clinical candidate was assessed.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure and Profiles of Screening Hit <b>5</b> and Optimized Quinoline Carboxamide Examples AZ31 (<b>6</b>) and <b>7</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0017.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="/" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center" char=".">ATM cell IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">ATR cell IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i><sub>7.4</sub></th><th class="colsep0 rowsep0" align="center">aq soln<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="/">human/rat heps<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">hERG IC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">0.82</td><td class="colsep0 rowsep0" align="center">4.4</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="center">19</td><td class="colsep0 rowsep0" align="char" char="/">12/74</td><td class="colsep0 rowsep0" align="center">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b> (AZ31)</td><td class="colsep0 rowsep0" align="char" char=".">0.046</td><td class="colsep0 rowsep0" align="center">>30</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="center">590</td><td class="colsep0 rowsep0" align="char" char="/"><2.6/<5.3</td><td class="colsep0 rowsep0" align="center">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">0.033</td><td class="colsep0 rowsep0" align="center">>19</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="center">69</td><td class="colsep0 rowsep0" align="char" char="/"><1.5/5.3</td><td class="colsep0 rowsep0" align="center">22</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">All IC<sub>50</sub> data are expressed in micromolar (μM) and ATM/ATR potency values are the geometric mean of at least three independent measurements. Further details for the biological assays can be found in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01896/suppl_file/jm7b01896_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Thermodynamic aqueous solubility was measured at pH 7.4, and the data are expressed in micromolar (μM). No assessment of solid state was made.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">The data are expressed in μL/min/10<sup>6</sup> cells</p></div></div></div><div class="NLM_p">Physiologically based pharmacokinetic (PBPK) models attempt to portray the body as a series of compartments that represent tissues and organs connected by the arterial and venous blood flow pathways.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> These models utilize measured physiological data to describe the tissues and organs by their volume and the blood flow to them and can be used to predict the disposition of novel compounds in human. Predicted human pharmacokinetic parameters can be used to simulate the dose required to achieve a target concentration for a defined duration which, when combined with an understanding of the target engagement required for efficacy in preclinical models, can be used to predict the efficacious clinical dose.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> PBPK modeling suggested that <b>7</b> would possess a relatively short half-life in humans (∼4 h) and would, therefore, require an oral dose of 700 mg of QD to deliver the desired clinical exposure. The simulation also predicts that a maximum unbound concentration (free <i>C</i><sub>max</sub>) of 1.3 μM would be reached following this dose. This relatively high predicted free <i>C</i><sub>max</sub> increases the likelihood that non-ATM mediated pharmacology may become manifest, thus reducing compound tolerability. While it is appreciated that alternative dosing regimens, for example BID dosing, could be employed in an effort to maintain the desired level and extend of target engagment while reducing both total dose and free <i>C</i><sub>max</sub>, such regimens are generally considered less attractive as they place increased burden on patients to remain compliant.</div><div class="NLM_p last">Many approaches to minimize compound attrition during clinical development have been suggested and recent analyses have recognized the link between an increased risk of nontarget mediated toxicity (including idiosyncratic toxicity) and increasing clinical dose (and by inference increasing free <i>C</i><sub>max</sub>).<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> As a result of these analyses, where possible, AstraZeneca has adopted the approach of selecting compounds for clinical development which have a low predicted clinically efficacious dose (<50 mg). However, attrition in clinical development is not solely due to toxicity, and consideration should also be given to the developability of a clinical candidate. For orally administered compounds, the parameter of maximum absorbable dose (<i>D</i><sub>abs</sub>) is often used, in conjunction with a predicted clinical dose, to understand whether a significant investment in formulation will be required to achieve the desired exposure. Poor developability can add significant cost and time to the clinical development of a clinical candidate and could limit the achievable clinical exposure by preventing the biological hypothesis from being properly tested.<a onclick="showRef(event, 'ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41">(39−41)</a> Computational simulation software (for example GastroPlus or the GI-Sim model) can be used to predict <i>D</i><sub>abs</sub> based on easily measured in vitro parameters, such as aqueous solubility and permeability, combined with knowledge of intestinal surface area and transit times.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In addition to selecting clinical candidates with a low predicted clinically efficacious dose, where possible, AstraZeneca looks to select candidates with a predicted <i>D</i><sub>abs</sub> at least 10-fold above the predicted clinically efficacious dose. As a consequence of good permeability in MDCK cells overexpressing MDR1 (<i>P</i><sub>app</sub> A–B = 12 × 10<sup>–6</sup> cm/s, efflux ratio = 8.7) and moderate aqueous solubility (69 μM), the <i>D</i><sub>abs</sub> of <b>7</b> was predicted to be approximately 500 mg. While the predicted clinically efficacious dose and <i>D</i><sub>abs</sub> would not necessarily preclude the development of <b>7</b> as a clinical candidate, we sought to continue compound optimization with an emphasis on reducing predicted clinical dose and increasing <i>D</i><sub>abs</sub>. Such compounds, we hypothesized, would carry a reduced risk of attrition during clinical development.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50787" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50787" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds reported herein were synthesized as shown in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch6" aria-label="6">6</a>. The versatile 6-bromo-4-chloro-7-fluoroquinoline-3-carboxamide (<b>10</b>) was prepared in four steps from commercially available 4-bromo-3-fluoroaniline <b>8</b>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Reaction of <b>8</b> with 1,3-diethyl 2-(ethoxymethylidene)propanedioate, followed by a high temperature cyclization, gave intermediate <b>9</b> which could be easily converted to intermediate <b>10</b> by hydrolysis, chlorination, and amide formation. Suzuki cross-coupling methodology was used to install the required aryl substituent into the 6-position of the quinoline ring to give <b>11</b>. S<sub>N</sub>Ar reaction with the appropriate amine, followed by Hoffman rearrangement<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and subsequent methylation, gave compounds <b>12</b>–<b>15</b>. Compounds <b>18</b>–<b>20</b> were prepared from <b>10</b> by employing the same transformations, albeit with the sequence altered. Compound <b>16</b> was prepared from <b>10</b> by S<sub>N</sub>Ar reaction with 3-(aminomethyl)pentane followed by Suzuki cross-coupling and a subsequent S<sub>N</sub>Ar reaction on the resultant fluoropyrimidine, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>12</b>–<b>15</b>, <b>16</b>, and <b>18</b>–<b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1,3-diethyl 2-(ethoxymethylidene)propanedioate, EtOH, 80 °C, 4 h (84%); (b) Ph<sub>2</sub>O, 240 °C, 2.5 h (64%); (c) NaOH, EtOH, water, 75 °C, 2 h (89%); (d) SOCl<sub>2</sub>, DMF, 75 °C, 2 h, NH<sub>4</sub>OH (100%); (e) aryl boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 90 °C, 4 h (72%); (f) amine, DIPEA, DMA, 30–100 °C, 5–6h (44–72%); (g) trichloroisocyanuric acid, DBU, MeOH, rt, 0.25–2 h (56–70%); (h) MeI, TBAB, NaOH, DCM, water, rt, 2.5–24 h, (21–49%); (i) 3-(aminomethyl)pentane, DIPEA, DMA, 100 °C, 5 h (100%); (j) 2-fluoro-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 95 °C, 3 h (82%); (k) 2-(pyrrolidin-1-yl)ethan-1-amine, DIPEA, DMA, 34 °C, 1 h (80%); (l) (S)-1-(tetrahydro-2H-pyran-4-yl)ethanamine, DIPEA, DMA, 100 °C, 24 h (70%); (m) trichloroisocyanuric acid, DBU, MeOH, rt, 20 min (100%); (n) MeI, TBAB, NaOH, DCM, water, rt, 2.5 h, (98%); (o) aryl boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF:water, 90 °C, 2 h (37%); (p) tetrahydro-2<i>H</i>-pyran-4-amine, DIPEA, DMA, 100 °C, 24 h (78%); (q) trichloroisocyanuric acid, DBU, MeOH, rt, 15 min (98%); (r) MeI, TBAB, NaOH, DCM, water, rt, 24 h, (26%); (s) aryl boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 80–90 °C, 1.5–2 h (40–74%).</p></p></figure><div class="NLM_p">The versatile intermediate ethyl 6-bromo-4-chloro-7-fluoroquinoline-3-carboxylate (<b>21</b>) could be easily prepared from <b>9</b> by treatment with thionyl chloride. An S<sub>N</sub>Ar reaction was used to install the methoxycyclobutyl motif, followed by ester hydrolysis, Curtius rearrangement, and subsequent methylation to afford <b>22</b>. Compounds <b>24</b>, <b>25</b>, and <b>28</b> were prepared using Suzuki cross-coupling methodology to install a simply substituted pyridyl ring followed by standard manipulations to complete the elaboration of the pyridyl substituent. Miyaura borylation<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> of <b>22</b> followed by Suzuki coupling afforded compound <b>27</b>. Compounds <b>29</b>–<b>33</b> were synthesized from intermediate <b>22</b> by Suzuki coupling of fully elaborated boronates, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>24</b>, <b>25</b>, and <b>27</b>–<b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) SOCl<sub>2</sub>, DMF, 80 °C, 4 h (70%); (b) 3-methoxycyclobutan-1-amine·HCl, DIPEA, DMA, 85 °C, 3 h (77%); (c) NaOH, EtOH, water, 40 °C, 2 h (81%); (d) DPPA, TEA, DMF, 60 °C, 2 h, (77%); (e) MeI, TBAB, NaOH, DCM, water, rt, 24 h, (75%); (f) (6-fluoropyridin-3-yl)boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 90 °C, 3 h; (g) amine, DMSO, 110 °C, 1–2 h (47–54%); (h) B<sub>2</sub>Pin<sub>2</sub>, (dppf)PdCl<sub>2</sub>, KOAc, dioxane, 80 °C, 2 h (76%); (i) aryl boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 80 °C, 2 h (17%); (j) (6-[[(<i>tert</i>-butoxy)carbonyl]amino]pyridin-3-yl)boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 100 °C, 3 h (70%); (k) 4-chlorobutanoyl chloride, DIPEA, DCM, rt, 16 h (66%); (l) TFA, DCM, rt, 30 min (99%); (m) dimethylamine, NaI, THF, 60 °C, 16 h, (19%); (n) arylboronic ester, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 80 °C, 2–6 h (22–62%).</p></p></figure><div class="NLM_p">Analogous transformations employing a Hoffman rearrangement were used to prepare compounds <b>37</b>–<b>40</b>, <b>42</b>, <b>43</b>, <b>45</b>–<b>48</b>, <b>50</b>, and <b>51</b> from 6-bromo-4-chloroquinoline-3-carboxamide (<b>35</b>), <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, or using a Curtius rearrangement to prepare compounds <b>57</b>–<b>61</b>, <b>63</b>, and <b>64</b> from ethyl 6-bromo-4-chloroquinoline-3-carboxylate (<b>52</b>), <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. <i>N</i>-Oxide <b>65</b> was made by the biocatalytic oxidation of <b>64</b>, <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0013.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 1<i>H</i>-Imidazo[4,5-<i>c</i>]quinolin-2(3<i>H</i>)-ones by Hoffmann Rearrangement<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1,3-diethyl 2-(ethoxymethylidene)propanedioate, EtOH, 78 °C, 24 h (90%); (b) Ph<sub>2</sub>O, 240 °C, 1 h; (c) NaOH, EtOH, water, 75 °C, 1.5 h (96%); (d) SOCl<sub>2</sub>, DMF, 70 °C, 2 h, NH<sub>4</sub>OH (95%); (e) 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 100 °C, 5 h (72%); (f) tetrahydro-2<i>H</i>-pyran-4-amine·HCl, DIPEA, DMF, 80 °C, 16 h (19%); (g) trichloroisocyanuric acid, DBU, MeOH, rt, 30 min (87%); (h) DMFDMA, DMF, 80 °C, 1.5 h (43%) or iodopropane, NaH, DMF, 55 °C, 30 min, (9%); (i) oxetan-3-amine, DIPEA, DMA, 100 °C, 18 h (100%); (j) trichloroisocyanuric acid, DBU, MeOH, rt, 24 h (19%); (k) MeI, TBAB, NaOH, DCM, water, rt, 36 h, (92%); (l) boronic ester, dichloro [1,1′-bis(ditertbutylphosphino)ferrocene] palladium(II), K<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 1 h (58%); (m) 3-methoxycyclobutan-1-amine·HCl, DIPEA, DMA, 100 °C, 16 h (68%); (n) trichloroisocyanuric acid, DBU, MeOH, rt, 18 h (99%); (o) MeI, TBAB, NaOH, DCM, water, rt, 12 h, (75%); (p) arylboronate, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 80–90 °C, 2–3 h (36–75%); (q) (6-fluoropyridin-3-yl)boronic acid, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 90 °C, 4 h (86%); (r) alcohol, NaH, DMF or DMA, rt, 10 min -24 h (25–75%) (for <b>45</b> an additional step: TFA, DCM, rt, 1 h, was required); (s) (6-(3-bromopropoxy)pyridin-3-yl)boronic ester, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 90 °C, 1 h (27%); (t) MsCl, DIPEA, DMF, rt, 30 min; (u) morpholine, DIPEA rt (9% over 2 steps).</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0014.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 1<i>H</i>-Imidazo[4,5-<i>c</i>]quinolin-2(3<i>H</i>)-ones by Curtius Rearrangement<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) SOCl<sub>2</sub>, DMF, 75 °C, 16 h (83%); (b) amine, DIPEA, DMA, 80–90 °C, 1.5–16 h (83–97%); (c) NaOH, THF, MeOH, water, 60 °C, 1.5–3 h (95–100%); (d) DPPA, TEA, DMF, 60 °C, 1–16 h, (80–98%); (e) MeI, TBAB, NaOH, DCM, water, rt, 1–12 h or DMFDMA, DMF, 80 °C, 3 h (75–96%); (f) (6-fluoropyridin-3-yl)boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 100 °C, 3 h (87%); (g) 3-(piperidin-1-yl)propan-1-ol, NaH, THF, rt, 24 h (28%); (h) aryl boronic ester, Cs<sub>2</sub>CO<sub>3</sub>, X-phos-2Gen or Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 90–100 °C, 2–3 h (41–62%); (i) tetrahydro-2<i>H</i>-pyran-4-amine, DIPEA, DMF, 60 °C, 16 h (100%); (j) 2-(methoxymethyl)-5-boronic ester-pyridine Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 100 °C, 2 h (95%); (k) NaOH, THF, water, 60 °C, 4 h (92%); (l) DPPA, TEA, DMF, 60 °C, 7 h, (79%); (m) MeI, TBAB, NaOH, DCM, water, rt, 72 h (62%); (n) tetrahydro-2<i>H</i>-pyran-4-amine, DIPEA, DMF, 60 °C, 16 h (100%); (o) NaOH, MeOH, water, 70 °C, 2 h (86%); (p) DPPA, TEA, DMF, 60 °C, 2 h, (99%); (q) MeI, TBAB, NaOH, DCM, water, rt, 16 h (93%); (r) (6-fluoropyridin-3-yl)boronic acid, Cl<sub>4</sub>Na<sub>2</sub>Pd, DTBPPS, K<sub>2</sub>CO<sub>3</sub>, dioxane:water, 100 °C, 16 h (96%); (s) alcohol, NaH, DMA or DMF, rt to 50 °C, 2–16 h, (82–90%); (t) NADP, K<sub>2</sub>PO<sub>4</sub>, Codexis KRED, Codexis BVMO, 2-propanol, water, rt, 41 h (39%).</p></p></figure><div class="NLM_p">Imidazo[4,5-<i>c</i>][1,5]naphthyridin-2-one <b>70</b> was synthesized in eight steps from 6-chloro-3-aminopyridine <b>67</b>. Enamine formation followed by cyclization and hydrolysis gave bicyclic <b>68</b>. Chlorination and amide formation followed by S<sub>N</sub>Ar and Hoffman rearrangement led to intermediate <b>69</b>, which was converted to <b>70</b> by methylation and finally Suzuki cross-coupling with the appropriate boronate, <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0015.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <b>70</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1,3-diethyl 2-(ethoxymethylidene)propanedioate, EtOH, 80 °C, 4 h (90%); (b) Ph<sub>2</sub>O, 220 °C, 2 h (37%); (c) NaOH, EtOH, water, 100 °C, 0.5 h (92%); (d) SOCl<sub>2</sub>, DMF, 80 °C, 2 h, NH<sub>4</sub>OH (100%); (e) tetrahydro-2<i>H</i>-pyran-4-amine·HCl, DIPEA, DMA, rt, 18 h (37%); (f) trichloroisocyanuric acid, DBU, MeOH, rt, 30 min (75%); (g) MeI, TBAB, NaOH, DCM, water, rt, 12 h (75%); (h) boronic ester, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 90 °C, 2 h (28%).</p></p></figure><div class="NLM_p">Imidazo[4,5-<i>c</i>]cinnolin-2-one <b>74</b> was made in 10 steps from 4-bromophenylhydrazine <b>71</b>. Initial reaction with diethyloxomalonate was followed by hydrolysis of both esters and acid chloride formation. Titanium chloride induced cyclization afforded cinnoline <b>72</b>. Chlorination, S<sub>N</sub>Ar, ester hydrolysis, and Curtius rearrangement led to the formation of tricylcic compound <b>73</b>, and methylation followed by a Suzuki cross-coupling produced <b>74</b>, <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0016.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>74</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) diethyloxomalonate, aq EtOH, rt, 18 h (92%); (b) NaOH, EtOH, 78 °C, 50 min (81%); (c) SOCl<sub>2</sub>, 44 °C, 2 h, (97%); (d) TiCl<sub>4</sub>, nitrobenzene, 95 °C, 18 h then EtOH, H<sub>2</sub>SO<sub>4</sub>, 95 °C, 5 h (34%); (e) SOCl<sub>2</sub>, 75 °C, 3 h, (100%); (f) tetrahydro-2<i>H</i>-pyran-4-amine·HCl, TEA, THF, rt, 30 min (98%); (g) NaOH, MeOH, water, rt, 1 h; (h) DPPA, TEA, DMF, 60 °C, 3 h (60% over 2 steps); (i) DMFDMA, DMF, 80 °C, 4 h (91%); (j) boronic ester, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 80 °C, 2 h (8.5%).</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24284" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24284" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A number of strategies for reducing the predicted clinically efficacious dose can be conceived; however, to identify the optimal strategy, it is important to consider the extent to which different parameters contribute to the dose prediction. For example, increasing potency (while keeping all other parameters constant) will reduce the predicted dose in a linear fashion; however, increases in the pharmacokinetic half-life can have a much more profound influence (especially where the predicted half-life is significantly shorter than the desired duration of target engagement). Given the relatively short predicted human half-life of <b>7</b>, especially in the context of achieving target engagement for a 24 h period, we embarked on a strategy to increase half-life while maintaining or improving potency, selectivity, and physicochemical properties. The use of PBPK modeling approaches to accurately predict human pharmacokinetics requires detailed in vitro and in vivo compound profiling and as such places a limit on the number of compounds for which such models can be built. However, a reasonable first estimate of human pharmacokinetic parameters can be produced based on a more limited set of in vitro parameters (i.e., plasma protein binding and the intrinsic clearance in human hepatocytes) combined with a prediction of the volume of distribution (<i>V</i><sub>ss</sub>). When combined with a knowledge of target potency and the required extent and duration of target engagement, an estimate of clinical dose can be made. This simplified prediction, termed early dose to man prediction (eD2M) within AstraZeneca, assumes complete absorption of a compound across the gut (i.e., <i>F</i><sub>abs</sub> = 100%), which would only be expected to hold true for highly permeable compounds.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> However, if available, <i>V</i><sub>ss</sub> and <i>F</i><sub>abs</sub> data determined experimentally in rodents can be incorporated to refine the prediction. The use of eD2M and <i>D</i><sub>abs</sub> predictions enables a comparison of compound quality across a large number of compounds and was used to guide the compound optimization described herein.</div><div class="NLM_p">Pharmacokinetic half-life is intrinsically linked to both the clearance (CL) and the <i>V</i><sub>ss</sub> of a compound, and both parameters were considered for optimization. Compound <b>7</b> displays low metabolic turnover in human hepatocyte incubations, suggesting that a further reduction in CL would be a challenge, therefore, a strategy to increase <i>V</i><sub>ss</sub> was considered more profitable. Many studies have been reported attempting to identify those molecular properties that influence <i>V</i><sub>ss</sub>, with ionization state often found to dominate.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> In particular, basic compounds generally show increased <i>V</i><sub>ss</sub> when compared with neutral or acidic compounds, thus suggesting that the incorporation of a basic substituent into our novel series of ATM inhibitors, while keeping other parameters constant, would deliver an increased predicted human half-life and reduced predicted clinical dose.</div><div class="NLM_p">Wide ranging SAR exploration in the 6-position of the quinoline carboxamide scaffold revealed the potential to incorporate a basic substituent, as exemplified by <b>16</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. Compound <b>16</b> showed an unexpected increase in ATM cell potency (IC<sub>50</sub> = 0.0086 μM), while selectivity over ATR was retained (IC<sub>50</sub> > 30 μM) and the basic nature of the compound resulted in an increased predicted human <i>V</i><sub>ss</sub> when compared to neutral compound <b>7</b> (3.5 L/kg cf. 1.2 L/kg). The improved primary potency and increased <i>V</i><sub>ss</sub> of <b>16</b> culminated in a low predicted clinical efficacious dose (eD2M = 11 mg QD), thereby highlighting how optimization of primary potency and pharmacokinetic properties can influence the predicted dose. Unfortunately, despite this low dose prediction the permeability of the <b>16</b> was poor and a significant efflux liability was observed in MDCK cells (<i>P</i><sub>app</sub> A–B = 0.8 × 10<sup>–6</sup> cm/s, efflux ratio = 28), suggesting that this compound is unlikely to have good oral bioavailability or <i>F</i><sub>abs</sub> and would, therefore, be unsuitable for further development. It should be noted that the anticipated poor <i>F</i><sub>abs</sub> of <b>16</b> will adversely affect the accuracy of the eD2M prediction. The poor permeability observed with a lipophilic compound such as <b>16</b> (log <i>D</i><sub>7.4</sub> = 2.8) emphasizes the impact that ionization and hydrogen bonding groups (in particular donating groups) can have on permeability. Previously reported SAR studies have established the importance of the 4-amino and 3-carboxamide motifs within this scaffold, culminating in the hypothesis that an internal hydrogen bond is formed between these motifs to organize the molecule into a bioactive conformation.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> As a consequence, all attempts to reduce hydrogen bond donor count within this scaffold have been unsuccessful and it was, therefore, considered improbable that a permeable, basic compound could be delivered without increasing lipophilicity to an unacceptable level. Accordingly, it was appreciated that an inherently more permeable series of selective ATM inhibitors would be required to allow the continuation of our strategy to increase both primary potency and pharmacokinetic half-life through the introduction of basic substituents.</div><figure id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of basic quinoline carboxamide <b>16</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Numerous examples of chemical scaffold hopping exist in which a cyclic motif within a molecule is replaced with a “pseudo” ring system (constrained by an intramolecular hydrogen bond), leading to compounds with similar conformations and biological activities.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The presence of a “pseudo” cyclic system within the quinoline carboxamide scaffold prompted the consideration of suitable cyclic systems which could replace this “pseudo” ring and retain the ability to correctly position any appended substituents. Such a strategy, if successful, was anticipated to maintain ATM potency and selectivity while reducing the number of hydrogen bond donors and increasing permeability. A number of possible tricyclic systems with the potential to fulfill the desired criteria were conceived, but the imidazo[5,4-<i>c</i>]quinolin-2-one scaffold was prioritized based on in-house data on novel, proprietry AstraZeneca compounds that was generated during routine cross project selectivity screening. This data highlighted the potential for compounds based on this scaffold to display potent activity against a range of PIKK family members. It should be noted that a similar scaffold is also present in a dual PI3K/mTOR inhibitor, NVP-BEZ235, which has been reported as undergoing clinical evaluation; NVP-BEZ235 is reported to have activity against ATM.<a onclick="showRef(event, 'ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref48 ref49 ref50">(48−50)</a> Although this activity for NVP-BEZ235 was not appreciated at the time of the work described, it further supports the proprietry AstrsaZeneca data supporting the potential of imidazo[5,4-<i>c</i>]quinolin-2-one containing compounds to deliver potent ATM inhibitors while also further highlighting the challenge to achieve PIKK family selectivity with such a scaffold. A comparison of <b>38</b> with <b>36</b> reveals that ATM potency is broadly maintained following the scaffold hop, confirming that both cores can correctly position substituents in a bioactive conformation, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. However, selectivity against closely related kinases appeared reduced with <b>38</b> being more potent against ATR than against ATM. Permeability is increased and efflux decreased for <b>38</b> when compared to <b>36</b> despite the compounds possessing similar levels of lipophilicity, supporting the importance of restricting hydrogen bond donors when optimizing permeability. Compound <b>38</b> retained good stability in hepatocyte incubations although aqueous solubility was reduced. Further investigation of the imidazo[5,4-<i>c</i>]quinolin-2-one demonstrated that the removal of a methyl group to deliver <b>37</b> was broadly tolerated, although the addition of a hydrogen bond donor may be expected to reduce permeability. Replacing the methyl with a larger substituent, <b>39</b>, resulted in the loss of activity against both ATM and ATR, suggesting that there is little opportunity to increase primary potency or selectivity in this region of the molecule.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structures and Profiles of <b>36</b>–<b>39</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0018.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>36</b></th><th class="colsep0 rowsep0" align="center"><b>38</b></th><th class="colsep0 rowsep0" align="center"><b>37</b></th><th class="colsep0 rowsep0" align="center"><b>39</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATM cell IC<sub>50</sub></td><td class="colsep0 rowsep0" align="center">0.95</td><td class="colsep0 rowsep0" align="center">0.36</td><td class="colsep0 rowsep0" align="center">1.6</td><td class="colsep0 rowsep0" align="center">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATR cell IC<sub>50</sub></td><td class="colsep0 rowsep0" align="center">3.1</td><td class="colsep0 rowsep0" align="center">0.087</td><td class="colsep0 rowsep0" align="center">0.051</td><td class="colsep0 rowsep0" align="center">>27.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>D</i><sub>7.4</sub></td><td class="colsep0 rowsep0" align="center">1.9</td><td class="colsep0 rowsep0" align="center">2.2</td><td class="colsep0 rowsep0" align="center">2.4</td><td class="colsep0 rowsep0" align="center">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">aqueous solubility</td><td class="colsep0 rowsep0" align="center">>610</td><td class="colsep0 rowsep0" align="center">17</td><td class="colsep0 rowsep0" align="center">12</td><td class="colsep0 rowsep0" align="center">41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human/rat Heps</td><td class="colsep0 rowsep0" align="center"><4/8.5</td><td class="colsep0 rowsep0" align="center"><4.9/9.4</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG IC<sub>50</sub></td><td class="colsep0 rowsep0" align="center">2.1</td><td class="colsep0 rowsep0" align="center">11</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDCK <i>P</i><sub>app</sub> A–B/efflux ratio<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">4.8/10</td><td class="colsep0 rowsep0" align="center">30/1.5</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco2 <i>P</i><sub>app</sub> A–B/efflux ratio<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">15/4.5</td><td class="colsep0 rowsep0" align="center">60/0.6</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Data reported as in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last"><i>P</i><sub>app</sub> A–B data are expressed in 10<sup>–6</sup> cm/s, and the efflux ratio is expressed as <i>P</i><sub>app</sub> B–A/<i>P</i><sub>app</sub> A–B.</p></div></div></div><div class="NLM_p">To better understand how these compounds bind to ATM, an in silico model of the protein was built using the MOE/2014 software (Chemical Computing Group) and the structure of related protein kinase mTOR as a template (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JSX">4JSX</a>). Alignment was performed based on sequence similarity and conserved features of protein kinases. Ten candidate homology models of ATM were built, retaining the original mTOR ligand to prevent collapse of the binding site and the best model in terms of protein structure quality criteria was selected and further refined. Standard procedures as outlined in the MOE documentation were employed throughout. Example ligands were docked into the binding site using the default docking algorithm in MOE, and 20 poses were kept for each with the best pose selected manually, based on SAR knowledge. When modeled into the ATP-binding site of ATM both <b>36</b> and <b>38</b> showed highly similar binding modes in which the molecules were anchored through a hydrogen bond from the quinoline nitrogen to Cys2770 in the hinge region of the kinase, <a data-tab="pane-pcw-Figures" href="#fig3a" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3a" id="" class=" internalNav">3</a></a>. A second hydrogen bond was formed from the pyridine ring to the conserved catalytic lysine (Lys2717), while the same ring bypasses the gatekeeper residue (Leu2767) to take part in an edge–face π-interaction with Tyr2755, within the back pocket. To make these interactions, the pyridine ring is twisted ∼35° out of the plane of the quinoline ring. These predicted interactions are consistent with the observed activities. The postulated internal hydrogen bond was predicted for <b>36</b> and is again consistent with the observed SAR. The tetrahydropyran group was not predicted to make any specific interaction and was predicted to partly occupy the ribose binding pocket</div><figure id="fig3a" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0003.jpeg" id="GRAPHIC-d141e2105-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) In silico model of ATM with <b>36</b> bound into the ATP binding site. (b) In silico model of ATM with <b>38</b> bound into the ATP binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig3a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further probe the hypothesized binding modes, the methoxymethylpyridine motif, present in both <b>6</b> and <b>7</b> and known to increase selectivity for ATM over ATR in the quinoline carboxamide scaffold, was incorporated into the imidazo[5,4-<i>c</i>]quinolin-2-one scaffold to produce <b>61</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. Encouragingly, <b>61</b> retained activity against ATM while activity against ATR was dramatically reduced, thereby restoring the desired selectivity profile. Compound <b>61</b> was highly permeable and stable in human hepatocyte incubations although aqueous solubility was low. The incorporation of a fluorine in the 7-position of the imidazo[5,4-<i>c</i>]quinolin-2-one core, <b>18</b>, was found to improve solubility and reduce metabolic turnover in rat hepatocyte incubations, albeit ATM potency was slightly diminished. Chloro- and methoxy-substituents were also tolerated in this position, albeit with a 3–10-fold reduction in ATM potency (data not shown). This SAR is analogous to that observed with the quinoline carboxamide scaffold, further supporting the modeled binding modes. On the basis of the quinoline carboxamide SAR, larger substituents in this position would not be expected to have good affinity for ATM and hence no further investigation was performed. Interestingly, the impact of the fluorine on hERG affinity appears less marked in the imidazo[5,4-<i>c</i>]quinolin-2-one scaffold. Divergent SAR between the two series was observed when replacing the tetrahydropyran motif where the introduction of a previously optimized chiral amine to the imidazo[5,4-<i>c</i>]quinolin-2-one scaffold, <b>20</b>, failed to deliver the anticipated increase in potency. This observation suggests that the positioning of this substituent differs slightly between the two scaffolds, which is also consistent with the proposed binding modes. More thorough evaluation of the SAR in this region uncovered a number of small cyclic alkyl groups with improved ATM potency, good selectivity, and high levels of permeability, for example <b>12</b>–<b>15</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. The addition of a hydrogen bond donor in this region did result in a reduction in permeability, <b>15</b>, albeit the overall profile remained encouraging. Pharmacokinetic evaluation of <b>13</b> in rat revealed the compound to have good bioavailability (>100%) and moderate CL (22.5 mL/min/kg). However, as anticipated for a neutral compound, <i>V</i><sub>ss</sub> was relatively low (0.98 L/kg), leading to a modest half-life (2.7 h). The properties of <b>13</b> resulted in a large predicted clinically efficacious dose (eD2M > 10000 mg QD) and thus highlighted that although the imidazo[5,4-<i>c</i>]quinolin-2-one scaffold had the potential to deliver selective ATM inhibitors, significant optimization of both primary potency and predicted human pharmacokinetics was required.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR Exploration of Neutral Imidazo[5,4-<i>c</i>]quinolin-2-ones<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0019.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0020.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Data reported as in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div></div><div></div></div><div class="NLM_p">With an understanding of how the two series bind, we were able to use our detailed knowledge of the quinoline carboxamide SAR to inform the design of compounds <b>29</b>, <b>30</b>, and <b>24</b>, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Consistent with the quinoline carboxamide SAR, the methoxy motif could be replaced by hydroxyl (<b>29</b>) or methylsulfonyl (<b>30</b>), leading to reduced lipophilicity with only limited impact on ATM potency; however, permeability was compromised to some extent and solubility remained low. The introduction of a basic substituent (<b>24</b>) resulted in a significant increase in ATM potency and solubility, and while permeability was compromised, the profile was considered superior to that for basic quinoline carboxamide compound <b>16</b>. The concept of lipophilic ligand efficiency (LLE) has been widely reported in the literature and is routinely used within the medicinal chemistry community as a measure of compound quality.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> When comparing the LLE (ATM cell pIC<sub>50</sub>, log<i>D</i><sub>7.4</sub>) of <b>13</b> and <b>24</b>, a clear improvement was observed (LLE = 4.3 and 6.5, respectively), indicating the advantageous nature of the basic side chain. This advantage is more apparent when comparing the predicted clinically efficacious clinical dose (<b>24</b>: eD2M = 24 mg QD) and was further validation for our focus on primary potency and predicted human pharmacokinetics. The low predicted clinically efficacious dose for <b>24</b> prompted the more thorough exploration of basic substituents with a focus on improving permeability while maintaining or increasing ATM potency. Removal of the hydrogen bond donor by methylation of the nitrogen, <b>25</b>, did increase permeability although a reduction in potency was observed, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Replacing the nitrogen with oxygen, <b>31</b>, was also found to increase permeability and the impact on ATM potency was much diminished, resulting in a more attractive balance of properties. Amidic linker groups were also investigated, <b>27</b> and <b>28</b>, but no improvement in permeability was observed. The high potency of <b>28</b> implied that longer basic chains could be accommodated, and it was quickly established that a three carbon chain, linked to the pyridine through an oxygen atom (<b>32</b>), was optimal. Compound <b>32</b> was a highly potent and selective ATM inhibitor with excellent solubility, reasonable hepatic stability, and no activity against hERG. The increased basicity of <b>32</b> compared to <b>31</b> (p<i>K</i><sub>a</sub> = 9.3 and 8.5, respectively) led to a reduction in log <i>D</i><sub>7.4</sub>, and while a slight reduction in permeability was observed, the profile remained highly attractive. The dramatic improvement in ATM potency for <b>32</b> compared to neutral compound <b>13</b>, alongside the increased predicted <i>V</i><sub>ss</sub> associated with a basic group (predicted human <i>V</i><sub>ss</sub> = 2.7 L/kg), culminated in a >1000-fold reduction in predicted clinically efficacious dose (<b>32</b>: eD2M = 16 mg QD).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Structure and Profile of Compounds <b>24</b>, <b>25</b>, <b>27</b>, <b>28</b>, <b>31</b>, and <b>32</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0021.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0022.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Data reported as in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div></div><div></div></div><div class="NLM_p">The positive impact of the basic substituent on both aqueous solubility and hERG affinity prompted the re-evaluation of the 7-fluoro substituent. Removal of the fluorine, <b>42</b>, delivered a further increase in ATM potency with little effect on other properties, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. Interestingly, incorporation of the fluorine substituent on the pyridyl ring, <b>43</b>, resulted ATM potency similar to <b>32</b>, while the inclusion of two fluorine atoms, <b>33</b>, gave a minor reduction in potency. This pattern of activity was seen across a range of fluorinated and nonfluorinated matched sets (data not shown), and a possible explanation for this could involve the preferred conformation of the biaryl bond linking the pyridyl ring to the imidazo[5,4-<i>c</i>]quinolin-2-one core. The proposed binding mode contains a dihedral angle of ∼35°, allowing a π-interaction between a ring hydrogen and Tyr2755 of the protein. Quantum mechanics calculations (DFT, B3LYP, 6-31G**) of this biaryl system confirm the binding mode prediction that a nonplanar conformation is preferred and the variation in conformational strain as a function of dihedral angle is shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. When no fluorine atoms are present (e.g., <b>42</b>), the energy minimum sits at 36°, while a fluorine at the 7-position of the core (e.g., <b>32</b>) increases the dihedral of the lowest energy conformation to 41°. The energy penalty incurred for fluorinated analogues to adopt the preferred binding conformation is consistent with the subtle reduction in potency observed. This hypothesis is also consistent with the observed SAR for the introduction of a chloro- or methoxy-substituent in this region.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Structure and Profile of Compounds <b>42</b>, <b>43</b>, and <b>33</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0023.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="/" /></col><col align="char" char="." /></col><col align="char" char="/" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center" char=".">ATM cell IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">ATR cell IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i><sub>7.4</sub></th><th class="colsep0 rowsep0" align="center" char=".">aq soln</th><th class="colsep0 rowsep0" align="center" char="/">human/rat heps</th><th class="colsep0 rowsep0" align="center" char=".">hERG IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char="/"><i>P</i><sub>app</sub> A–B/efflux ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="char" char=".">0.00025</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">540</td><td class="colsep0 rowsep0" align="char" char="/">8.7/5.1</td><td class="colsep0 rowsep0" align="char" char=".">>33</td><td class="colsep0 rowsep0" align="char" char="/">7.8/3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="char" char=".">0.00076</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">>1100</td><td class="colsep0 rowsep0" align="char" char="/">15/9.3</td><td class="colsep0 rowsep0" align="char" char=".">>33</td><td class="colsep0 rowsep0" align="char" char="/">4.2/3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0026</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">>1000</td><td class="colsep0 rowsep0" align="char" char="/">14/9.0</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char="/">10/2.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Data reported as in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div></div></div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Relative energy for the conformational strain of a biaryl system as a function of dihedral with different substitution patterns, from quantum mechanics (DFT, B3LYP, 6-31G**).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Pharmacokinetic evaluation of <b>42</b> in both rat and dog revealed moderate clearance (19.5 and 27.6 mL/min/kg, respectively) but the relatively high <i>V</i><sub>ss</sub> (5.7 and 11 L/kg, respectively), driven by the basic nature of the compound (p<i>K</i><sub>a</sub> = 9.5), resulted in a half-life of approximately 5 h in both species. The permeable nature of <b>42</b> led to good bioavailability in both rat and dog (50% and 65%, respectively). PBPK modeling suggested that <b>42</b> would have a moderate to high clearance in humans (∼13 mL/min/kg) but that a high <i>V</i><sub>ss</sub> (>10 L/kg) would produce a long half-life (∼15 h). The predicted clinically efficacious dose was estimated to be 3 mg QD with a free <i>C</i><sub>max</sub> in the region of 0.001 μM. GI-Sim modeling predicted the <i>D</i><sub>abs</sub> for <b>42</b> would to be 3500 mg, thereby suggesting that compound <b>42</b> could be well suited for clinical development. However, the moderate to high predicted human clearance of <b>42</b> was considered to consitute a risk for lower than desired bioavailability in man due to high first pass metabolism, especially when you consider the errors associated with predicted values. Therefore, despite the highly promising nature of <b>42</b>, we believed there remained an opportunity for further compound optimization, and in particular we sought to investigate the potential impact of cytochrome P450 mediated oxidative demethylation of the basic center. The methylamino analogue <b>45</b>, a potential product of such oxidative metabolism, was found to retain excellent potency and selectivity for ATM, <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. As a consequence of the removal of a lipophilic methyl group, combined with the increased basicity of the compound (p<i>K</i><sub>a</sub> = 10.3), the log <i>D</i><sub>7.4</sub> is dramatically reduced, and this, in conjunction with an increase in H-bond donnor count, results in compromised permeability. The incorporation of cyclic bases, <b>46</b>–<b>48</b>, was well tolerated and moderate improvements in metabolic stability were observed. However, detailed in vitro metabolite ID studies for <b>42</b> highlighted that oxidative dealkylation of the base was not the major metabolic pathway. Similar studies for <b>45</b> suggested that the cyclic base has the potential to undergo oxidative ring opening giving rise to potentially reactive species. Surprisingly, the morpholine containing and hydroxypiperidine containing compounds, <b>50</b> and <b>51</b>, have lost much of their affinity for ATM. It is currently unclear whether this was driven by a reduction in basicity (p<i>K</i><sub>a</sub> = 6.7 and 8.4, respectively) or the inability of the protein to accommodate hydrophilic atoms in that region.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Structure and Profile of Compounds <b>45</b>–<b>48</b>, <b>51</b>, and <b>52</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0024.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0025.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Data reported as in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div></div><div></div></div><div class="NLM_p">To further enhance our understanding of the SAR, we were keen to establish whether observations in different regions were independent of each other (i.e., additive SAR). Such knowledge was anticipated to help inform future compound design. A Free-Wilson type regression model, in which specific values are attached to individual structural motifs, was built using available data for the ATM cell pIC<sub>50</sub> and found to predict well (RMSE < 0.3), suggesting that the SAR is broadly additive in nature.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The use of such models has been employed by a number of groups to efficiency explore chemical space by helping to identify the combination of substituents most likely to result in a desired profile.<a onclick="showRef(event, 'ref54 ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56 ref57">(54−57)</a> A similar strategy was adopted in which virtual compounds containing all possible combinations of tolerated substituents were prioritized for synthesis based on the likelihood of possessing high ATM potency and falling within a desired lipophilicity range (predicted log <i>D</i><sub>7.4</sub> between 1.0 and 2.5). This strategy produced a number of highly potent compounds with good selectivity and physicochemical properties, exemplified by compounds in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>, and <b>64</b> was identified as having a particularly attractive balance of properties. While the tight control of lipophilicity and hydrogen bond donor count delivered compounds with generally acceptable levels of permeability, where these controls were not rigidly applied (or the predicted properties proved less accurate) compromised permeability could be observed, for example <b>40</b> and <b>60</b>. Although aqueous solubility remained high across the range of lipophilicity examined a trend of reduced solubility with increasing lipophilicity was observed, for example <b>63</b> and <b>57</b>.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Structure and Profile of Compounds <b>35</b>–<b>42</b><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0026.gif" alt="" id="fx10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0027.gif" alt="" id="fx11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Data reported as in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div></div><div></div></div><div class="NLM_p">Following thorough examination of the substitution around the imidazo[5,4-<i>c</i>]quinolin-2-one core attention was focused on changes to this core. In particular, the introduction of an additional heteroatom to produce imidazo[4,5-<i>c</i>][1,5]naphthyridin-2-one and imidazo[4,5-<i>c</i>]cinnolin-2-one containing compounds was explored, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. Compounds based on the imidazo[4,5-<i>c</i>][1,5]naphthyridin-2-one scaffold, such as <b>70</b>, were found to broadly maintain potency against ATM but generally showed increased activity against ATR (<b>70</b>: ATM IC<sub>50</sub> = 0.0017 μM; ATR IC<sub>50</sub> = 2.0 μM) when compared to analogous compounds from the imidazo[5,4-<i>c</i>]quinolin-2-one scaffold. Increased lipophilicity and hepatic turnover were also observed for this scaffold (<b>70</b>: log <i>D</i><sub>7.4</sub> = 1.6; rat hepatocyte CL<sub>int</sub> = 9.2 μL/min/10<sup>6</sup> cells; human hepatocyte CL<sub>int</sub> = 12.8 μL/min/10<sup>6</sup> cells). Compounds based on the imidazo[4,5-<i>c</i>]cinnolin-2-one scaffold, such as <b>74</b>, showed reduced potency against ATM although selectivity over ATR was retained (<b>74</b>: ATM IC<sub>50</sub> = 0.022 μM; ATR IC<sub>50</sub> > 30 μM). A reduction in lipophilicity was observed, and compounds generally showed good hepatic stability (<b>74</b>: log <i>D</i><sub>7.4</sub> = 0.8; rat hepatocyte CL<sub>int</sub> = 2.5 μL/min/10<sup>6</sup> cells, human hepatocyte CL<sub>int</sub> < 1 μL/min/10<sup>6</sup> cells). While these data demonstrate that high quality imidazo[4,5-<i>c</i>][1,5]naphthyridin-2-one or the imidazo[4,5-<i>c</i>]cinnolin-2-one containing ATM inhibitors could be identified, based on the initial profiling, none of the compounds characterized were considered to have a more attractive balance of properties than <b>64</b>.</div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0005.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of <b>70</b> and <b>74</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Detailed profiling of <b>64</b> revealed exceptional affinity to ATM enzyme and excellent selectivity over closely related targets in a range of available enzyme and cell assays, <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>. In addition, excellent general kinome selectivity was observed with only two kinases out of a panel of 397 showing >70% inhibition when screened at 1 μM (mTOR, 93%; LRRK2, 87%; see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01896/suppl_file/jm7b01896_si_001.pdf" class="ext-link">Supporting Information</a>). Slurry experiments were used to identify the stable crystalline form for <b>64</b>, and this was shown to have high levels of solubility in biorelevant media such as phosphate buffer at pH 6.5, simulated gastric fluid (SGF), and fasted state simulated intestinal fluid (FaSSIF), <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>. Compound <b>64</b> showed good levels of unbound drug in rat, dog, and human plasma, reasonable permeability, and did not inhibit any of the five major isoforms of human cytochrome P450 at concentrations up to 30 μM. Pharmacokinetic evaluation of <b>64</b> in both rat and dog show the compound has low to moderate clearance, moderate to high <i>V</i><sub>ss</sub> and good bioavailability, <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Selectivity Profile of <b>64</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">enzyme IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">cell IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="center">0.00004<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">0.00057</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATR</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DNA-PK</td><td class="colsep0 rowsep0" align="center">0.14</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mTOR</td><td class="colsep0 rowsep0" align="center">0.20</td><td class="colsep0 rowsep0" align="center">0.61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kα</td><td class="colsep0 rowsep0" align="center">0.32</td><td class="colsep0 rowsep0" align="center">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kβ</td><td class="colsep0 rowsep0" align="center">1.8</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kγ</td><td class="colsep0 rowsep0" align="center">1.1</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="center">0.27</td><td class="colsep0 rowsep0" align="center"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> estimated following correction for tight binding based on the Morrison equation (eq 9.6 in R. A. Copeland, <i>Enzymes</i>, 2nd edition, Wiley, 2000).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></p></div></div></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Physicochemical and Preclinical Pharmacokinetic Properties of <b>64</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>64</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility (pH6.5/SGF/FaSSIF)</td><td class="colsep0 rowsep0" align="left">>5 mg/mL in all media</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">% free (rat, dog, human)</td><td class="colsep0 rowsep0" align="left">11%, 41%, 29%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDCK <i>P</i><sub>app</sub> A–B/efflux ratio</td><td class="colsep0 rowsep0" align="left">6.6 × 10<sup>–6</sup> cm·s<sup>–1</sup>/5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco2 <i>P</i><sub>app</sub> A–B/efflux ratio</td><td class="colsep0 rowsep0" align="left">5.6 × 10<sup>–6</sup> cm·s<sup>–1</sup>/8.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco2 <i>P</i><sub>app</sub> A–B @ pH 6.5</td><td class="colsep0 rowsep0" align="left">19 × 10<sup>–6</sup> cm·s<sup>–1</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hepatocyte CL<sub>int</sub> (rat, dog, human)</td><td class="colsep0 rowsep0" align="left">3.3, 3.3, 5.7, μL/min/10<sup>6</sup> cells</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat PK (CL, <i>V</i><sub>ss</sub>, <i>T</i><sub>1/2</sub>, <i>F</i>)</td><td class="colsep0 rowsep0" align="left">15.5 mL/min/kg, 4.3 L/kg, 4.4 h, 57%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog PK (CL, <i>V</i><sub><b>ss</b></sub>, <i>T</i><sub>1/2</sub>, <i>F</i>)</td><td class="colsep0 rowsep0" align="left">33.3 mL/min/kg, 17.6 L/kg, 7.6 h, 54%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP inhibition (3A4, 2D6, 2C9, 1A2, 2C19)</td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> > 30 μM</td></tr></tbody></table></div></div><div class="NLM_p">The predicted binding mode of <b>64</b> highlighted the good complementarity of the molecule with the ATP binding site of ATM and predicted the same interactions with the kinase hinge (Cys2770), catalytic lysine (Lys2717), and back pocket (Tyr2755) that were present with <b>38</b>, <a data-tab="pane-pcw-Figures" href="#fig6a" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6a" id="" class=" internalNav">6</a></a>a. In addition to this, the basic amine is predicted to sit in a highly polar subpocket, beyond the back pocket, surrounded on three sides by the acidic residues Asp2725, Asp2720, and Asp2889. The interaction of the basic amine with these acidic residues is consistent with the observed increase in activity following optimization of the basic chain. In addition to understanding the likely bioactive conformation, it is often informative to understand the unbound conformation of a molecule and assess how they differ. To this end, we employed NMR techniques to determine accurately the unbound conformations of <b>64</b> and their dynamic motion in a physiologically relevant solvent.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> These studies concluded that the tetrahydropyran ring existed in a chair conformation with two distinct orientations: the major population of conformers (∼60%) has the axial 4-hydrogen directed away from the carbonyl group, the minor population (∼40%) has the same hydrogen directed toward the carbonyl, <a data-tab="pane-pcw-Figures" href="#fig6a" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6a" id="" class=" internalNav">6</a></a>b. The solution conformation also confirmed the anticipated twist between the pyridyl ring and the core and highlighted the rigid nature of the core. The conformation of the basic chain could not be determined indicating that there is free rotation in this region. The high degree of similarity between the solution conformation and the predicted bioactive conformation is likely to explain the exceptional level of affinity observed for <b>64</b> and closely related molecules.</div><figure id="fig6a" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0006.jpeg" id="GRAPHIC-d141e3184-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Predicted binding mode of <b>64</b> in ATM. (b) Solution conformation of <b>64</b> as determined by NMR (major isomer in green, minor isomer in gray).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig6a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A detailed description of the in vitro and in vivo pharmacology of compound <b>64</b> is described elsewhere,<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> but the following data is included to exemplify the potential of <b>64</b> as an oral therapeutic agent. Compound <b>64</b> shows good exposure in mice following oral administration, and its ability to potentiate the efficacy of DNA DSB inducing agents was assessed by combining with both irinotecan and olaparib.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> A combination of irinotecan dosed at 50 mg/kg IP Q7D with <b>64</b> dosed orally at 20 mg/kg QD (on days 2–4 of a weekly cycle) was tolerated and caused tumor regression in an SW620 xenograft model in immunocompromised mice, thereby showing a clear potentiation of irinotecan monotherapy efficacy in this model, <a data-tab="pane-pcw-Figures" href="#fig7a" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7a" id="" class=" internalNav">7</a></a>a. No appreciable efficacy was observed in this model when <b>64</b> was dosed as a monotherapy. The combination of <b>64</b>, dosed orally at 5 mg/kg QD (on days 1–3 of a weekly cycle), with olaparib, dosed orally at 50 mg/kg QD, was tolerated and caused tumor regression in immunocompromised mice bearing HBCx-10 patient derived tumors, thereby showing a clear potentiation of olaparib monotherapy efficacy in this model, <a data-tab="pane-pcw-Figures" href="#fig7a" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7a" id="" class=" internalNav">7</a></a>b. HBCx-10 is a ductal adenocarcinoma with mutated Brca2, mutated TP53, no HER2 overexpression, and no PR/ERα overexpression (i.e., it is triple-negative), which is sensitive to monotherapy treatment with olaparib when used as a mouse xenograft model.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Examination of the tumor growth in individual animals on this study showed that the efficacy of olaparib as a monotherapy in this model is variable, with only four out of 10 mice treated showing tumor regression, <a data-tab="pane-pcw-Figures" href="#fig7a" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7a" id="" class=" internalNav">7</a></a>c. However, when combined with <b>64</b>, the response to olaparib was considerably improved, with nine out of 10 mice treated showing tumor regression, <a data-tab="pane-pcw-Figures" href="#fig7a" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7a" id="" class=" internalNav">7</a></a>d. These in vivo studies clearly validate the ability of ATM inhibition to potentiate the efficacy of DNA DSB inducing therapies and supported the clinical evaluation of ATM inhibition as a novel mechanism to improve the efficacy of existing cancer therapies.</div><figure id="fig7a" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0007.jpeg" id="GRAPHIC-d141e3250-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) <b>64</b> potentiates the efficacy of irinotecan in an SW620 xenograft model. (b) <b>64</b> potentiates the efficacy of olaparib in a HBCx-10 patient derived tumor xenograft model. (c) Four out of 10 mice show tumor regressions in a HBCx-10 patient derived tumor xenograft model following treatment with olaparib (50 mg/kg PO QD). (d) Nine out of 10 mice show tumor regressions in a HBCx-10 patient derived tumor xenograft model following treatment with olaparib (50 mg/kg PO QD) and <b>64</b> (5 mg/kg PO QD days 1–3 weekly).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig7a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">PBPK based modeling predicted that <b>64</b> will have a moderate clearance in man (∼8 mL/min/kg) and a moderate to high <i>V</i><sub>ss</sub> (5.8 L/kg), resulting in a half-life of ∼10 h. Oral bioavailability is predicted to be good (66%), resulting in a predicted efficacious dose of 5 mg QD and a free <i>C</i><sub>max</sub> of approximately 0.002 μM. Screening in commercial panels of pharmacologically relevant targets (e.g., CEREP panel) suggested that <b>64</b> would not exhibit non-ATM mediated pharmacology at this dose (or reasonable multiples thereof). A simulated human pharmacokinetic profile of <b>64</b> is shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>. GI-Sim models predicted that <b>64</b> will have a high <i>D</i><sub>abs</sub> (>4000 mg), and, therefore, <b>64</b> can be considered to have a relatively low risk of being unable to achieve the exposure required to test the biological hypothesis of ATM inhibition in the clinic and is unlikely to require lengthy and costly formulation development. Compound <b>64</b> was selected as a clinical candidate and given the identifier AZD0156. The pharmacokinetics of <b>64</b> in rat and dog was well behaved and showed broadly dose linear exposure in the range required to enable toxicology studies in these species. The detailed preclinical in vivo toxicological evaluation of <b>64</b> supported dosing to patients, and <b>64</b> (AZD0156) is currently under investigation in phase I clinical studies in combination with either olaparib or inrinotecan (ClinicalTrials.gov identifier: NCT02588105).</div><figure id="fig8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0008.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. PBPK simulation of steady state human exposure following a 6 mg daily oral dose of <b>64</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The potential for <b>64</b> to generate pharmacologically active metabolites was assessed using in vitro metabolite identification studies. These studies determined that a major route of metabolism for <b>64</b> in humans was likely to be flavin-containing monooxygenase (FMO) mediated <i>N</i>-oxidation of the basic nitrogen moiety, leading to the generation of <b>65</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>. Discrete synthesis and profiling of <b>65</b> showed that this metabolite retained activity against ATM, albeit reduced, but remained selective over closely related targets (ATM IC<sub>50</sub> = 0.005 μM; ATR IC<sub>50</sub> = 10 μM). Although <b>65</b> was less active than the parent molecule, the potential for the metabolite to contribute to efficacy was appreciated; however, metabolic conversion of <b>64</b> to generate <b>65</b> in hepatocyte incubations was relatively low (≤10% in rat, dog, and human hepatocytes), and only low levels were detected in rat and dog in vivo studies (<10% of parent by AUC). On the basis of this data, we concluded that the contribution of this metabolite to any observed clinical efficacy was likely to be minor.</div><figure id="fig9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0009.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structure of <b>65</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While details of the clinical utility of <b>64</b> in combination with DNA DSB-inducing therapies will be reported elsewhere, early human pharmacokinetic data is now available. To assess the pharmacokinetic half-life, blood samples were collected from patients’ whole blood at predose, 0.25, 0.5, 1, 2, 3, 4, 6, 8, 12, ∼24, ∼48, and ∼72 h post a single oral dose and at predose, 0.25, 0.5, 1, 2, 3, 4, 6, 8, and 12 h post dose at steady state following twice daily oral administration. <b>64</b> was quantitated in human plasma samples using a fully validated bioanalytical method at Covance Laboratories Limited, Indianapolis, IN, US. The method employs protein precipitation and liquid chromatography followed by tandem mass spectrometric detection (LC-MS/MS).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The analytical method has a calibration range of 0.2–200 ng/mL, and a noncompartmental method was used to derive pharmacokinetic parameters for <b>64</b> from plasma concentration–time data using Phoenix WinNonlin (version 6.4; Certara, L.P., Princeton, NJ, US). The pharmacokinetic profile of <b>64</b> following twice daily oral administration, at steady state, is shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>. The terminal half-life at steady-state was between 9 and 12 h with a median <i>T</i><sub>max</sub> between 2.0 to 2.5 h post dose. The systemic exposure of <b>64</b> increased in an approximately dose proportional manner with moderate to high variability, <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>. More detailed studies will be required to better understand the factors governing the clincal exposure of <b>64</b>, but it should be noted that the terminal half-life observed is broadly in line with the prediction highlighting the utility of such predictions. It should also be noted that the drive to optimize both the predicted clinical dose and the <i>D</i><sub>abs</sub> has resulted in a molecule that has shown broadly dose proportional exposure at doses in excess of the original predicted dose, again highlighting the validity of optimization against these parameters.</div><figure id="fig10" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0010.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Mean (+ standard deviation) plasma concentration (ng/mL) of <b>64</b> versus time at steady state following twice daily oral administration at the dose levels of 15, 30, 60, and 120 mg BID in patients with solid tumors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Pharmacokinetic Parameters of <b>64</b> after Multiple Oral Administrations at Steady State in Patients with Solid Tumors<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg)</th><th class="colsep0 rowsep0" align="center" char="±"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="±">AUC<sub>0–12</sub> (ng·h/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">15 mg BID (<i>n</i> = 6)</td><td class="colsep0 rowsep0" align="char" char="±">6.67 ± 2.37</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char="±">40.35 ± 18.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">30 mg BID (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="char" char="±">17.46 ± 10.05</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char="±">105.10 ± 52.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">60 mg BID (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="char" char="±">39.63 ± 25.01</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char="±">206.30 ± 97.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">120 mg BID (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="char" char="±">58.83 ± 36.70</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char="±">330.20 ± 171.90</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup><sup>a</sup></sup><p class="last">Data are mean ± standard deviation with the exception of <i>T</i><sub>max</sub> where the data is the median</p></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">ATM plays a key role in the detection and repair of the cytotoxic DNA DSBs and as such represents an important pharmaceutical target with the potential to increase the efficacy of existing therapies whose mechanism of action involves the induction of DNA DSBs. Previous research within our laboratories had identified the first high-quality potent and selective inhibitors of ATM, such as <b>7</b>, with properties suitable for oral administration to facilitate in vivo target validation. However, concerns around the ability to develop such compounds as clinical candidates resulted in continued optimization with a particular emphasis on reducing the predicted clinical dose and identifying compounds with good developability. The potential to target the optimization of both primary potency and the predicted human pharmacokinetic profile to reduce the predicted clinical dose was appreciated and, in particular, given the relatively low hepatic turnover of <b>7</b>, we sought to increase <i>V</i><sub>ss</sub>. The ability to introduce basic functionality was explored and resulted in the identification of <b>16</b>, which showed improved ATM potency and increased predicted <i>V</i><sub>ss</sub>; however, compromised permeability precluded the further development of this compound. An understanding of the structure–property relationships for this series revealed a low likelihood of achieving a permeable compound with increased <i>V</i><sub>ss</sub> (i.e., basic compound), and a scaffold hopping strategy was adopted. Combining knowledge of the predicted binding modes with internal data suggested that the imidazo[5,4-<i>c</i>]quinolin-2-one scaffold may provide a suitable alternative, albeit with reduced selectivity. Optimization of this scaffold resulted in the discovery of permeable compounds with exceptional potency and selectivity and possessing good physicochemical properties. Of these compounds, <b>64</b> (AZD0156) was considered to have a particularly attractive balance of properties and showed good pharmacokinetics in preclinical studies. <b>64</b> is predicted to have a low clinically efficacious dose and is considered unlikely to require detailed formulation work to achieve relevant clinical exposures. In addition, <b>64</b> has demonstrated the ability to potentiate the efficacy of DNA DSB inducing agents in disease relevant mouse xenograft models. The early human pharmacokinetic data suggests that the predicted phamacokinetic half-life is broadly in line with the observed value, thus higlighting the utility of driving optimization based on such parameters. A more detailed understanding of the factors influencing the clincal exposure observed with <b>64</b> will no doubt emerge with time, but current data supports the continued clincal exploration of <b>64</b>, a first in class, potent, and selective ATM inhibitor, as a potential cancer therapy.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46155" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46155" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Methods</h3><div class="NLM_p">All experiments were carried out under an inert atmosphere and at ambient temperature unless otherwise stated. Microwave reactions were performed using one of the following reactors: Biotage initiator, Personal Chemistry Emrys optimizer, Personal Chemistry Smithcreator, or CEM Explorer. Workup procedures were carried out using traditional phase separating techniques or by using strong cation exchange (SCX) chromatography using Isolute SPE flash SCX-2 column (International Sorbent Technology Limited, Mid Glamorgan, U.K.). When necessary, organic solvents were dried over anhydrous MgSO<sub>4</sub> or Na<sub>2</sub>SO<sub>4</sub>. Flash chromatography purifications were performed on an automated Armen Glider Flash:Spot II Ultimate (Armen Instrument, Saint-Ave, France) or automated Presearch combiflash companions using prepacked Merck normal phase Si60 silica cartridges (granulometry: 15–40 or 40–63 μm) obtained from Merck, Darmstad, Germany, siliclyle silica cartridges or graceresolv silica cartridges. Preparative reverse phase HPLC was performed on a Waters instrument (600/2700 or 2525) fitted with a ZMD or ZQ ESCi mass spectrometers and a Waters X-Terra or a Waters X-Bridge or a Waters SunFire reverse-phase column (C-18, 5 μm silica, 19 mm or 50 mm diameter, 100 mm length, flow rate of 40 mL/min) using decreasingly polar mixtures of water (containing 1% ammonia) and acetonitrile or decreasingly polar mixtures of water (containing 0.1% formic acid) and acetonitrile as eluents. Intermediates were not necessarily purified, but their structures and purity were assessed by TLC, NMR, HPLC, and mass spectral techniques and are consistent with the proposed structures. The purity of compounds for biological testing were assessed by NMR, HPLC, and mass spectral techniques and are consistent with the proposed structures; purity was ≥95%. Electrospray mass spectral data were obtained using a Waters ZMD or Waters ZQ LC/mass spectrometer acquiring both positive and negative ion data, and generally, only ions relating to the parent structure are reported; proton NMR chemical shift values were measured on the delta scale using either a Bruker DPX300 spectrometer operating at a field strength of 300 MHz, a Bruker DRX400 operating at 400 MHz, a Bruker DRX500 operating at 500 MHz, or a Bruker AV700 operating at 700 MHz. Unless otherwise stated, NMR spectra were obtained at 400 MHz in deuterated dimethyl sulfoxide. The following abbreviations have been used: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad; qn, quintet. Compounds were optionally isolated as the methanesulfonate salt by dissolving the isolated base in DCM and treating with 1 M methanesufonic acid in DCM (1.1 equiv) and stirring at ambient temperature. The solvent was removed in vacuo and if required the residue triturated with diethyl ether to afford the desired salt. Where the synthesis of an intermediate or reagent is not described then it has either already been described in the literature,<a onclick="showRef(event, 'ref30 ref61'); return false;" href="javascript:void(0);" class="ref ref30 ref61">(30,61)</a> or is available from commercial sources.</div><div class="NLM_p">The following abbreviations may be used: Abbreviations: THF = tetrahydrofuran; DIPEA = diisopropylethylamine; DMF = <i>N</i>,<i>N</i>-dimethylformamide; DMSO = dimethyl sulfoxide; DMA = <i>N</i>,<i>N</i>-dimethylacetamide; DME = 1,2-dimethoxyethane; DCM = dichloromethane; MeOH = methanol;</div><div class="NLM_p last">The preparation of <b>64</b> from 8-bromo-3-methyl-1-(oxan-4-yl)imidazo[5,4-<i>c</i>]quinolin-2-one is described below.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 8-(6-Fluoropyridin-3-yl)-3-methyl-1-(oxan-4-yl)imidazo[5,4-<i>c</i>]quinolin-2-one (<b>62</b>)</h3><div class="NLM_p last">Monopalladium(IV) disodium tetrachloride (0.02 equiv) was added to 8-bromo-3-methyl-1-(oxan-4-yl)imidazo[5,4-<i>c</i>]quinolin-2-one (1 equiv), (6-fluoropyridin-3-yl)boronic acid (25.7 g, 182.21 mmol), K<sub>2</sub>CO<sub>3</sub> (3 equiv), and 3-(di-<i>tert</i>-butylphosphino)propane-1-sulfonic acid (0.01 equiv) in 1,4-dioxane and water at ambient temperature under air. The resulting mixture was stirred at 80 °C for 16 h. The reaction mixture was diluted with water and the precipitate collected by filtration, washed with water, and dried under vacuum. The resulting solid was dissolved with DCM and the mixture filtered through Celite to remove palladium residues. The solvent was removed under reduced pressure to afford the desired material (96%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.85–2.01 (2H, m), 2.86–3.02 (2H, m), 3.57–3.68 (5H, m), 4.16–4.31 (2H, m), 5.11 (1H, t), 6.98–7.19 (1H, m), 7.83 (1H, dd), 8.16 (1H, td), 8.30 (1H, dd), 8.50 (1H, s), 8.60 (1H, s), 8.77 (1H, s). <i>m</i>/<i>z</i> (ES+) [M + H]<sup>+</sup> = 379.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 8-[6-[3-(Dimethylamino)propoxy]-3-pyridyl]-3-methyl-1-tetrahydropyran-4-yl-imidazo[4,5-<i>c</i>]quinolin-2-one (<b>64</b>)</h3><div class="NLM_p last">Sodium hydride (60% dispersion in mineral oil) (4 equiv) was added portionwise to 3-(dimethylamino)propan-1-ol (2 equiv) in DMF (500 mL) at 10 °C over a period of 20 min under nitrogen. The resulting mixture was stirred at ambient temperature for 1 h and then 8-(6-fluoropyridin-3-yl)-3-methyl-1-(oxan-4-yl)imidazo[5,4-<i>c</i>]quinolin-2-one (1 equiv) was added portionwise to the reaction mixture at 10 °C over a period of 20 min under nitrogen. The resulting mixture was stirred at ambient temperature for 16 h and then diluted with water and the precipitate collected by filtration, washed with water, and dried under vacuum. The dried solid was triturated with EtOAc, filtered, and the solid purified by crystallization from MeCN to afford the desired product (82%). The material could be converted to a stable crystalline form following suspension in MeCN and stirring at ambient temperature overnight. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.81–1.99 (4H, m), 2.16 (6H, s), 2.37 (2H, t), 2.73 (2H, qd), 3.51 (3H, s), 3.59 (2H, t), 4.07 (2H, dd), 4.37 (2H, t), 5.14 (1H, ddd), 6.94–7.01 (1H, m), 7.95 (1H, dd), 8.14 (1H, d), 8.18 (1H, dd), 8.43 (1H, s), 8.66 (1H, d), 8.89 (1H, s). <i>m</i>/<i>z</i> (ES+) [M + H]<sup>+</sup> = 462.6. <sup>1</sup>H NMR (700 MHz, CDCl<sub>3,</sub> 300 K) δ 1.94 (dd, <i>J</i> = 4.40, 13.30 Hz, 2H), 1.99 (p, <i>J</i> = 6.97 Hz, 2H), 2.27 (s, 6H), 2.47 (t, <i>J</i> = 7.42 Hz, 2H), 2.96 (qd, <i>J</i> = 4.22, 12.00 Hz, 2H), 3.58–3.63 (m, 5H), 4.24 (dd, <i>J</i> = 4.77, 11.88 Hz, 2H), 4.42 (t, <i>J</i> = 6.50 Hz, 2H), 5.08 (t, <i>J</i> = 11.10 Hz, 1H), 6.89 (d, <i>J</i> = 8.55 Hz, 1H), 7.80 (d, <i>J</i> = 8.92 Hz, 1H), 7.92 (dd, <i>J</i> = 2.57, 8.71 Hz, 1H), 8.21 (d, <i>J</i> = 8.84 Hz, 1H), 8.39 (s, 1H), 8.51 (d, <i>J</i> = 2.56 Hz, 1H), 8.70 (s, 1H). <sup>13</sup>C NMR (176 MHz, CDCl<sub>3</sub>, 300 K) δ 27.59, 30.41, 45.68, 53.48, 56.62, 64.85, 67.87, 111.56, 116.00, 118.48, 123.65, 125.87, 129.07, 129.34, 132.28, 132.50, 136.26, 137.45, 144.90, 145.45, 153.74, 164.04. HRMS (ESI<sup>+</sup>): anal. calcd for (M + H<sup>+</sup>): C<sub>26</sub>H<sub>31</sub>N<sub>5</sub>O<sub>3</sub> 462.24997, found 462.25024. The absolute purity of the sample was determined to be 99.6% w/w ± 2% by by absolute Internal Calibrant qNMR (spectra available in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01896/suppl_file/jm7b01896_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01896" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86647" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86647" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01896" class="ext-link">10.1021/acs.jmedchem.7b01896</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures for the key biological assays, the synthesis and analytical data of final compounds and key intermediates, experimental procedure and data for the NMR structural, and conformational elucidation of <b>64</b>, the purity assessment of <b>64</b>, and the kinome selectivity data for <b>64</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01896/suppl_file/jm7b01896_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Coordinates for the homology model (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01896/suppl_file/jm7b01896_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular formular strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01896/suppl_file/jm7b01896_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01896/suppl_file/jm7b01896_si_001.pdf">jm7b01896_si_001.pdf (1.0 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01896/suppl_file/jm7b01896_si_002.pdb">jm7b01896_si_002.pdb (1.54 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01896/suppl_file/jm7b01896_si_003.csv">jm7b01896_si_003.csv (2.59 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01896" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54628" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54628" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kurt G. Pike</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech
Unit, AstraZeneca, Building 310, Cambridge Science
Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9731-7500" title="Orcid link">http://orcid.org/0000-0002-9731-7500</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b2d9c7c0c69cc2dbd9d7f2d3c1c6c0d3c8d7dcd7d1d39cd1dddf"><span class="__cf_email__" data-cfemail="9ef5ebeceab0eef7f5fbdeffedeaecffe4fbf0fbfdffb0fdf1f3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bernard Barlaam</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech
Unit, AstraZeneca, Building 310, Cambridge Science
Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elaine Cadogan</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech
Unit, AstraZeneca, Building 310, Cambridge Science
Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Campbell</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Sciences, AstraZeneca, Silk Road Business Park, Macclesfield SK10 2NA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yingxue Chen</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech Unit, AstraZeneca, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicola Colclough</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech
Unit, AstraZeneca, Building 310, Cambridge Science
Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nichola L. Davies</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech
Unit, AstraZeneca, Building 310, Cambridge Science
Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Camila de-Almeida</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech
Unit, AstraZeneca, Building 310, Cambridge Science
Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sebastien L. Degorce</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech
Unit, AstraZeneca, Building 310, Cambridge Science
Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology,
IMED Biotech Unit, AstraZeneca, Centre de
Recherches, Z. I. la Pompelle, BP 1050, 51689 Reims Cedex 2, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Myriam Didelot</span> - <span class="hlFld-Affiliation affiliation">Oncology,
IMED Biotech Unit, AstraZeneca, Centre de
Recherches, Z. I. la Pompelle, BP 1050, 51689 Reims Cedex 2, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allan Dishington</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech Unit, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Ducray</span> - <span class="hlFld-Affiliation affiliation">Oncology,
IMED Biotech Unit, AstraZeneca, Centre de
Recherches, Z. I. la Pompelle, BP 1050, 51689 Reims Cedex 2, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen T. Durant</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech
Unit, AstraZeneca, Building 310, Cambridge Science
Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lorraine A. Hassall</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech Unit, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane Holmes</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech Unit, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gareth D. Hughes</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech
Unit, AstraZeneca, Building 310, Cambridge Science
Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip A. MacFaul</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech Unit, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith R. Mulholland</span> - <span class="hlFld-Affiliation affiliation">Chemical Development, AstraZeneca, Silk Road Business Park, Macclesfield SK10 2NA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas M. McGuire</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech
Unit, AstraZeneca, Building 310, Cambridge Science
Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gilles Ouvry</span> - <span class="hlFld-Affiliation affiliation">Oncology,
IMED Biotech Unit, AstraZeneca, Centre de
Recherches, Z. I. la Pompelle, BP 1050, 51689 Reims Cedex 2, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0499-6055" title="Orcid link">http://orcid.org/0000-0003-0499-6055</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Pass</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech
Unit, AstraZeneca, Building 310, Cambridge Science
Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Graeme Robb</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech
Unit, AstraZeneca, Building 310, Cambridge Science
Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natalie Stratton</span> - <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhenhua Wang</span> - <span class="hlFld-Affiliation affiliation">Pharmaron Beijing
Co., Ltd., 6 Taihe Road BDA, Beijing 100176, P.R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joanne Wilson</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech
Unit, AstraZeneca, Building 310, Cambridge Science
Park, 319 Milton Road, Cambridge CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Baochang Zhai</span> - <span class="hlFld-Affiliation affiliation">Pharmaron Beijing
Co., Ltd., 6 Taihe Road BDA, Beijing 100176, P.R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kang Zhao</span> - <span class="hlFld-Affiliation affiliation">Pharmaron Beijing
Co., Ltd., 6 Taihe Road BDA, Beijing 100176, P.R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nidal Al-Huniti</span> - <span class="hlFld-Affiliation affiliation">Oncology, IMED Biotech Unit, AstraZeneca, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d141e3803-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24854" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24854" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge the contribution of Aurelien Peru, Franck Lach, Janet Hawkins, Rosemary Croft, Anil Patel, Jonathan Burgess, and Stuart Wells for their contribution to chemical synthesis, to Anna Cronin and Lyn Rosenbrier-Ribeiro for their assistance analyzing secondary pharmacology risks, to Ian Barrett and Caroline Truman for their input into assay design and data generation, and to Philip Jewsbury for helpful discussions regarding the manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ATM</td><td class="NLM_def"><p class="first last">ataxia telangiectasia mutated</p></td></tr><tr><td class="NLM_term">DSB</td><td class="NLM_def"><p class="first last">double-strand breaks</p></td></tr><tr><td class="NLM_term">HRR</td><td class="NLM_def"><p class="first last">homologous recombination repair</p></td></tr><tr><td class="NLM_term">NHEJ</td><td class="NLM_def"><p class="first last">nonhomologous end-joining</p></td></tr><tr><td class="NLM_term">IR</td><td class="NLM_def"><p class="first last">ionizing radiation</p></td></tr><tr><td class="NLM_term">PBPK</td><td class="NLM_def"><p class="first last">physiologically based pharmacokinetic</p></td></tr><tr><td class="NLM_term">D<sub>abs</sub></td><td class="NLM_def"><p class="first last">maximum absorbable dose</p></td></tr><tr><td class="NLM_term">eD2M</td><td class="NLM_def"><p class="first last">early dose to man prediction</p></td></tr><tr><td class="NLM_term">GSF</td><td class="NLM_def"><p class="first last">simulated gastric fluid</p></td></tr><tr><td class="NLM_term">FaSSIF</td><td class="NLM_def"><p class="first last">fasted state simulated intestinal fluid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">DMA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylacetamide</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">1,2-dimethoxyethane</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40118" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40118" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 64 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartek, J.</span></span> <span> </span><span class="NLM_article-title">The DNA damage response in human biology and disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">1071</span>– <span class="NLM_lpage">1078</span>, <span class="refDoi"> DOI: 10.1038/nature08467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1038%2Fnature08467" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=1071-1078&author=S.+P.+Jacksonauthor=J.+Bartek&title=The+DNA+damage+response+in+human+biology+and+disease&doi=10.1038%2Fnature08467"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature08467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08467%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DBartek%26aufirst%3DJ.%26atitle%3DThe%2520DNA%2520damage%2520response%2520in%2520human%2520biology%2520and%2520disease%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D1071%26epage%3D1078%26doi%3D10.1038%2Fnature08467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ciccia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elledge, S. J.</span></span> <span> </span><span class="NLM_article-title">The DNA damage response: making it safe to play with knives</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2010.09.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.molcel.2010.09.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=20965415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCjtr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=179-204&author=A.+Cicciaauthor=S.+J.+Elledge&title=The+DNA+damage+response%3A+making+it+safe+to+play+with+knives&doi=10.1016%2Fj.molcel.2010.09.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The DNA Damage Response: Making It Safe to Play with Knives</span></div><div class="casAuthors">Ciccia, Alberto; Elledge, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-204</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Damage to our genetic material is an ongoing threat to both our ability to faithfully transmit genetic information to our offspring as well as our own survival.  To respond to these threats, eukaryotes have evolved the DNA damage response (DDR).  The DDR is a complex signal transduction pathway that has the ability to sense DNA damage and transduce this information to the cell to influence cellular responses to DNA damage.  Cells possess an arsenal of enzymic tools capable of remodeling and repairing DNA; however, their activities must be tightly regulated in a temporal, spatial, and DNA lesion-appropriate fashion to optimize repair and prevent unnecessary and potentially deleterious alterations in the structure of DNA during normal cellular processes.  This review will focus on how the DDR controls DNA repair and the phenotypic consequences of defects in these crit. regulatory functions in mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofclv-VUxTXLVg90H21EOLACvtfcHk0lj2NNi7xGS8Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCjtr7P&md5=71d5ed7d3a82d9b395877510bbe4df03</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2010.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2010.09.019%26sid%3Dliteratum%253Aachs%26aulast%3DCiccia%26aufirst%3DA.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520DNA%2520damage%2520response%253A%2520making%2520it%2520safe%2520to%2520play%2520with%2520knives%26jtitle%3DMol.%2520Cell%26date%3D2010%26volume%3D40%26spage%3D179%26epage%3D204%26doi%3D10.1016%2Fj.molcel.2010.09.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoeijmakers, J. H.</span></span> <span> </span><span class="NLM_article-title">Genome maintenance mechanisms for preventing cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>411</i></span>,  <span class="NLM_fpage">366</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1038/35077232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1038%2F35077232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=11357144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVSjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=366-374&author=J.+H.+Hoeijmakers&title=Genome+maintenance+mechanisms+for+preventing+cancer&doi=10.1038%2F35077232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Genome maintenance mechanisms for preventing cancer</span></div><div class="casAuthors">Hoeijmakers, Jan H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">6835</span>),
    <span class="NLM_cas:pages">366-374</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with 67 refs.  The early notion that cancer is caused by mutations in genes crit. for the control of cell growth implied that genome stability is important for preventing oncogenesis.  During the past decade, knowledge about the mechanisms by which genes erode and the mol. machinery designed to counteract this time-dependent genetic degeneration has increased markedly.  At the same time, it has become apparent that inherited or acquired deficiencies in genome maintenance systems contribute significantly to the onset of cancer.  This review summarizes the main DNA caretaking systems and their impact on genome stability and carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCLg3z9y6ZD7Vg90H21EOLACvtfcHk0lj2NNi7xGS8Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVSjs74%253D&md5=7ef77f478c786849b0ec44a9d3c5bd28</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F35077232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35077232%26sid%3Dliteratum%253Aachs%26aulast%3DHoeijmakers%26aufirst%3DJ.%2BH.%26atitle%3DGenome%2520maintenance%2520mechanisms%2520for%2520preventing%2520cancer%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D366%26epage%3D374%26doi%3D10.1038%2F35077232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeggo, P. A.</span></span> <span> </span><span class="NLM_article-title">DNA Double-strand break repair in a cellular context</span>. <i>Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1016/j.clon.2014.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.clon.2014.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=24630811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A280%3ADC%252BC2crjvFOlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=243-249&author=A.+Shibataauthor=P.+A.+Jeggo&title=DNA+Double-strand+break+repair+in+a+cellular+context&doi=10.1016%2Fj.clon.2014.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">DNA double-strand break repair in a cellular context</span></div><div class="casAuthors">Shibata A; Jeggo P A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical oncology (Royal College of Radiologists (Great Britain))</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">243-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Substantial insight into the mechanisms responding to DNA double-strand breaks has been gained from molecular, biochemical and structural approaches.  Attention is now focusing on understanding the interplay between the pathways, how they interface through the cell cycle and the communication with other DNA transactions, such as replication and transcription.  Understanding these aspects will facilitate an assessment of how cancer cells have modified these processes to achieve unlimited proliferative capacity and adaptability, and pave the way to identify targets suitable for therapy.  Here, we briefly overview the processes responding to double-strand breaks and discuss our current understanding of their interplay in a cellular context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlKWntb1MSj8-crCu0nI_sfW6udTcc2eaT7EKPjuNovbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crjvFOlsw%253D%253D&md5=4c933f2b2ae6393845f266f2d8336ee7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.clon.2014.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clon.2014.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DShibata%26aufirst%3DA.%26aulast%3DJeggo%26aufirst%3DP.%2BA.%26atitle%3DDNA%2520Double-strand%2520break%2520repair%2520in%2520a%2520cellular%2520context%26jtitle%3DClin.%2520Oncol.%26date%3D2014%26volume%3D26%26spage%3D243%26epage%3D249%26doi%3D10.1016%2Fj.clon.2014.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Radhakrishnan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jette, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lees-Miller, S. P.</span></span> <span> </span><span class="NLM_article-title">Non-homologous end joining: emerging themes and unanswered questions</span>. <i>DNA Repair</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/j.dnarep.2014.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.dnarep.2014.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=24582502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlSks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2014&pages=2-8&author=S.+K.+Radhakrishnanauthor=N.+Jetteauthor=S.+P.+Lees-Miller&title=Non-homologous+end+joining%3A+emerging+themes+and+unanswered+questions&doi=10.1016%2Fj.dnarep.2014.01.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Non-homologous end joining: Emerging themes and unanswered questions</span></div><div class="casAuthors">Radhakrishnan, Sarvan Kumar; Jette, Nicholas; Lees-Miller, Susan P.</div><div class="citationInfo"><span class="NLM_cas:title">DNA Repair</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2-8</span>CODEN:
                <span class="NLM_cas:coden">DRNEAR</span>;
        ISSN:<span class="NLM_cas:issn">1568-7864</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Non-homologous end joining (NHEJ) is the major pathway for the repair of ionizing radiation induced DNA double strand breaks in human cells.  Here, we discuss current insights into the mechanism of NHEJ and the interplay between NHEJ and other pathways for repair of IR-induced DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquSMYUuuBAkrVg90H21EOLACvtfcHk0li429PjvRlNBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlSks74%253D&md5=bde81e38cc6cda0d04bc8c66473be237</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.dnarep.2014.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dnarep.2014.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DRadhakrishnan%26aufirst%3DS.%2BK.%26aulast%3DJette%26aufirst%3DN.%26aulast%3DLees-Miller%26aufirst%3DS.%2BP.%26atitle%3DNon-homologous%2520end%2520joining%253A%2520emerging%2520themes%2520and%2520unanswered%2520questions%26jtitle%3DDNA%2520Repair%26date%3D2014%26volume%3D17%26spage%3D2%26epage%3D8%26doi%3D10.1016%2Fj.dnarep.2014.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, M. J.</span></span> <span> </span><span class="NLM_article-title">Targeting the DNA damage response</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2015.10.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.molcel.2015.10.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2015&pages=547-560&author=M.+J.+O%E2%80%99Connor&title=Targeting+the+DNA+damage+response&doi=10.1016%2Fj.molcel.2015.10.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2015.10.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2015.10.040%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BJ.%26atitle%3DTargeting%2520the%2520DNA%2520damage%2520response%26jtitle%3DMol.%2520Cell%26date%3D2015%26volume%3D60%26spage%3D547%26epage%3D560%26doi%3D10.1016%2Fj.molcel.2015.10.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiloh, Y.</span></span> <span> </span><span class="NLM_article-title">Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart</span>. <i>Annu. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1146/annurev.genet.31.1.635</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1146%2Fannurev.genet.31.1.635" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1997&pages=635-662&author=Y.+Shiloh&title=Ataxia-telangiectasia+and+the+Nijmegen+breakage+syndrome%3A+related+disorders+but+genes+apart&doi=10.1146%2Fannurev.genet.31.1.635"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1146%2Fannurev.genet.31.1.635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.genet.31.1.635%26sid%3Dliteratum%253Aachs%26aulast%3DShiloh%26aufirst%3DY.%26atitle%3DAtaxia-telangiectasia%2520and%2520the%2520Nijmegen%2520breakage%2520syndrome%253A%2520related%2520disorders%2520but%2520genes%2520apart%26jtitle%3DAnnu.%2520Rev.%2520Genet.%26date%3D1997%26volume%3D31%26spage%3D635%26epage%3D662%26doi%3D10.1146%2Fannurev.genet.31.1.635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fruman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span> <span> </span><span class="NLM_article-title">Phosphoinositide kinases</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">507</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.67.1.481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1146%2Fannurev.biochem.67.1.481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=9759495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFOmsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1998&pages=481-507&author=D.+A.+Frumanauthor=R.+E.+Meyersauthor=L.+C.+Cantley&title=Phosphoinositide+kinases&doi=10.1146%2Fannurev.biochem.67.1.481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphoinositide kinases</span></div><div class="casAuthors">Fruman, David A.; Meyers, Rachel E.; Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">481-507</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 153 refs.  Several phosphorylated derivs. of phosphatidylinositol, collectively termed phosphoinositides, have been identified in eukaryotic cells from yeast to mammals.  Phosphoinositides are involved in the regulation of diverse cellular processes, including proliferation, survival, cytoskeletal organization, vesicle trafficking, glucose transport, and platelet function.  The enzymes that phosphorylate phosphatidylinositol and its derivs. are termed phosphoinositide kinases.  Recent advances have challenged previous hypotheses about the substrate selectivity of different phosphoinositide kinase families.  Here we re-examine the pathways of phosphoinositide synthesis and the enzymes involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMU_JFi14u3bVg90H21EOLACvtfcHk0lhzLgj4oo7qOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFOmsb4%253D&md5=0b2fece266a4fc3f1b2a38b1693665c2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.67.1.481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.67.1.481%26sid%3Dliteratum%253Aachs%26aulast%3DFruman%26aufirst%3DD.%2BA.%26aulast%3DMeyers%26aufirst%3DR.%2BE.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DPhosphoinositide%2520kinases%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1998%26volume%3D67%26spage%3D481%26epage%3D507%26doi%3D10.1146%2Fannurev.biochem.67.1.481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiloh, Y.</span></span> <span> </span><span class="NLM_article-title">ATM and related protein kinases: safeguarding genome integrity</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1038/nrc1011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1038%2Fnrc1011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=12612651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFGhtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=155-168&author=Y.+Shiloh&title=ATM+and+related+protein+kinases%3A+safeguarding+genome+integrity&doi=10.1038%2Fnrc1011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">ATM and related protein kinases: safeguarding genome integrity</span></div><div class="casAuthors">Shiloh, Yosef</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">155-168</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Maintenance of genome stability is essential for avoiding the passage to neoplasia.  The DNA-damage response - a cornerstone of genome stability - occurs by a swift transduction of the DNA-damage signal to many cellular pathways.  A prime example is the cellular response to DNA double-strand breaks, which activate the ATM protein kinase that, in turn, modulates numerous signaling pathways.  ATM mutations lead to the cancer-predisposing genetic disorder ataxia-telangiectasia (A-T).  Understanding ATM's mode of action provides new insights into the assocn. between defective responses to DNA damage and cancer, and brings us closer to resolving the issue of cancer predisposition in some A-T carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6rldvrvSuQLVg90H21EOLACvtfcHk0lhzLgj4oo7qOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFGhtr4%253D&md5=2d84325b04979dad3e33155fefa421e6</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrc1011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1011%26sid%3Dliteratum%253Aachs%26aulast%3DShiloh%26aufirst%3DY.%26atitle%3DATM%2520and%2520related%2520protein%2520kinases%253A%2520safeguarding%2520genome%2520integrity%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D155%26epage%3D168%26doi%3D10.1038%2Fnrc1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ditch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paull, T. T.</span></span> <span> </span><span class="NLM_article-title">The ATM protein kinase and cellular redox signaling: beyond the DNA damage response</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2011.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.tibs.2011.10.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=15-22&issue=1&author=S.+Ditchauthor=T.+T.+Paull&title=The+ATM+protein+kinase+and+cellular+redox+signaling%3A+beyond+the+DNA+damage+response&doi=10.1016%2Fj.tibs.2011.10.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2011.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2011.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DDitch%26aufirst%3DS.%26aulast%3DPaull%26aufirst%3DT.%2BT.%26atitle%3DThe%2520ATM%2520protein%2520kinase%2520and%2520cellular%2520redox%2520signaling%253A%2520beyond%2520the%2520DNA%2520damage%2520response%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2012%26volume%3D37%26issue%3D1%26spage%3D15%26epage%3D22%26doi%3D10.1016%2Fj.tibs.2011.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korabecny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nepovimova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodny, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moravcova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanzlikova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span> <span> </span><span class="NLM_article-title">The development of ataxia telangiectasia mutated kinase inhibitors</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">811</span>, <span class="refDoi"> DOI: 10.2174/1389557514666140820123656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.2174%2F1389557514666140820123656" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=805-811&author=M.+Andrsauthor=J.+Korabecnyauthor=E.+Nepovimovaauthor=D.+Junauthor=Z.+Hodnyauthor=S.+Moravcovaauthor=H.+Hanzlikovaauthor=K.+Kuca&title=The+development+of+ataxia+telangiectasia+mutated+kinase+inhibitors&doi=10.2174%2F1389557514666140820123656"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F1389557514666140820123656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557514666140820123656%26sid%3Dliteratum%253Aachs%26aulast%3DAndrs%26aufirst%3DM.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DHodny%26aufirst%3DZ.%26aulast%3DMoravcova%26aufirst%3DS.%26aulast%3DHanzlikova%26aufirst%3DH.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DThe%2520development%2520of%2520ataxia%2520telangiectasia%2520mutated%2520kinase%2520inhibitors%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2014%26volume%3D14%26spage%3D805%26epage%3D811%26doi%3D10.2174%2F1389557514666140820123656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paull, T. T.</span></span> <span> </span><span class="NLM_article-title">ATM Activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>308</i></span> (<span class="NLM_issue">5721</span>),  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">554</span>, <span class="refDoi"> DOI: 10.1126/science.1108297</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1126%2Fscience.1108297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=15790808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlOjt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2005&pages=551-554&issue=5721&author=J.+H.+Leeauthor=T.+T.+Paull&title=ATM+Activation+by+DNA+double-strand+breaks+through+the+Mre11-Rad50-Nbs1+complex&doi=10.1126%2Fscience.1108297"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">ATM Activation by DNA Double-Strand Breaks Through the Mre11-Rad50-Nbs1 Complex</span></div><div class="casAuthors">Lee, Ji-Hoon; Paull, Tanya T.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">5721</span>),
    <span class="NLM_cas:pages">551-554</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The ataxia-telangiectasia mutated (ATM) kinase signals the presence of DNA double-strand breaks in mammalian cells by phosphorylating proteins that initiate cell-cycle arrest, apoptosis, and DNA repair.  We show that the Mre11-Rad50-Nbs1 (MRN) complex acts as a double-strand break sensor for ATM and recruits ATM to broken DNA mols.  Inactive ATM dimers were activated in vitro with DNA in the presence of MRN, leading to phosphorylation of the downstream cellular targets p53 and Chk2.  ATM autophosphorylation was not required for monomerization of ATM by MRN.  The unwinding of DNA ends by MRN was essential for ATM stimulation, which is consistent with the central role of single-stranded DNA as an evolutionarily conserved signal for DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSkz54bE4FN7Vg90H21EOLACvtfcHk0lh_9TeUYLo7Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlOjt7k%253D&md5=5b62f8c0fbcf0605d7c34257c383528a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.1108297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1108297%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DPaull%26aufirst%3DT.%2BT.%26atitle%3DATM%2520Activation%2520by%2520DNA%2520double-strand%2520breaks%2520through%2520the%2520Mre11-Rad50-Nbs1%2520complex%26jtitle%3DScience%26date%3D2005%26volume%3D308%26issue%3D5721%26spage%3D551%26epage%3D554%26doi%3D10.1126%2Fscience.1108297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bakkenist, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastan, M. B.</span></span> <span> </span><span class="NLM_article-title">DNA Damage activates ATM through intermolecular autophosphorylation and dimer dissociation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>421</i></span>,  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1038/nature01368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1038%2Fnature01368" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2003&pages=499-506&author=C.+J.+Bakkenistauthor=M.+B.+Kastan&title=DNA+Damage+activates+ATM+through+intermolecular+autophosphorylation+and+dimer+dissociation&doi=10.1038%2Fnature01368"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature01368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01368%26sid%3Dliteratum%253Aachs%26aulast%3DBakkenist%26aufirst%3DC.%2BJ.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26atitle%3DDNA%2520Damage%2520activates%2520ATM%2520through%2520intermolecular%2520autophosphorylation%2520and%2520dimer%2520dissociation%26jtitle%3DNature%26date%3D2003%26volume%3D421%26spage%3D499%26epage%3D506%26doi%3D10.1038%2Fnature01368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurimasa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D. J.</span></span> <span> </span><span class="NLM_article-title">ATM Phosphorylates histone H2AX in response to DNA double-strand breaks</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span> (<span class="NLM_issue">45</span>),  <span class="NLM_fpage">42462</span>– <span class="NLM_lpage">42467</span>, <span class="refDoi"> DOI: 10.1074/jbc.C100466200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1074%2Fjbc.C100466200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=11571274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVGmsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=42462-42467&issue=45&author=S.+Burmaauthor=B.+P.+Chenauthor=M.+Murphyauthor=A.+Kurimasaauthor=D.+J.+Chen&title=ATM+Phosphorylates+histone+H2AX+in+response+to+DNA+double-strand+breaks&doi=10.1074%2Fjbc.C100466200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">ATM phosphorylates histone H2AX in response to DNA double-strand breaks</span></div><div class="casAuthors">Burma, Sandeep; Chen, Benjamin P.; Murphy, Michael; Kurimasa, Akihiro; Chen, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">42462-42467</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A very early step in the response of mammalian cells to DNA double-strand breaks is the phosphorylation of histone H2AX at serine 139 at the sites of DNA damage.  Although the phosphatidylinositol 3-kinases, DNA-PK (DNA-dependent protein kinase), ATM (ataxia telangiectasia mutated), and ATR (ATM and Rad3-related), have all been implicated in H2AX phosphorylation, the specific kinase involved has not yet been identified.  To definitively identify the specific kinase(s) that phosphorylates H2AX in vivo, we have utilized DNA-PKcs-/- and Atm-/- cell lines and mouse embryonic fibroblasts.  We find that H2AX phosphorylation and nuclear focus formation are normal in DNA-PKcs-/- cells and severely compromised in Atm-/- cells.  We also find that ATM can phosphorylate H2AX in vitro and that ectopic expression of ATM in Atm-/- fibroblasts restores H2AX phosphorylation in vivo.  The minimal H2AX phosphorylation in Atm-/- fibroblasts can be abolished by low concns. of wortmannin suggesting that DNA-PK, rather than ATR, is responsible for low levels of H2AX phosphorylation in the absence of ATM.  Our results clearly establish ATM as the major kinase involved in the phosphorylation of H2AX and suggest that ATM is one of the earliest kinases to be activated in the cellular response to double-strand breaks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoILtTZr6r8mbVg90H21EOLACvtfcHk0lh_9TeUYLo7Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVGmsb4%253D&md5=9264731343a6ae15ddd675ac43edefa3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C100466200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C100466200%26sid%3Dliteratum%253Aachs%26aulast%3DBurma%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DB.%2BP.%26aulast%3DMurphy%26aufirst%3DM.%26aulast%3DKurimasa%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DD.%2BJ.%26atitle%3DATM%2520Phosphorylates%2520histone%2520H2AX%2520in%2520response%2520to%2520DNA%2520double-strand%2520breaks%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D45%26spage%3D42462%26epage%3D42467%26doi%3D10.1074%2Fjbc.C100466200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scully, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, A.</span></span> <span> </span><span class="NLM_article-title">Double strand break repair functions of histone H2AX</span>. <i>Mutat. Res., Fundam. Mol. Mech. Mutagen.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>750</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1016/j.mrfmmm.2013.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.mrfmmm.2013.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=23916969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlKrtb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=750&publication_year=2013&pages=5-14&issue=1%E2%80%932&author=R.+Scullyauthor=A.+Xie&title=Double+strand+break+repair+functions+of+histone+H2AX&doi=10.1016%2Fj.mrfmmm.2013.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Double strand break repair functions of histone H2AX</span></div><div class="casAuthors">Scully, Ralph; Xie, Anyong</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">750</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">5-14</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Chromosomal double strand breaks provoke an extensive reaction in neighboring chromatin, characterized by phosphorylation of histone H2AX on serine 139 of its C-terminal tail (to form "γH2AX").  The γH2AX response contributes to the repair of double strand breaks encountered in a variety of different contexts, including those induced by ionizing radiation, physiol. programmed breaks that characterize normal immune cell development and the pathol. exposure of DNA ends triggered by telomere dysfunction.  γH2AX also participates in the evolutionarily conserved process of sister chromatid recombination, a homologous recombination pathway involved in the suppression of genomic instability during DNA replication and directly implicated in tumor suppression.  At a biochem. level, the γH2AX response provides a compelling example of how the "histone code" is adapted to the regulation of double strand break repair.  Here, we review progress in research aimed at understanding how γH2AX contributes to double strand break repair in mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe08jJUUxRfLVg90H21EOLACvtfcHk0li_YTugzIeliQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlKrtb3O&md5=48675a7db433aaf7b93efe7c119548ba</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.mrfmmm.2013.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrfmmm.2013.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DScully%26aufirst%3DR.%26aulast%3DXie%26aufirst%3DA.%26atitle%3DDouble%2520strand%2520break%2520repair%2520functions%2520of%2520histone%2520H2AX%26jtitle%3DMutat.%2520Res.%252C%2520Fundam.%2520Mol.%2520Mech.%2520Mutagen.%26date%3D2013%26volume%3D750%26issue%3D1%25E2%2580%25932%26spage%3D5%26epage%3D14%26doi%3D10.1016%2Fj.mrfmmm.2013.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyal, l.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taya, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smorodinsky, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prives, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiss, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiloh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziv, Y.</span></span> <span> </span><span class="NLM_article-title">Enhanced phosporylation of p53 by ATM in response to DNA damage</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">5383</span>),  <span class="NLM_fpage">1674</span>– <span class="NLM_lpage">1677</span>, <span class="refDoi"> DOI: 10.1126/science.281.5383.1674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1126%2Fscience.281.5383.1674" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=1674-1677&issue=5383&author=S.+Baninauthor=l.+Moyalauthor=S.-Y.+Shiehauthor=Y.+Tayaauthor=C.+W.+Andersonauthor=L.+Chessaauthor=N.+I.+Smorodinskyauthor=C.+Privesauthor=Y.+Reissauthor=Y.+Shilohauthor=Y.+Ziv&title=Enhanced+phosporylation+of+p53+by+ATM+in+response+to+DNA+damage&doi=10.1126%2Fscience.281.5383.1674"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.281.5383.1674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.281.5383.1674%26sid%3Dliteratum%253Aachs%26aulast%3DBanin%26aufirst%3DS.%26aulast%3DMoyal%26aufirst%3Dl.%26aulast%3DShieh%26aufirst%3DS.-Y.%26aulast%3DTaya%26aufirst%3DY.%26aulast%3DAnderson%26aufirst%3DC.%2BW.%26aulast%3DChessa%26aufirst%3DL.%26aulast%3DSmorodinsky%26aufirst%3DN.%2BI.%26aulast%3DPrives%26aufirst%3DC.%26aulast%3DReiss%26aufirst%3DY.%26aulast%3DShiloh%26aufirst%3DY.%26aulast%3DZiv%26aufirst%3DY.%26atitle%3DEnhanced%2520phosporylation%2520of%2520p53%2520by%2520ATM%2520in%2520response%2520to%2520DNA%2520damage%26jtitle%3DScience%26date%3D1998%26volume%3D281%26issue%3D5383%26spage%3D1674%26epage%3D1677%26doi%3D10.1126%2Fscience.281.5383.1674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elledge, S. J.</span></span> <span> </span><span class="NLM_article-title">Linkage of ATM to cell cycle regulation by the Chk2 protein kinase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>282</i></span> (<span class="NLM_issue">5395</span>),  <span class="NLM_fpage">1893</span>– <span class="NLM_lpage">1897</span>, <span class="refDoi"> DOI: 10.1126/science.282.5395.1893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1126%2Fscience.282.5395.1893" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=1893-1897&issue=5395&author=S.+Matsuokaauthor=M.+Huangauthor=S.+J.+Elledge&title=Linkage+of+ATM+to+cell+cycle+regulation+by+the+Chk2+protein+kinase&doi=10.1126%2Fscience.282.5395.1893"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.282.5395.1893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.282.5395.1893%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuoka%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DLinkage%2520of%2520ATM%2520to%2520cell%2520cycle%2520regulation%2520by%2520the%2520Chk2%2520protein%2520kinase%26jtitle%3DScience%26date%3D1998%26volume%3D282%26issue%3D5395%26spage%3D1893%26epage%3D1897%26doi%3D10.1126%2Fscience.282.5395.1893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marine, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozano, G.</span></span> <span> </span><span class="NLM_article-title">Mdm2-Mediated ubiquitylation: p53 and beyond</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1038/cdd.2009.68</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1038%2Fcdd.2009.68" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=19498444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=93-102&issue=1&author=J.-C.+Marineauthor=G.+Lozano&title=Mdm2-Mediated+ubiquitylation%3A+p53+and+beyond&doi=10.1038%2Fcdd.2009.68"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mdm2-mediated ubiquitylation: p53 and beyond</span></div><div class="casAuthors">Marine, J.-C.; Lozano, G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-102</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The really interesting genes (RING)-finger-contg. oncoprotein, Mdm2, is a promising drug target for cancer therapy.  A key Mdm2 function is to promote ubiquitylation and proteasomal-dependent degrdn. of the tumor suppressor protein p53.  Recent reports provide novel important insights into Mdm2-mediated regulation of p53 and how the phys. and functional interactions between these two proteins are regulated.  Moreover, a p53-independent role of Mdm2 has recently been confirmed by genetic data.  These advances and their potential implications for the development of new cancer therapeutic strategies form the focus of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmHYHeLCnS3LVg90H21EOLACvtfcHk0liR9i0U3h94_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnurvE&md5=1930cf89eeaa86d3db3f7f94640c8cc8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2009.68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2009.68%26sid%3Dliteratum%253Aachs%26aulast%3DMarine%26aufirst%3DJ.-C.%26aulast%3DLozano%26aufirst%3DG.%26atitle%3DMdm2-Mediated%2520ubiquitylation%253A%2520p53%2520and%2520beyond%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2010%26volume%3D17%26issue%3D1%26spage%3D93%26epage%3D102%26doi%3D10.1038%2Fcdd.2009.68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kastan, M.</span></span> <span> </span><span class="NLM_article-title">Ataxia-telangiectasia-broad implications for a rare disorder</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>333</i></span>,  <span class="NLM_fpage">622</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1056/NEJM199509073331014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1056%2FNEJM199509073331014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=1995&pages=622-663&author=M.+Kastan&title=Ataxia-telangiectasia-broad+implications+for+a+rare+disorder&doi=10.1056%2FNEJM199509073331014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1056%2FNEJM199509073331014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199509073331014%26sid%3Dliteratum%253Aachs%26aulast%3DKastan%26aufirst%3DM.%26atitle%3DAtaxia-telangiectasia-broad%2520implications%2520for%2520a%2520rare%2520disorder%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1995%26volume%3D333%26spage%3D622%26epage%3D663%26doi%3D10.1056%2FNEJM199509073331014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moding, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirsch, D. G.</span></span> <span> </span><span class="NLM_article-title">Strategies for optimizing the response of cancer and normal tissues to radiation</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1038/nrd4003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1038%2Fnrd4003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=23812271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVaiu7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=526-542&author=E.+J.+Modingauthor=M.+B.+Kastanauthor=D.+G.+Kirsch&title=Strategies+for+optimizing+the+response+of+cancer+and+normal+tissues+to+radiation&doi=10.1038%2Fnrd4003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for optimizing the response of cancer and normal tissues to radiation</span></div><div class="casAuthors">Moding, Everett J.; Kastan, Michael B.; Kirsch, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">526-542</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Approx. 50% of all patients with cancer receive radiation therapy at some point during the course of their treatment, and the majority of these patients are treated with curative intent.  Despite recent advances in the planning of radiation treatment and the delivery of image-guided radiation therapy, acute toxicity and potential long-term side effects often limit the ability to deliver a sufficient dose of radiation to control tumors locally.  In the past two decades, a better understanding of the hallmarks of cancer and the discovery of specific signalling pathways by which cells respond to radiation have provided new opportunities to design molecularly targeted therapies to increase the therapeutic window of radiation therapy.  Here, we review efforts to develop approaches that could improve outcomes with radiation therapy by increasing the probability of tumor cure or by decreasing normal tissue toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou7EQIkMMxvrVg90H21EOLACvtfcHk0liR9i0U3h94_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVaiu7zK&md5=f7a6b5ed442870ec03086ded64a28fc5</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrd4003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4003%26sid%3Dliteratum%253Aachs%26aulast%3DModing%26aufirst%3DE.%2BJ.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26aulast%3DKirsch%26aufirst%3DD.%2BG.%26atitle%3DStrategies%2520for%2520optimizing%2520the%2520response%2520of%2520cancer%2520and%2520normal%2520tissues%2520to%2520radiation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D526%26epage%3D542%26doi%3D10.1038%2Fnrd4003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cremona, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, A.</span></span> <span> </span><span class="NLM_article-title">ATM Signaling and cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">3351</span>– <span class="NLM_lpage">3360</span>, <span class="refDoi"> DOI: 10.1038/onc.2013.275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1038%2Fonc.2013.275" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=3351-3360&issue=26&author=C.+A.+Cremonaauthor=A.+Behrens&title=ATM+Signaling+and+cancer&doi=10.1038%2Fonc.2013.275"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fonc.2013.275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2013.275%26sid%3Dliteratum%253Aachs%26aulast%3DCremona%26aufirst%3DC.%2BA.%26aulast%3DBehrens%26aufirst%3DA.%26atitle%3DATM%2520Signaling%2520and%2520cancer%26jtitle%3DOncogene%26date%3D2014%26volume%3D33%26issue%3D26%26spage%3D3351%26epage%3D3360%26doi%3D10.1038%2Fonc.2013.275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkaria, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshleman, J. S.</span></span> <span> </span><span class="NLM_article-title">ATM as a target for novel radiosensitizers</span>. <i>Semin. Radiat. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1053/srao.2001.26030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1053%2Fsrao.2001.26030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=11677656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A280%3ADC%252BD3MrntFChsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=316-327&author=J.+N.+Sarkariaauthor=J.+S.+Eshleman&title=ATM+as+a+target+for+novel+radiosensitizers&doi=10.1053%2Fsrao.2001.26030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">ATM as a target for novel radiosensitizers</span></div><div class="casAuthors">Sarkaria J N; Eshleman J S</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in radiation oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">316-27</span>
        ISSN:<span class="NLM_cas:issn">1053-4296</span>.
    </div><div class="casAbstract">DNA damage checkpoints are complex signal transduction pathways that are critical for normal cellular recovery following potentially lethal genotoxic insults.  The ataxia-telangiectasia mutated (ATM) protein kinase is a critical component in these pathways and integrates the cellular response to damage by phosphorylating key proteins involved in cell cycle regulation and DNA repair.  Lack of normal ATM function in the inherited ataxia-telangiectasia (A-T) syndrome results in a pleiotropic clinical syndrome characterized by a marked increased risk of cancer and profound hypersensitivity to ionizing radiation.  Cells derived from patients with A-T share some of these attributes with genomic instability, loss of normal cell cycle arrest pathways, defects in DNA repair and increased radiation sensitivity.  The radiosensitivity of A-T cells suggests that pharmacological inhibitors of the ATM kinase should be effective radiosensitizing agents.  In fact, caffeine inhibits ATM kinase activity at concentrations that result in an A-T-like phenotype with loss of cell cycle checkpoints and hypersensitivity to ionizing radiation.  Although the clinical use of caffeine as a radiosensitizer is limited by potentially lethal systemic toxicities, more potent methyl xanthines may selectively inhibit the ATM pathway at clinically achievable levels.  Interestingly, caffeine and other methyl xanthines preferentially radiosensitize cells that lack normal p53 function.  Because p53 is commonly inactivated in epithelial malignancies, this suggests that small molecule inhibitors of ATM might selectively sensitize the majority of tumors to the lethal effects of ionizing radiation while sparing normal tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQH5CDYZIko7sNIRw0GKUoEfW6udTcc2eai007ecskR1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MrntFChsw%253D%253D&md5=238687773f51a0bf55ae6c6dbee78cec</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1053%2Fsrao.2001.26030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fsrao.2001.26030%26sid%3Dliteratum%253Aachs%26aulast%3DSarkaria%26aufirst%3DJ.%2BN.%26aulast%3DEshleman%26aufirst%3DJ.%2BS.%26atitle%3DATM%2520as%2520a%2520target%2520for%2520novel%2520radiosensitizers%26jtitle%3DSemin.%2520Radiat.%2520Oncol.%26date%3D2001%26volume%3D11%26spage%3D316%26epage%3D327%26doi%3D10.1053%2Fsrao.2001.26030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">590</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2009.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.ctrv.2009.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=19635647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=590-596&author=Y.+Zhuauthor=J.+Huauthor=Y.+Huauthor=W.+Liu&title=Targeting+DNA+repair+pathways%3A+a+novel+approach+to+reduce+cancer+therapeutic+resistance&doi=10.1016%2Fj.ctrv.2009.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting DNA repair pathways: A novel approach to reduce cancer therapeutic resistance</span></div><div class="casAuthors">Zhu, Yongjian; Hu, Jue; Hu, Yiduo; Liu, Weiguo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">590-596</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Increased chemo-resistance and radio-resistance of cancer cells is a major obstacle in the treatment and management of malignant cancers.  An important mechanism that underlies the development of such therapeutic resistance is that cancer cells recognize DNA lesions induced by DNA-damaging agents and by ionizing radiation, and repair these lesions by activating various DNA repair pathways.  Therefore, Use of pharmacol. agents that can inhibit certain DNA repair pathways in cancer cells has the potential for enhancing the targeted cytotoxicity of anticancer treatments and reversing the assocd. therapeutic resistance assocd. with DNA repair; such agents, offering a promising opportunity to achieve better therapeutic efficacy.  Here we review the major DNA repair pathways and discuss recent advances in the development of novel inhibitors of DNA repair pathways; many of these agents are under preclin./clin. investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbMZUKq5LyO7Vg90H21EOLACvtfcHk0lhnmKKRMCtQNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt73M&md5=f5a39c6da606a9dbfd82775e70e88c34</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2009.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2009.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DTargeting%2520DNA%2520repair%2520pathways%253A%2520a%2520novel%2520approach%2520to%2520reduce%2520cancer%2520therapeutic%2520resistance%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2009%26volume%3D35%26spage%3D590%26epage%3D596%26doi%3D10.1016%2Fj.ctrv.2009.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. C.</span></span> <span> </span><span class="NLM_article-title">Targeted cancer therapies based on the inhibition of DNA strand break repair</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">7816</span>– <span class="NLM_lpage">7824</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1210879</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1038%2Fsj.onc.1210879" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=7816-7824&author=M.+J.+O%E2%80%99Connorauthor=N.+M.+Martinauthor=G.+C.+Smith&title=Targeted+cancer+therapies+based+on+the+inhibition+of+DNA+strand+break+repair&doi=10.1038%2Fsj.onc.1210879"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210879%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BJ.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26aulast%3DSmith%26aufirst%3DG.%2BC.%26atitle%3DTargeted%2520cancer%2520therapies%2520based%2520on%2520the%2520inhibition%2520of%2520DNA%2520strand%2520break%2520repair%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D7816%26epage%3D7824%26doi%3D10.1038%2Fsj.onc.1210879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hollick, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigoreau, L. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cano-Soumillac, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockcroft, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frigerio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golding, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guiard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardcastle, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hummersone, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menear, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ord, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, R. J.</span></span> <span> </span><span class="NLM_article-title">Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1958</span>– <span class="NLM_lpage">1972</span>, <span class="refDoi"> DOI: 10.1021/jm061121y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061121y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1958-1972&author=J.+J.+Hollickauthor=L.+J.+M.+Rigoreauauthor=C.+Cano-Soumillacauthor=X.+Cockcroftauthor=N.+J.+Curtinauthor=M.+Frigerioauthor=B.+T.+Goldingauthor=S.+Guiardauthor=I.+R.+Hardcastleauthor=I.+Hicksonauthor=M.+G.+Hummersoneauthor=K.+A.+Menearauthor=N.+M.+B.+Martinauthor=I.+Matthewsauthor=D.+R.+Newellauthor=R.+Ordauthor=C.+J.+Richardsonauthor=G.+C.+M.+Smithauthor=R.+J.+Griffin&title=Pyranone%2C+thiopyranone%2C+and+pyridone+inhibitors+of+phosphatidylinositol+3-kinase+related+kinases.+Structure-activity+relationships+for+DNA-dependent+protein+kinase+inhibition%2C+and+identification+of+the+first+potent+and+selective+inhibitor+of+the+ataxia+telangiectasia+mutated+kinase&doi=10.1021%2Fjm061121y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm061121y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061121y%26sid%3Dliteratum%253Aachs%26aulast%3DHollick%26aufirst%3DJ.%2BJ.%26aulast%3DRigoreau%26aufirst%3DL.%2BJ.%2BM.%26aulast%3DCano-Soumillac%26aufirst%3DC.%26aulast%3DCockcroft%26aufirst%3DX.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DFrigerio%26aufirst%3DM.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGuiard%26aufirst%3DS.%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DHummersone%26aufirst%3DM.%2BG.%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DMartin%26aufirst%3DN.%2BM.%2BB.%26aulast%3DMatthews%26aufirst%3DI.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DOrd%26aufirst%3DR.%26aulast%3DRichardson%26aufirst%3DC.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26atitle%3DPyranone%252C%2520thiopyranone%252C%2520and%2520pyridone%2520inhibitors%2520of%2520phosphatidylinositol%25203-kinase%2520related%2520kinases.%2520Structure-activity%2520relationships%2520for%2520DNA-dependent%2520protein%2520kinase%2520inhibition%252C%2520and%2520identification%2520of%2520the%2520first%2520potent%2520and%2520selective%2520inhibitor%2520of%2520the%2520ataxia%2520telangiectasia%2520mutated%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1958%26epage%3D1972%26doi%3D10.1021%2Fjm061121y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. C. M.</span>; <span class="NLM_string-name">Martin, N. M. B.</span>; <span class="NLM_string-name">Jackson, S. P.</span>; <span class="NLM_string-name">O’Connor, M. J.</span>; <span class="NLM_string-name">Lau, A. Y. K.</span>; <span class="NLM_string-name">Cockcroft, X. -L. F.</span>; <span class="NLM_string-name">Matthews, I. T. W.</span>; <span class="NLM_string-name">Menear, K. A.</span>; <span class="NLM_string-name">Rigoreau, L. J. M.</span>; <span class="NLM_string-name">Hummersone, M. G.</span>; <span class="NLM_string-name">Girffin, R. J.</span></span> <span> </span><span class="NLM_article-title">Pyranones Useful as ATM Protein Kinase Inhibitors</span>. WO patent <span class="NLM_patent">WO 2003070726</span>, Aug 28, <span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=G.+C.+M.+Smith&author=N.+M.+B.+Martin&author=S.+P.+Jackson&author=M.+J.+O%E2%80%99Connor&author=A.+Y.+K.+Lau&author=X.+-L.+F.+Cockcroft&author=I.+T.+W.+Matthews&author=K.+A.+Menear&author=L.+J.+M.+Rigoreau&author=M.+G.+Hummersone&author=R.+J.+Girffin&title=Pyranones+Useful+as+ATM+Protein+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26atitle%3DPyranones%2520Useful%2520as%2520ATM%2520Protein%2520Kinase%2520Inhibitors%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hickson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reaper, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. C. M.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">9152</span>– <span class="NLM_lpage">9159</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-2727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1158%2F0008-5472.CAN-04-2727" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=9152-9159&author=I.+Hicksonauthor=Y.+Zhaoauthor=C.+J.+Richardsonauthor=S.+J.+Greenauthor=N.+M.+B.+Martinauthor=A.+I.+Orrauthor=P.+M.+Reaperauthor=S.+P.+Jacksonauthor=N.+J.+Curtinauthor=G.+C.+M.+Smith&title=Identification+and+characterization+of+a+novel+and+specific+inhibitor+of+the+ataxia-telangiectasia+mutated+kinase+ATM&doi=10.1158%2F0008-5472.CAN-04-2727"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-2727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-2727%26sid%3Dliteratum%253Aachs%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DRichardson%26aufirst%3DC.%2BJ.%26aulast%3DGreen%26aufirst%3DS.%2BJ.%26aulast%3DMartin%26aufirst%3DN.%2BM.%2BB.%26aulast%3DOrr%26aufirst%3DA.%2BI.%26aulast%3DReaper%26aufirst%3DP.%2BM.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520novel%2520and%2520specific%2520inhibitor%2520of%2520the%2520ataxia-telangiectasia%2520mutated%2520kinase%2520ATM%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D9152%26epage%3D9159%26doi%3D10.1158%2F0008-5472.CAN-04-2727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batey, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slade, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, N. J.</span></span> <span> </span><span class="NLM_article-title">Preclinical evaluation of a novel ATM inhibitor, KU-59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">959</span>– <span class="NLM_lpage">967</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-12-0707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1158%2F1535-7163.MCT-12-0707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=23512991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVOksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=959-967&issue=6&author=M.+A.+Bateyauthor=Y.+Zhaoauthor=S.+Kyleauthor=C.+Richardsonauthor=A.+Sladeauthor=N.+M.+Martinauthor=A.+Lauauthor=D.+R.+Newellauthor=N.+J.+Curtin&title=Preclinical+evaluation+of+a+novel+ATM+inhibitor%2C+KU-59403%2C+in+vitro+and+in+vivo+in+p53+functional+and+dysfunctional+models+of+human+cancer&doi=10.1158%2F1535-7163.MCT-12-0707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Evaluation of a Novel ATM Inhibitor, KU59403, In Vitro and In Vivo in p53 Functional and Dysfunctional Models of Human Cancer</span></div><div class="casAuthors">Batey, Michael A.; Zhao, Yan; Kyle, Suzanne; Richardson, Caroline; Slade, Andrew; Martin, Niall M. B.; Lau, Alan; Newell, David R.; Curtin, Nicola J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">959-967</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Ataxia telangiectasia mutated (ATM) kinase signals DNA double-strand breaks (DSB) to cell-cycle arrest via p53 and DNA repair.  ATM-defective cells are sensitive to DSB-inducing agents, making ATM an attractive target for anticancer chemo- and radiosensitization.  KU59403 is an ATM inhibitor with the potency, selectivity, and soly. for advanced preclin. evaluation.  KU59403 was not cytotoxic to human cancer cell lines (SW620, LoVo, HCT116, and MDA-MB-231) per se but significantly increased the cytotoxicity of topoisomerase I and II poisons: camptothecin, etoposide, and doxorubicin.  Chemo- and radiosensitization by ATM inhibition was not p53-dependent.  Following administration to mice, KU59403 distributed to tissues and concns. exceeding those required for in vitro activity were maintained for at least 4 h in tumor xenografts.  KU59403 significantly enhanced the antitumor activity of topoisomerase poisons in mice bearing human colon cancer xenografts (SW620 and HCT116) at doses that were nontoxic alone and well-tolerated in combination.  Chemosensitization was both dose- and schedule-dependent.  KU59403 represents a major advance in ATM inhibitor development, being the 1st compd. to show good tissue distribution and significant chemosensitization in in vivo models of human cancer, without major toxicity.  KU59403 provides the 1st proof-of-principle preclin. data to support the future clin. development of ATM inhibitors.  Mol Cancer Ther; 12(6); 959-67. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNlMwHzEdbQrVg90H21EOLACvtfcHk0lgyCm5PTOM3Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVOksL8%253D&md5=82771364eb5cd8a3baf13e5cd48b5389</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0707%26sid%3Dliteratum%253Aachs%26aulast%3DBatey%26aufirst%3DM.%2BA.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DKyle%26aufirst%3DS.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DSlade%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26atitle%3DPreclinical%2520evaluation%2520of%2520a%2520novel%2520ATM%2520inhibitor%252C%2520KU-59403%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520in%2520p53%2520functional%2520and%2520dysfunctional%2520models%2520of%2520human%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26issue%3D6%26spage%3D959%26epage%3D967%26doi%3D10.1158%2F1535-7163.MCT-12-0707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suryadevara, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbrook, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemoff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, R. K.</span></span> <span> </span><span class="NLM_article-title">Optimization of a novel series of ataxia-telangiectasia mutated kinase inhibitors as potential radiosensitizing agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">559</span>– <span class="NLM_lpage">577</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01092</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01092" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGnsr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=559-577&author=J.+Minauthor=K.+Guoauthor=P.+K.+Suryadevaraauthor=F.+Zhuauthor=G.+Holbrookauthor=Y.+Chenauthor=C.+Feauauthor=B.+M.+Youngauthor=A.+Lemoffauthor=M.+C.+Connellyauthor=M.+B.+Kastanauthor=R.+K.+Guy&title=Optimization+of+a+novel+series+of+ataxia-telangiectasia+mutated+kinase+inhibitors+as+potential+radiosensitizing+agents&doi=10.1021%2Facs.jmedchem.5b01092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents</span></div><div class="casAuthors">Min, Jaeki; Guo, Kexiao; Suryadevara, Praveen K.; Zhu, Fangyi; Holbrook, Gloria; Chen, Yizhe; Feau, Clementine; Young, Brandon M.; Lemoff, Andrew; Connelly, Michele C.; Kastan, Michael B.; Guy, R. Kiplin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">559-577</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We previously reported a novel inhibitor of the ataxia-telangiectasia mutated (ATM) kinase, which is a target for novel radiosensitizing drugs.  While our initial lead, compd. 4, was relatively potent and nontoxic, it exhibited poor stability to oxidative metab. and relatively poor selectivity against other kinases.  The current study focused on balancing potency and selectivity with metabolic stability through structural modification to the metabolized site on the quinazoline core.  We performed extensive structure-activity and structure-property relationship studies on this quinazoline ATM kinase inhibitor in order to identify structural variants with enhanced selectivity and metabolic stability.  We show that, while the C-7-methoxy group is essential for potency, replacing the C-6-methoxy group considerably improves metabolic stability without affecting potency.  Promising analogs 20, 27g, and 27n were selected based on in vitro pharmacol. and evaluated in murine pharmacokinetic and tolerability studies.  Compd. 27g possessed significantly improve pharmacokinetics relative to that of 4.  Compd. 27g was also significantly more selective against other kinases than 4.  Therefore, 27g is a good candidate for further development as a potential radiosensitizer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl6-cCkwsTybVg90H21EOLACvtfcHk0lgyCm5PTOM3Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGnsr%252FF&md5=bc4edb4fdd0aa77689e3acc34278a836</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01092%26sid%3Dliteratum%253Aachs%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DK.%26aulast%3DSuryadevara%26aufirst%3DP.%2BK.%26aulast%3DZhu%26aufirst%3DF.%26aulast%3DHolbrook%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DFeau%26aufirst%3DC.%26aulast%3DYoung%26aufirst%3DB.%2BM.%26aulast%3DLemoff%26aufirst%3DA.%26aulast%3DConnelly%26aufirst%3DM.%2BC.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26atitle%3DOptimization%2520of%2520a%2520novel%2520series%2520of%2520ataxia-telangiectasia%2520mutated%2520kinase%2520inhibitors%2520as%2520potential%2520radiosensitizing%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D559%26epage%3D577%26doi%3D10.1021%2Facs.jmedchem.5b01092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degorce, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlaam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadogan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dishington, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducray, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassall, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lach, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouvry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomason, A. G.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel 3-quinoline carboxamides as potent, selective and orally bioavailable inhibitors of ataxia telangiectasia mutated (ATM) kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6281</span>– <span class="NLM_lpage">6292</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00519</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6281-6292&author=S.+L.+Degorceauthor=B.+Barlaamauthor=E.+Cadoganauthor=A.+Dishingtonauthor=R.+Ducrayauthor=S.+C.+Glossopauthor=L.+A.+Hassallauthor=F.+Lachauthor=A.+Lauauthor=T.+M.+McGuireauthor=T.+Nowakauthor=G.+Ouvryauthor=K.+G.+Pikeauthor=A.+G.+Thomason&title=Discovery+of+novel+3-quinoline+carboxamides+as+potent%2C+selective+and+orally+bioavailable+inhibitors+of+ataxia+telangiectasia+mutated+%28ATM%29+kinase&doi=10.1021%2Facs.jmedchem.6b00519"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00519%26sid%3Dliteratum%253Aachs%26aulast%3DDegorce%26aufirst%3DS.%2BL.%26aulast%3DBarlaam%26aufirst%3DB.%26aulast%3DCadogan%26aufirst%3DE.%26aulast%3DDishington%26aufirst%3DA.%26aulast%3DDucray%26aufirst%3DR.%26aulast%3DGlossop%26aufirst%3DS.%2BC.%26aulast%3DHassall%26aufirst%3DL.%2BA.%26aulast%3DLach%26aufirst%3DF.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DMcGuire%26aufirst%3DT.%2BM.%26aulast%3DNowak%26aufirst%3DT.%26aulast%3DOuvry%26aufirst%3DG.%26aulast%3DPike%26aufirst%3DK.%2BG.%26aulast%3DThomason%26aufirst%3DA.%2BG.%26atitle%3DDiscovery%2520of%2520novel%25203-quinoline%2520carboxamides%2520as%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520inhibitors%2520of%2520ataxia%2520telangiectasia%2520mutated%2520%2528ATM%2529%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6281%26epage%3D6292%26doi%3D10.1021%2Facs.jmedchem.6b00519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karlin, J.</span>; <span class="NLM_string-name">Allen, J.</span>; <span class="NLM_string-name">Odedra, R.</span>; <span class="NLM_string-name">Hughes, G.</span>; <span class="NLM_string-name">Farrington, P.</span>; <span class="NLM_string-name">Ducray, R.</span>; <span class="NLM_string-name">Ouvry, G.</span>; <span class="NLM_string-name">Degorce, S.</span>; <span class="NLM_string-name">Wilson, J.</span>; <span class="NLM_string-name">Smith, A.</span>; <span class="NLM_string-name">Patel, B.</span>; <span class="NLM_string-name">Thomason, A.</span>; <span class="NLM_string-name">Vincent, J.</span>; <span class="NLM_string-name">Colclough, N.</span>; <span class="NLM_string-name">Ahmad, S. F.</span>; <span class="NLM_string-name">Beckta, J. M.</span>; <span class="NLM_string-name">Tokarz, M.</span>; <span class="NLM_string-name">Mukhopadhyay, N. D.</span>; <span class="NLM_string-name">Barlaam, B.</span>; <span class="NLM_string-name">Pike, K. G.</span>; <span class="NLM_string-name">Cadogan, E.</span>; <span class="NLM_string-name">Pass, M.</span>; <span class="NLM_string-name">Valerie, K.</span>; <span class="NLM_string-name">Durant, S.</span></span>, <span> </span><span class="NLM_article-title">Blood–Brain Barrier penetrating ATM Inhibitor Radio-Sensitizes Intracranial Gliomas in Mice</span>.  <i>Abstracts of Papers, Annual Meeting of the American Association of Cancer Research, New Orleans, LA, 2006</i>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Karlin&author=J.+Allen&author=R.+Odedra&author=G.+Hughes&author=P.+Farrington&author=R.+Ducray&author=G.+Ouvry&author=S.+Degorce&author=J.+Wilson&author=A.+Smith&author=B.+Patel&author=A.+Thomason&author=J.+Vincent&author=N.+Colclough&author=S.+F.+Ahmad&author=J.+M.+Beckta&author=M.+Tokarz&author=N.+D.+Mukhopadhyay&author=B.+Barlaam&author=K.+G.+Pike&author=E.+Cadogan&author=M.+Pass&author=K.+Valerie&author=S.+Durant&title=Blood%E2%80%93Brain+Barrier+penetrating+ATM+Inhibitor+Radio-Sensitizes+Intracranial+Gliomas+in+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DKarlin%26aufirst%3DJ.%26atitle%3DBlood%25E2%2580%2593Brain%2520Barrier%2520penetrating%2520ATM%2520Inhibitor%2520Radio-Sensitizes%2520Intracranial%2520Gliomas%2520in%2520Mice%26jtitle%3DAbstracts%2520of%2520Papers%252C%2520Annual%2520Meeting%2520of%2520the%2520American%2520Association%2520of%2520Cancer%2520Research%252C%2520New%2520Orleans%252C%2520LA%252C%25202006%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. G.</span>, <span class="NLM_string-name">Barlaam, B.</span>; <span class="NLM_string-name">Colclough, N.</span>; <span class="NLM_string-name">McGuire, T. M.</span>; <span class="NLM_string-name">Cadogan, E.</span>; <span class="NLM_string-name">Pass, M.</span>; <span class="NLM_string-name">Hassall, L. A.</span>; <span class="NLM_string-name">Hawkins, J.</span>; <span class="NLM_string-name">Holmes, J.</span>; <span class="NLM_string-name">Dishington, A.</span>; <span class="NLM_string-name">Robb, G.</span>; <span class="NLM_string-name">Ducray, R.</span>; <span class="NLM_string-name">Ouvry, G.</span>; <span class="NLM_string-name">Degorce, S. L.</span>; <span class="NLM_string-name">Lau, A.</span>; <span class="NLM_string-name">MacFaul, P.</span>; <span class="NLM_string-name">Hughes, G.</span></span> <span> </span><span class="NLM_article-title">Identifying High Quality, Potent and Selective Inhibitors of ATM Kinase: Discovery of AZD0156</span>.  <i>RSC-SCI Kinase 2016, Nottingham, UK, 2016</i>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=K.+G.+Pike&author=B.+Barlaam&author=N.+Colclough&author=T.+M.+McGuire&author=E.+Cadogan&author=M.+Pass&author=L.+A.+Hassall&author=J.+Hawkins&author=J.+Holmes&author=A.+Dishington&author=G.+Robb&author=R.+Ducray&author=G.+Ouvry&author=S.+L.+Degorce&author=A.+Lau&author=P.+MacFaul&author=G.+Hughes&title=Identifying+High+Quality%2C+Potent+and+Selective+Inhibitors+of+ATM+Kinase%3A+Discovery+of+AZD0156"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DK.%2BG.%26atitle%3DIdentifying%2520High%2520Quality%252C%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520ATM%2520Kinase%253A%2520Discovery%2520of%2520AZD0156%26jtitle%3DRSC-SCI%2520Kinase%25202016%252C%2520Nottingham%252C%2520UK%252C%25202016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Redfern, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palethorpe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegl, P. K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strang, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camm, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, T. G.</span></span> <span> </span><span class="NLM_article-title">Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development</span>. <i>Cardiovasc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/S0008-6363(02)00846-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2FS0008-6363%2802%2900846-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=12667944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit12gsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2003&pages=32-45&author=W.+S.+Redfernauthor=L.+Carlssonauthor=A.+S.+Davisauthor=W.+G.+Lynchauthor=I.+MacKenzieauthor=S.+Palethorpeauthor=P.+K.+S.+Sieglauthor=I.+Strangauthor=A.+T.+Sullivanauthor=R.+Wallisauthor=A.+J.+Cammauthor=T.+G.+Hammond&title=Relationships+between+preclinical+cardiac+electrophysiology%2C+clinical+QT+interval+prolongation+and+torsade+de+pointes+for+a+broad+range+of+drugs%3A+evidence+for+a+provisional+safety+margin+in+drug+development&doi=10.1016%2FS0008-6363%2802%2900846-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development</span></div><div class="casAuthors">Redfern, W. S.; Carlsson, L.; Davis, A. S.; Lynch, W. G.; MacKenzie, I.; Palethorpe, S.; Siegl, P. K. S.; Strang, I.; Sullivan, A. T.; Wallis, R.; Camm, A. J.; Hammond, T. G.</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-45</span>CODEN:
                <span class="NLM_cas:coden">CVREAU</span>;
        ISSN:<span class="NLM_cas:issn">0008-6363</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review discussing attempts to det. the relative value of preclin. cardiac electrophysiol. data (in vitro and in vivo) for predicting risk of torsades de pointes (TdP) in clin. use.  Published data on human ether-a-go-go-related gene-encoded voltage-dependent potassium channel (hERG) (or IKr) activity, cardiac action potential duration (at 90% repolarization; APD90), and QT prolongation in dogs were compared against QT effects and reports of TdP in humans for 100 drugs.  These data were set against the free plasma concns. attained during clin. use (effective therapeutic plasma concns.; ETPCunbound).  The drugs were divided into five categories: (1) Class Ia and III antiarrhythmics; (2) withdrawn from market due to TdP; (3) measurable incidence/numerous reports of TdP in humans; (4) isolated reports of TdP in humans; (5) no reports of TdP in humans.  Data from hERG (or IKr) assays in addn. to ETPCunbound data were available for 52 drugs.  For Category 1 drugs, data for hERG/IKr IC50, APD90, QTc in animals and QTc in humans were generally close to or superimposed on the ETPCunbound values.  This relationship was uncoupled in the other categories, with more complex relationships between the data.  In Category 1 (except amiodarone), the ratios between hERG/IKr IC50 and ETPCunbound (max) ranged 0.1-31-fold.  Similar ranges were obtained for drugs in Category 2 (0.31-13-fold) and Category 3 (0.03-35-fold).  A large spread was found for Category 4 drugs (0.13-35,700-fold); this category embraced an assortment of mechanisms ranging from drugs which may well be affecting IKr currents in clin. use (e.g., sparfloxacin) to others such as nifedipine (35,700-fold) where channel block is not involved.  Finally, for the majority of Category 5 drugs there was a >30-fold sepn. between hERG/IKr activity and ETPCunbound values, with the notable exception of verapamil (1.7-fold), which is free from QT prolongation in man; this is probably explained by its multiple interactions with cardiac ion channels.  The dataset confirms the widely held belief that most drugs assocd. with TdP in humans are also assocd. with hERG K+ channel block at concns. close to or superimposed upon the free plasma concns. found in clin. use.  A 30-fold margin between Cmax and hERG IC50 may suffice for drugs currently undergoing clin. evaluation, but for future drug discovery programs, pharmaceutical companies should consider increasing this margin, particularly for drugs aimed at nondebilitating diseases.  However, interactions with multiple cardiac ion channels can either mitigate or exacerbate the prolongation of APD and QT that would ensue from block of IKr currents alone, and delay of repolarization per se is not necessarily torsadogenic.  Clearly, an integrated assessment of in vitro and in vivo data is required in order to predict the torsadogenic risk of a new candidate drug in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkpRDUH0rhyrVg90H21EOLACvtfcHk0lhfb9EJluQ_wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit12gsb8%253D&md5=a236c07febd2e05fe70e61604619bf2e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0008-6363%2802%2900846-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0008-6363%252802%252900846-5%26sid%3Dliteratum%253Aachs%26aulast%3DRedfern%26aufirst%3DW.%2BS.%26aulast%3DCarlsson%26aufirst%3DL.%26aulast%3DDavis%26aufirst%3DA.%2BS.%26aulast%3DLynch%26aufirst%3DW.%2BG.%26aulast%3DMacKenzie%26aufirst%3DI.%26aulast%3DPalethorpe%26aufirst%3DS.%26aulast%3DSiegl%26aufirst%3DP.%2BK.%2BS.%26aulast%3DStrang%26aufirst%3DI.%26aulast%3DSullivan%26aufirst%3DA.%2BT.%26aulast%3DWallis%26aufirst%3DR.%26aulast%3DCamm%26aufirst%3DA.%2BJ.%26aulast%3DHammond%26aufirst%3DT.%2BG.%26atitle%3DRelationships%2520between%2520preclinical%2520cardiac%2520electrophysiology%252C%2520clinical%2520QT%2520interval%2520prolongation%2520and%2520torsade%2520de%2520pointes%2520for%2520a%2520broad%2520range%2520of%2520drugs%253A%2520evidence%2520for%2520a%2520provisional%2520safety%2520margin%2520in%2520drug%2520development%26jtitle%3DCardiovasc.%2520Res.%26date%3D2003%26volume%3D58%26spage%3D32%26epage%3D45%26doi%3D10.1016%2FS0008-6363%2802%2900846-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leahy, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arundel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakey, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, M.</span></span> <span> </span><span class="NLM_article-title">Physiologic based pharmacokinetic modeling and QSAR</span>. <i>Bioactive Compd. Des.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADyaK2sXivFOmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&pages=147-151&author=D.+E.+Leahyauthor=P.+A.+Arundelauthor=G.+E.+Blakeyauthor=M.+Rowland&title=Physiologic+based+pharmacokinetic+modeling+and+QSAR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Physiologic based pharmacokinetic modeling and QSAR</span></div><div class="casAuthors">Leahy, D. E.; Arundel, P. A.; Blakey, G. E.; Rowland, M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioactive Compound Design</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">147-151</span>CODEN:
                <span class="NLM_cas:coden">63SXAI</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Bios Scientific Publishers</span>)
        </div><div class="casAbstract">A preliminary anal. of tissue pharmacokinetic data generated in rat for a series of 5-alkyl-5-Et barbituric acids is reported.  The anal. partially supports the hypothesis that the whole animal pharmacokinetic profile can be simulated from a knowledge of physiol. parameters such as tissue vols. and blood flows, combined with the key solute dependent properties such as tissue partition coeffs.  In addn., physiol. parameters are shown to be simply dependent on phys. properties such as lipophilicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrsVa9zOrR5bVg90H21EOLACvtfcHk0lhfb9EJluQ_wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFOmsQ%253D%253D&md5=9d8528b3ad5990f2b43e645297c6ba97</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeahy%26aufirst%3DD.%2BE.%26aulast%3DArundel%26aufirst%3DP.%2BA.%26aulast%3DBlakey%26aufirst%3DG.%2BE.%26aulast%3DRowland%26aufirst%3DM.%26atitle%3DPhysiologic%2520based%2520pharmacokinetic%2520modeling%2520and%2520QSAR%26jtitle%3DBioactive%2520Compd.%2520Des.%26date%3D1996%26spage%3D147%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nestorov, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aarons, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arundel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, M.</span></span> <span> </span><span class="NLM_article-title">Lumping of whole-body physiologically based pharmacokinetic models</span>. <i>J. Pharmacokinet. Biopharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1023/A:1023272707390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1023%2FA%3A1023272707390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=9773391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVGqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1998&pages=21-46&issue=1&author=I.+A.+Nestorovauthor=L.+J.+Aaronsauthor=P.+A.+Arundelauthor=M.+Rowland&title=Lumping+of+whole-body+physiologically+based+pharmacokinetic+models&doi=10.1023%2FA%3A1023272707390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Lumping of whole-body physiologically based pharmacokinetic models</span></div><div class="casAuthors">Nestorov, Ivan A.; Aarons, Leon J.; Arundel, Philip A.; Rowland, Malcolm</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacokinetics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-46</span>CODEN:
                <span class="NLM_cas:coden">JPBPBJ</span>;
        ISSN:<span class="NLM_cas:issn">0090-466X</span>.
    
            (<span class="NLM_cas:orgname">Plenum Publishing Corp.</span>)
        </div><div class="casAbstract">Lumping is a common pragmatic approach aimed at the redn. of whole-body physiol. based pharmacokinetic (PBPK) model dimensionality and complexity.  Incorrect lumping is equiv. to model misspecification with all the neg. consequences to the subsequent model implementation.  Proper lumping should guarantee that no useful information about the kinetics of the underlying processes is lost.  To enforce this guarantee, formal std. lumping procedures and techniques need to be defined and implemented.  This study examines the lumping process from a system theory point of view, which provides a formal basis for the derivation of principles and std. procedures of lumping.  The lumping principle in PBPK modeling is defined as follows: Only tissues with identical model specification, and occupying identical positions in the system structure should be lumped together at each lumping iteration.  In order to lump together serial tissues, they should have similar or close time consts.  In order to lump together serial tissues, they should equilibrate very rapidly with one another.  The lumping procedure should include the following stages: (i) tissue specification conversion (when tissues with different model specifications are to be lumped together); (ii) classification of the tissues into classes with significantly different kinetics, according to the basic principle of lumping above; (iii) calcn. of the parameters of the lumped compartments; (i.v.) simulation of the lumped system; (v) lumping of the exptl. data; and (vi) verification of the lumped model.  The use of the lumping principles and procedures to be adopted is illustrated with an example of a commonly implemented whole-body physiol. based pharmacokinetic model structure to characterize the pharmacokinetics of a homologous series of barbiturates in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVeHN8G_f36LVg90H21EOLACvtfcHk0lihCkTBi4FlLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVGqu7s%253D&md5=cd1dda43fc8597d9235001fd2a4bdf01</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023272707390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023272707390%26sid%3Dliteratum%253Aachs%26aulast%3DNestorov%26aufirst%3DI.%2BA.%26aulast%3DAarons%26aufirst%3DL.%2BJ.%26aulast%3DArundel%26aufirst%3DP.%2BA.%26aulast%3DRowland%26aufirst%3DM.%26atitle%3DLumping%2520of%2520whole-body%2520physiologically%2520based%2520pharmacokinetic%2520models%26jtitle%3DJ.%2520Pharmacokinet.%2520Biopharmaceutics%26date%3D1998%26volume%3D26%26issue%3D1%26spage%3D21%26epage%3D46%26doi%3D10.1023%2FA%3A1023272707390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGinnity, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, R. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of human pharmacokinetics, therapeutic dose and exposure predictions using marketed oral drugs</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.2174/138920007780866799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.2174%2F138920007780866799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=17584017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsl2jtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=463-479&author=D.+F.+McGinnityauthor=J.+Collingtonauthor=R.+P.+Austinauthor=R.+J.+Riley&title=Evaluation+of+human+pharmacokinetics%2C+therapeutic+dose+and+exposure+predictions+using+marketed+oral+drugs&doi=10.2174%2F138920007780866799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of human pharmacokinetics, therapeutic dose and exposure predictions using marketed oral drugs</span></div><div class="casAuthors">McGinnity, D. F.; Collington, J.; Austin, R. P.; Riley, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-479</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">In this article approaches to predict human pharmacokinetics (PK) are discussed and the capability of the exemplified methodologies to est. individual PK parameters and therapeutic dose for a set of marketed oral drugs has been assessed.  For a set of 63 drugs where the min. efficacious concn. (MEC) and human PK were known, the clin. dose was shown to be well predicted or in some cases over-estd. using a simple one-compartment oral PK model.  For a subset of these drugs, in vitro potency against the primary human targets was gathered, and compared to the obsd. MEC.  When cor. for plasma protein binding, the MEC of the majority of compds. was ≤ 3 fold over the resp. in vitro target potency value.  A series of in vitro and in vivo expts. were conducted to predict the human PK parameters.  Metabolic clearance was generally predicted well from human hepatocytes.  Interestingly, for this compd. set, allometry or glomerular filtration rate (GFR) ratio methods appeared to be applicable for renal CL even where CLrenal > GFR.  For ∼90% of compds. studied, the predicted CL using in vitro-in vivo (IVIV) extrapolation together with a CLrenal est., where appropriate, was within 2-fold of that obsd. clin.  Encouragingly vol. of distribution at steady state (Vss) estd. in preclin. species (rat and dog) when cor. for plasma protein binding, predicted human Vss successfully on the majority of occasions - 73% of compds. within 2-fold.  In this lab., absorption estd. from oral rat PK studies was lower than the obsd. human absorption for most drugs, even when soly. and permeability appeared not to be limiting.  Preliminary data indicate absorption in the dog may be more representative of human for compds. absorbed via the transcellular pathway.  Using predicted PK and MEC values estd. from in vitro potency assays there was a good correlation between predicted and obsd. dose.  This anal. suggests that for oral therapies, human PK parameters and clin. dose can be estd. from a consideration of data obtained from in vitro screens using human derived material and in vivo animal studies.  The benefits and limitations of this holistic approach to PK and dose prediction within the drug discovery process are exemplified and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdbfKDFLO_UrVg90H21EOLACvtfcHk0lihCkTBi4FlLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsl2jtL4%253D&md5=765bdc4b870b660e813e36ae3719ddb5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F138920007780866799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920007780866799%26sid%3Dliteratum%253Aachs%26aulast%3DMcGinnity%26aufirst%3DD.%2BF.%26aulast%3DCollington%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DR.%2BP.%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26atitle%3DEvaluation%2520of%2520human%2520pharmacokinetics%252C%2520therapeutic%2520dose%2520and%2520exposure%2520predictions%2520using%2520marketed%2520oral%2520drugs%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2007%26volume%3D8%26spage%3D463%26epage%3D479%26doi%3D10.2174%2F138920007780866799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atsumi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takakusa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, O.</span></span> <span> </span><span class="NLM_article-title">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1970</span>– <span class="NLM_lpage">1977</span>, <span class="refDoi"> DOI: 10.1124/dmd.109.027797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1124%2Fdmd.109.027797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=19487250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1970-1977&issue=9&author=S.+Nakayamaauthor=R.+Atsumiauthor=H.+Takakusaauthor=Y.+Kobayashiauthor=A.+Kuriharaauthor=Y.+Nagaiauthor=D.+Nakaiauthor=O.+Okazaki&title=A+zone+classification+system+for+risk+assessment+of+idiosyncratic+drug+toxicity+using+daily+dose+and+covalent+binding&doi=10.1124%2Fdmd.109.027797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span></div><div class="casAuthors">Nakayama, Shintaro; Atsumi, Ryo; Takakusa, Hideo; Kobayashi, Yoshimasa; Kurihara, Atsushi; Nagai, Yoko; Nakai, Daisuke; Okazaki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1970-1977</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The risk of idiosyncratic drug toxicity (IDT) is of great concern to the pharmaceutical industry.  Current hypotheses based on retrospective studies suggest that the occurrence of IDT is related to covalent binding and daily dose.  The authors detd. the covalent binding of 42 radiolabeled drugs in three test systems (human liver microsomes and hepatocytes in vitro and rat liver in vivo) to assess the risk of IDT.  On the basis of safety profiles given in official documentation, tested drugs were classified into the safety categories of safe, warning, black box warning, and withdrawn.  The covalent binding in each of the three test systems did not distinguish the safety categories clearly.  However, when the log-normalized covalent binding was plotted against the log-normalized daily dose, the distribution of the plot in the safety categories became clear.  An ordinal logistic regression anal. indicated that both covalent binding and daily dose were significantly correlated with safety category and that covalent binding in hepatocytes was the best predictor among the three systems.  When two sepn. lines were drawn on the correlation graph between covalent binding in human hepatocytes and daily dose by a regression anal. to create three zones, 30 of 37 tested drugs were located in zones corresponding to their resp. classified safety categories.  In conclusion, the authors established a zone classification system using covalent binding in human hepatocytes and daily dose for the risk assessment of IDTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtahZPkNJ3JbVg90H21EOLACvtfcHk0lh813t0CiyZgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO&md5=425119e0451fc50ec6ca95d5e3fe5fd3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.027797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.027797%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DAtsumi%26aufirst%3DR.%26aulast%3DTakakusa%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DKurihara%26aufirst%3DA.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DNakai%26aufirst%3DD.%26aulast%3DOkazaki%26aufirst%3DO.%26atitle%3DA%2520zone%2520classification%2520system%2520for%2520risk%2520assessment%2520of%2520idiosyncratic%2520drug%2520toxicity%2520using%2520daily%2520dose%2520and%2520covalent%2520binding%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26issue%3D9%26spage%3D1970%26epage%3D1977%26doi%3D10.1124%2Fdmd.109.027797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borlak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, W.</span></span> <span> </span><span class="NLM_article-title">High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1002/hep.26208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1002%2Fhep.26208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=23258593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVaisrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2013&pages=388-396&author=M.+Chenauthor=J.+Borlakauthor=W.+Tong&title=High+lipophilicity+and+high+daily+dose+of+oral+medications+are+associated+with+significant+risk+for+drug-induced+liver+injury&doi=10.1002%2Fhep.26208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury</span></div><div class="casAuthors">Chen, Minjun; Borlak, Juergen; Tong, Weida</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">388-396</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Drug-induced liver injury (DILI) is a leading cause of drug failure in clin. trials and a major reason for drug withdrawals from the market.  Although there is evidence that dosages of ≥100 mg/day are assocd. with increased risk for hepatotoxicity, many drugs are safe at such dosages.  There is an unmet need to predict risk for DILI more reliably, and lipophilicity might be a contributing factor.  We analyzed the combined factors of daily dose and lipophilicity for 164 US Food and Drug Administration-approved oral medications and obsd. high risk for hepatotoxicity (odds ratio [OR], 14.05; P < 0.001) for drugs given at dosages ≥100 mg/day and octanol-water partition coeff. (logP) ≥3.  This defined the "rule-of-two.".  Similar results were obtained for an independent set of 179 oral medications with 85% of the rule-of-two positives being assocd. with hepatotoxicity (OR, 3.89; P < 0.01).  Using the World Health Organization's Anatomical Therapeutic Chem. classification system, the rule-of-two performed best in predicting DILI in seven therapeutic categories.  Among 15 rule-of-two positives, 14 were withdrawn from hepatotoxic drugs, and one was over-the-counter medication labeled for liver injury.  We addnl. examd. drug pairs that have similar chem. structures and act on the same mol. target but differ in their potential for DILI.  Again, the rule-of-two predicted hepatotoxicity reliably.  Finally, the rule-of-two was applied to clin. case studies to identify hepatotoxic drugs in complex comedication regimes to further demonstrate its use.  Conclusion: Apart from dose, lipophilicity contributes significantly to risk for hepatotoxicity.  Applying the rule-of-two is an appropriate means of estg. risk for DILI compared with dose alone. (HEPATOl. 2013).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1EE02L_JCdLVg90H21EOLACvtfcHk0lh813t0CiyZgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVaisrrM&md5=a88e02ff29653bdeee53b59a4da46d06</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fhep.26208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26208%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DM.%26aulast%3DBorlak%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DW.%26atitle%3DHigh%2520lipophilicity%2520and%2520high%2520daily%2520dose%2520of%2520oral%2520medications%2520are%2520associated%2520with%2520significant%2520risk%2520for%2520drug-induced%2520liver%2520injury%26jtitle%3DHepatology%26date%3D2013%26volume%3D58%26spage%3D388%26epage%3D396%26doi%3D10.1002%2Fhep.26208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swindell, A. C.</span></span> <span> </span><span class="NLM_article-title">Guidance in the setting of drug particle size specification to minimize variability in absorption</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1795</span>– <span class="NLM_lpage">1798</span>, <span class="refDoi"> DOI: 10.1023/A:1016068705255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1023%2FA%3A1016068705255" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1996&pages=1795-1798&author=K.+C.+Johnsonauthor=A.+C.+Swindell&title=Guidance+in+the+setting+of+drug+particle+size+specification+to+minimize+variability+in+absorption&doi=10.1023%2FA%3A1016068705255"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1023%2FA%3A1016068705255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1016068705255%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DK.%2BC.%26aulast%3DSwindell%26aufirst%3DA.%2BC.%26atitle%3DGuidance%2520in%2520the%2520setting%2520of%2520drug%2520particle%2520size%2520specification%2520to%2520minimize%2520variability%2520in%2520absorption%26jtitle%3DPharm.%2520Res.%26date%3D1996%26volume%3D13%26spage%3D1795%26epage%3D1798%26doi%3D10.1023%2FA%3A1016068705255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilgers, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biermacher, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sims, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palandra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosley, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shobe, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, P. S.</span></span> <span> </span><span class="NLM_article-title">Predicting oral absorption of drugs: a case study with a novel class of antimicrobial agents</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1155</span>, <span class="refDoi"> DOI: 10.1023/A:1025084527878</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1023%2FA%3A1025084527878" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2003&pages=1149-1155&issue=8&author=A.+R.+Hilgersauthor=D.+P.+Smithauthor=J.+J.+Biermacherauthor=J.+S.+Dayauthor=J.+L.+Jensenauthor=S.+M.+Simsauthor=W.+J.+Adamsauthor=J.+M.+Friisauthor=J.+Palandraauthor=J.+D.+Hosleyauthor=E.+M.+Shobeauthor=P.+S.+Burton&title=Predicting+oral+absorption+of+drugs%3A+a+case+study+with+a+novel+class+of+antimicrobial+agents&doi=10.1023%2FA%3A1025084527878"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1023%2FA%3A1025084527878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1025084527878%26sid%3Dliteratum%253Aachs%26aulast%3DHilgers%26aufirst%3DA.%2BR.%26aulast%3DSmith%26aufirst%3DD.%2BP.%26aulast%3DBiermacher%26aufirst%3DJ.%2BJ.%26aulast%3DDay%26aufirst%3DJ.%2BS.%26aulast%3DJensen%26aufirst%3DJ.%2BL.%26aulast%3DSims%26aufirst%3DS.%2BM.%26aulast%3DAdams%26aufirst%3DW.%2BJ.%26aulast%3DFriis%26aufirst%3DJ.%2BM.%26aulast%3DPalandra%26aufirst%3DJ.%26aulast%3DHosley%26aufirst%3DJ.%2BD.%26aulast%3DShobe%26aufirst%3DE.%2BM.%26aulast%3DBurton%26aufirst%3DP.%2BS.%26atitle%3DPredicting%2520oral%2520absorption%2520of%2520drugs%253A%2520a%2520case%2520study%2520with%2520a%2520novel%2520class%2520of%2520antimicrobial%2520agents%26jtitle%3DPharm.%2520Res.%26date%3D2003%26volume%3D20%26issue%3D8%26spage%3D1149%26epage%3D1155%26doi%3D10.1023%2FA%3A1025084527878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gelder, J.</span></span> <span> </span><span class="NLM_article-title">Developability assessment of clinical drug products with maximum absorbable doses</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>427</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">260</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1016/j.ijpharm.2012.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.ijpharm.2012.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=22349050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtF2hsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2012&pages=260-269&issue=2&author=X.+Dingauthor=J.+P.+Roseauthor=J.+Van+Gelder&title=Developability+assessment+of+clinical+drug+products+with+maximum+absorbable+doses&doi=10.1016%2Fj.ijpharm.2012.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Developability assessment of clinical drug products with maximum absorbable doses</span></div><div class="casAuthors">Ding, Xuan; Rose, John P.; Van Gelder, Jan</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">427</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">260-269</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Maximum absorbable dose refers to the max. amt. of an orally administered drug that can be absorbed in the gastrointestinal tract.  Maximum absorbable dose, or Dabs, has proved to be an important parameter for quantifying the absorption potential of drug candidates.  The purpose of this work is to validate the use of Dabs in a developability assessment context, and to establish appropriate protocol and interpretation criteria for this application.  Three methods for calcg. Dabs were compared by assessing how well the methods predicted the absorption limit for a set of real clin. candidates.  Dabs was calcd. for these clin. candidates by means of a simple equation and two computer simulation programs, GastroPlus and an program developed at Eli Lilly and Company.  Results from single dose escalation studies in Phase I clin. trials were analyzed to identify the max. absorbable doses for these compds.  Compared to the clin. results, the equation and both simulation programs provide conservative ests. of Dabs, but in general Dabs from the computer simulations are more accurate, which may find obvious advantage for the simulations in developability assessment.  Computer simulations also revealed the complex behavior assocd. with absorption satn. and suggested in most cases that the Dabs limit is not likely to be achieved in a typical clin. dose range.  On the basis of the validation findings, an approach is proposed for assessing absorption potential, and best practices are discussed for the use of Dabs ests. to inform clin. formulation development strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-tXMDaAGuRbVg90H21EOLACvtfcHk0lhdWvM_l_eXOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtF2hsbk%253D&md5=0dd141927adc493e6343fd8ec3e3fbae</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2012.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2012.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DX.%26aulast%3DRose%26aufirst%3DJ.%2BP.%26aulast%3DVan%2BGelder%26aufirst%3DJ.%26atitle%3DDevelopability%2520assessment%2520of%2520clinical%2520drug%2520products%2520with%2520maximum%2520absorbable%2520doses%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2012%26volume%3D427%26issue%3D2%26spage%3D260%26epage%3D269%26doi%3D10.1016%2Fj.ijpharm.2012.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sjogren, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westergren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanisch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindfors, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennernas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahamsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannergren, C.</span></span> <span> </span><span class="NLM_article-title">In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">679</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2013.05.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.ejps.2013.05.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=23727464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSlsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=679-698&author=E.+Sjogrenauthor=J.+Westergrenauthor=I.+Grantauthor=G.+Hanischauthor=L.+Lindforsauthor=H.+Lennernasauthor=B.+Abrahamssonauthor=C.+Tannergren&title=In+silico+predictions+of+gastrointestinal+drug+absorption+in+pharmaceutical+product+development%3A+application+of+the+mechanistic+absorption+model+GI-Sim&doi=10.1016%2Fj.ejps.2013.05.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: Application of the mechanistic absorption model GI-Sim</span></div><div class="casAuthors">Sjogren, Erik; Westergren, Jan; Grant, Iain; Hanisch, Gunilla; Lindfors, Lennart; Lennernas, Hans; Abrahamsson, Bertil; Tannergren, Christer</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">679-698</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Oral drug delivery is the predominant administration route for a major part of the pharmaceutical products used worldwide.  Further understanding and improvement of gastrointestinal drug absorption predictions is currently a highly prioritized area of research within the pharmaceutical industry.  The fraction absorbed (fabs) of an oral dose after administration of a solid dosage form is a key parameter in the estn. of the in vivo performance of an orally administrated drug formulation.  This study discloses an evaluation of the predictive performance of the mechanistic physiol. based absorption model GI-Sim.  GI-Sim deploys a compartmental gastrointestinal absorption and transit model as well as algorithms describing permeability, dissoln. rate, salt effects, partitioning into micelles, particle and micelle drifting in the aq. boundary layer, particle growth and amorphous or cryst. pptn.  Twelve APIs with reported or expected absorption limitations in humans, due to permeability, dissoln. and/or soly., were investigated.  Predictions of the intestinal absorption for different doses and formulations were performed based on physicochem. and biopharmaceutical properties, such as soly. in buffer and simulated intestinal fluid, mol. wt., pKa, diffusivity and mol. d., measured or estd. human effective permeability and particle size distribution.  The performance of GI-Sim was evaluated by comparing predicted plasma concn.-time profiles along with oral pharmacokinetic parameters originating from clin. studies in healthy individuals.  The capability of GI-Sim to correctly predict impact of dose and particle size as well as the in vivo performance of nanoformulations was also investigated.  The overall predictive performance of GI-Sim was good as >95% of the predicted pharmacokinetic parameters (Cmax and AUC) were within a 2-fold deviation from the clin. observations and the predicted plasma AUC was within one std. deviation of the obsd. mean plasma AUC in 74% of the simulations.  GI-Sim was also able to correctly capture the trends in dose- and particle size dependent absorption for the study drugs with soly. and dissoln. limited absorption, resp.  In addn., GI-Sim was also shown to be able to predict the increase in absorption and plasma exposure achieved with nanoformulations.  Based on the results, the performance of GI-Sim was shown to be suitable for early risk assessment as well as to guide decision making in pharmaceutical formulation development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriPOOmNPmHhrVg90H21EOLACvtfcHk0lhdWvM_l_eXOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSlsr%252FJ&md5=b6eb6e66b7642463fd1191cfe3bdbc51</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2013.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2013.05.019%26sid%3Dliteratum%253Aachs%26aulast%3DSjogren%26aufirst%3DE.%26aulast%3DWestergren%26aufirst%3DJ.%26aulast%3DGrant%26aufirst%3DI.%26aulast%3DHanisch%26aufirst%3DG.%26aulast%3DLindfors%26aufirst%3DL.%26aulast%3DLennernas%26aufirst%3DH.%26aulast%3DAbrahamsson%26aufirst%3DB.%26aulast%3DTannergren%26aufirst%3DC.%26atitle%3DIn%2520silico%2520predictions%2520of%2520gastrointestinal%2520drug%2520absorption%2520in%2520pharmaceutical%2520product%2520development%253A%2520application%2520of%2520the%2520mechanistic%2520absorption%2520model%2520GI-Sim%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D49%26spage%3D679%26epage%3D698%26doi%3D10.1016%2Fj.ejps.2013.05.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, A. W.</span></span> <span> </span><span class="NLM_article-title">On the action of bromine in alkaline solution on amides</span>. <i>Ber. Dtsch. Chem. Ges.</i> <span class="NLM_year" style="font-weight: bold;">1881</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2725</span>– <span class="NLM_lpage">2736</span>, (title translated from “Ueber die Einwirkung des Broms in alkalischer Lösung auf Amide”). <span class="refDoi"> DOI: 10.1002/cber.188101402242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1002%2Fcber.188101402242" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1881&pages=2725-2736&author=A.+W.+Hofmann&title=On+the+action+of+bromine+in+alkaline+solution+on+amides&doi=10.1002%2Fcber.188101402242"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fcber.188101402242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.188101402242%26sid%3Dliteratum%253Aachs%26aulast%3DHofmann%26aufirst%3DA.%2BW.%26atitle%3DOn%2520the%2520action%2520of%2520bromine%2520in%2520alkaline%2520solution%2520on%2520amides%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%26date%3D1881%26volume%3D14%26spage%3D2725%26epage%3D2736%26doi%3D10.1002%2Fcber.188101402242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyaura, N.</span></span> <span> </span><span class="NLM_article-title">Palladium(0)-catalyzed cross-coupling reaction of alkoxydiboron with haloarenes: a direct procedure for arylboronic esters</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7508</span>– <span class="NLM_lpage">7510</span>, <span class="refDoi"> DOI: 10.1021/jo00128a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00128a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=7508-7510&author=T.+Ishiyamaauthor=M.+Murataauthor=N.+Miyaura&title=Palladium%280%29-catalyzed+cross-coupling+reaction+of+alkoxydiboron+with+haloarenes%3A+a+direct+procedure+for+arylboronic+esters&doi=10.1021%2Fjo00128a024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters</span></div><div class="casAuthors">Ishiyama, Tatsuo; Murata, Miki; Miyaura, Norio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7508-10</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The palladium-catalyzed cross-coupling reaction of the pinacol ester of diboronic acid I with haloarenes gave a direct procedure for arylboronic esters II (Ar = aryl) from aryl halides in a range of 60-98%.  The reaction was catalyzed by PdCl2(dppf) (3 mol %) at 80° in the presence of KOAc (3 equiv) in DMSO and available with various functional groups such as nitrile, cyanide, ester, and carbonyl groups.  The trans-ArPd(II)(OAc)(PPh3)2 intermediate was isolated and characterized to propose the catalytic cycle involving the transmetalation between the phenylpalladium(II) acetate complex and I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobehJBGFjDH7Vg90H21EOLACvtfcHk0ljo_9QecyiAmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D&md5=2666902270ec1efc5742480b133f1255</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjo00128a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00128a024%26sid%3Dliteratum%253Aachs%26aulast%3DIshiyama%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DMiyaura%26aufirst%3DN.%26atitle%3DPalladium%25280%2529-catalyzed%2520cross-coupling%2520reaction%2520of%2520alkoxydiboron%2520with%2520haloarenes%253A%2520a%2520direct%2520procedure%2520for%2520arylboronic%2520esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D7508%26epage%3D7510%26doi%3D10.1021%2Fjo00128a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Page, K. M.</span></span> <span> </span><span class="NLM_article-title">Validation of early human dose prediction: a key metric for compound crogression in drug discovery</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.5b00840</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.5b00840" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGrs7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=609-620&issue=2&author=K.+M.+Page&title=Validation+of+early+human+dose+prediction%3A+a+key+metric+for+compound+crogression+in+drug+discovery&doi=10.1021%2Facs.molpharmaceut.5b00840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of Early Human Dose Prediction: A Key Metric for Compound Progression in Drug Discovery</span></div><div class="casAuthors">Page, Ken M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">609-620</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human dose prediction is increasingly recognized as an important parameter in Drug Discovery.  Validation of a method using only in vitro and predicted parameters incorporated into a PK model was undertaken by predicting human dose and free Cmax for a no. of marketed drugs and AZ Development compds.  Doses were compared to those most relevant to marketed drugs or to clin. administered doses of AZ compds. normalized either to predicted Cmin or Cmax values.  Av. (AFE) and abs. av. (AAFE) fold-error anal. showed that best predictions were obtained using a QSAR model as the source of Vss, with Fabs set to 1 for acids and 0.5 for all other ion classes; for clearance prediction no binding correction to the well stirred model (WSM) was used for bases, while it was set to Fup/Fup0.5 for all other ion classes.  Using this combination of methods, predicted doses for 45 to 68% of the Cmin- and Cmax-normalized and marketed drug data sets were within 3-fold of the obsd. values, while 82 to 92% of these data sets were within 10-fold.  This method for early human dose prediction is able to rank, identify, and flag risks or optimization opportunities for future development compds. within 10 days of first synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT--CfNq9EGLVg90H21EOLACvtfcHk0ljo_9QecyiAmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGrs7%252FO&md5=612ece6c4e2729ab4694b0ae168e4cba</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.5b00840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.5b00840%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DK.%2BM.%26atitle%3DValidation%2520of%2520early%2520human%2520dose%2520prediction%253A%2520a%2520key%2520metric%2520for%2520compound%2520crogression%2520in%2520drug%2520discovery%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2016%26volume%3D13%26issue%3D2%26spage%3D609%26epage%3D620%26doi%3D10.1021%2Facs.molpharmaceut.5b00840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Volume of distribution in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5691</span>– <span class="NLM_lpage">5698</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00201</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00201" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFSlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5691-5698&author=D.+A.+Smithauthor=K.+Beaumontauthor=T.+S.+Maurerauthor=L.+Di&title=Volume+of+distribution+in+drug+design&doi=10.1021%2Facs.jmedchem.5b00201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Volume of Distribution in Drug Design</span></div><div class="casAuthors">Smith, Dennis A.; Beaumont, Kevin; Maurer, Tristan S.; Di, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5691-5698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Vol. of distribution is one of the most important pharmacokinetic properties of a drug candidate.  It is a major determinant of half-life and dosing frequency of a drug.  For a similar log P, a basic mol. will tend to exhibit higher vol. of distribution than a neutral mol.  Acids often exhibit low vols. of distribution.  Although a design strategy against vol. of distribution can be advantageous in achieving desirable dosing regimen, it must be well-directed in order to avoid detrimental effects to other important properties.  Strategies to increase vol. of distribution include adding lipophilicity and introducing basic functional groups in a way that does not increase metabolic clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP7QwgPahf4bVg90H21EOLACvtfcHk0lhbd02PlT4QQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFSlsb0%253D&md5=2c7289b3602a8edef2d9ef0e6a82e483</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00201%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DVolume%2520of%2520distribution%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5691%26epage%3D5698%26doi%3D10.1021%2Facs.jmedchem.5b00201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caravatti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guagnano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoepfer, J.</span></span> <span> </span><span class="NLM_article-title">Entry into a new class of protein kinase inhibitors by pseudo ring design</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">900</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.12.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.bmcl.2007.12.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=18248988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=897-900&author=P.+Furetauthor=G.+Caravattiauthor=V.+Guagnanoauthor=M.+Langauthor=T.+Meyerauthor=J.+Schoepfer&title=Entry+into+a+new+class+of+protein+kinase+inhibitors+by+pseudo+ring+design&doi=10.1016%2Fj.bmcl.2007.12.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Entry into a new class of protein kinase inhibitors by pseudo ring design</span></div><div class="casAuthors">Furet, Pascal; Caravatti, Giorgio; Guagnano, Vito; Lang, Marc; Meyer, Thomas; Schoepfer, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">897-900</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A pyrimidin-4-yl-urea motif forming a pseudo ring by intramol. hydrogen bonding has been designed to mimic the pyrido[2,3-d]pyrimidin-7-one core structure of a well-established class of protein kinase inhibitors.  Potent inhibition of a no. of protein kinases was obtained with the first prototype compd. synthesized to probe the design concept.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5MZZKS4I03LVg90H21EOLACvtfcHk0lhbd02PlT4QQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWksb0%253D&md5=989b4bb7f1d5177be45d4edf31290de5</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.041%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DCaravatti%26aufirst%3DG.%26aulast%3DGuagnano%26aufirst%3DV.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DSchoepfer%26aufirst%3DJ.%26atitle%3DEntry%2520into%2520a%2520new%2520class%2520of%2520protein%2520kinase%2520inhibitors%2520by%2520pseudo%2520ring%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D897%26epage%3D900%26doi%3D10.1016%2Fj.bmcl.2007.12.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maira, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brueggen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritsch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brachmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chene, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pover, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoemaker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Echeverría, C.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammailian target of rapamycin inhibitor with potent in vivo antitumor activity</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1851</span>– <span class="NLM_lpage">1863</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=18606717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&issue=7&author=S.+M.+Mairaauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Cheneauthor=A.+De+Poverauthor=K.+Schoemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+Garc%C3%ADa-Echeverr%C3%ADa&title=Identification+and+characterization+of+NVP-BEZ235%2C+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammailian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity&doi=10.1158%2F1535-7163.MCT-08-0017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span></div><div class="casAuthors">Maira, Sauveur-Michel; Stauffer, Frederic; Brueggen, Josef; Furet, Pascal; Schnell, Christian; Fritsch, Christine; Brachmann, Saskia; Chene, Patrick; De Pover, Alain; Schoemaker, Kevin; Fabbro, Doriano; Gabriel, Daniela; Simonen, Marjo; Murphy, Leon; Finan, Peter; Sellers, William; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1851-1863</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells, providing unique opportunities for anticancer therapeutic intervention.  NVP-BEZ235 is an imidazo[4,5-c]quinoline deriv. that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.  In cellular settings using human tumor cell lines, this mol. is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest.  The cellular activity of NVP-BEZ235 translates well in in vivo models of human cancer.  Thus, the compd. was well tolerated, displayed disease stasis when administered orally, and enhanced the efficacy of other anticancer agents when used in in vivo combination studies.  Ex vivo pharmacokinetic/pharmacodynamic analyses of tumor tissues showed a time-dependent correlation between compd. concn. and PI3K/Akt pathway inhibition.  Collectively, the preclin. data show that NVP-BEZ235 is a potent dual PI3K/mTOR modulator with favorable pharmaceutical properties.  NVP-BEZ235 is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyO784qv52vrVg90H21EOLACvtfcHk0lhbd02PlT4QQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D&md5=5b1979e134dd12065198d86dbc11ce15</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarc%25C3%25ADa-Echeverr%25C3%25ADa%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520NVP-BEZ235%252C%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammailian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26issue%3D7%26spage%3D1851%26epage%3D1863%26doi%3D10.1158%2F1535-7163.MCT-08-0017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gil del Alcazar, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardebeck, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomimatsu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachoo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habib, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burma, S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1235</span>– <span class="NLM_lpage">1248</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-1607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1158%2F1078-0432.CCR-13-1607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=24366691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC2cXks1Ohurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1235-1248&issue=5&author=C.+R.+Gil+del+Alcazarauthor=M.+C.+Hardebeckauthor=B.+Mukherjeeauthor=N.+Tomimatsuauthor=X.+Gaoauthor=J.+Yanauthor=X.-J.+Xieauthor=R.+Bachooauthor=L.+Liauthor=A.+A.+Habibauthor=S.+Burma&title=Inhibition+of+DNA+double-strand+break+repair+by+the+dual+PI3K%2FmTOR+inhibitor+NVP-BEZ235+as+a+strategy+for+radiosensitization+of+glioblastoma&doi=10.1158%2F1078-0432.CCR-13-1607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of DNA Double-Strand Break Repair by the Dual PI3K/mTOR Inhibitor NVP-BEZ235 as a Strategy for Radiosensitization of Glioblastoma</span></div><div class="casAuthors">Gil del Alcazar, Carlos Rodrigo; Hardebeck, Molly Catherine; Mukherjee, Bipasha; Tomimatsu, Nozomi; Gao, Xiaohuan; Yan, Jingsheng; Xie, Xian-Jin; Bachoo, Robert; Li, Li; Habib, Amyn A.; Burma, Sandeep</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1235-1248</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Inhibitors of the DNA damage response (DDR) have great potential for radiosensitization of numerous cancers, including glioblastomas, which are extremely radio- and chemoresistant brain tumors.  Currently, there are no DNA double-strand break (DSB) repair inhibitors that have been successful in treating glioblastoma.  Our lab. previously demonstrated that the dual phosphoinositide 3-kinase/mTOR inhibitor NVP-BEZ235 can potently inhibit the two central DDR kinases, DNA-dependent protein kinase catalytic subunit (DNA-PKcs) and ataxia-telangiectasia mutated (ATM), in vitro.  Here, we tested whether NVP-BEZ235 could also inhibit ATM and DNA-PKcs in tumors in vivo and assessed its potential as a radio- and chemosensitizer in preclin. mouse glioblastoma models.  Exptl. Design: The radiosensitizing effect of NVP-BEZ235 was tested by following tumor growth in s.c. and orthotopic glioblastoma models.  Tumors were generated using the radioresistant U87-vIII glioma cell line and GBM9 neurospheres in nude mice.  These tumors were then treated with ionizing radiation and/or NVP-BEZ235 and analyzed for DNA-PKcs and ATM activation, DSB repair inhibition, and attenuation of growth.  Results: NVP-BEZ235 potently inhibited both DNA-PKcs and ATM kinases and attenuated the repair of ionizing radiation-induced DNA damage in tumors.  This resulted in striking tumor radiosensitization, which extended the survival of brain tumor-bearing mice.  Notably, tumors displayed a higher DSB-load when compared with normal brain tissue.  NVP-BEZ235 also sensitized a subset of s.c. tumors to temozolomide, a drug routinely used concurrently with ionizing radiation for the treatment of glioblastoma.  Conclusions: These results demonstrate that it may be possible to significantly improve glioblastoma therapy by combining ionizing radiation with potent and bioavailable DNA repair inhibitors such as NVP-BEZ235.  Clin Cancer Res; 20(5); 1235-48. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU7klfy2L_M7Vg90H21EOLACvtfcHk0lgW1PxUtdFkGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXks1Ohurg%253D&md5=22c4c555e6d11d3ea1b426ce7bb261c7</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-1607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-1607%26sid%3Dliteratum%253Aachs%26aulast%3DGil%2Bdel%2BAlcazar%26aufirst%3DC.%2BR.%26aulast%3DHardebeck%26aufirst%3DM.%2BC.%26aulast%3DMukherjee%26aufirst%3DB.%26aulast%3DTomimatsu%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DX.-J.%26aulast%3DBachoo%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHabib%26aufirst%3DA.%2BA.%26aulast%3DBurma%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520DNA%2520double-strand%2520break%2520repair%2520by%2520the%2520dual%2520PI3K%252FmTOR%2520inhibitor%2520NVP-BEZ235%2520as%2520a%2520strategy%2520for%2520radiosensitization%2520of%2520glioblastoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26issue%3D5%26spage%3D1235%26epage%3D1248%26doi%3D10.1158%2F1078-0432.CCR-13-1607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomimatsu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amancherla, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichamoorthy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burma, S.</span></span> <span> </span><span class="NLM_article-title">The dual PI3K/mTOR inhibitor NVP-BEZ235 is a potent inhibitor of ATM- and DNA-PKcs-mediated DNA damage responses</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1593/neo.111512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1593%2Fneo.111512" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=34-43&author=B.+Mukherjeeauthor=N.+Tomimatsuauthor=K.+Amancherlaauthor=C.+V.+Camachoauthor=N.+Pichamoorthyauthor=S.+Burma&title=The+dual+PI3K%2FmTOR+inhibitor+NVP-BEZ235+is+a+potent+inhibitor+of+ATM-+and+DNA-PKcs-mediated+DNA+damage+responses&doi=10.1593%2Fneo.111512"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1593%2Fneo.111512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.111512%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DB.%26aulast%3DTomimatsu%26aufirst%3DN.%26aulast%3DAmancherla%26aufirst%3DK.%26aulast%3DCamacho%26aufirst%3DC.%2BV.%26aulast%3DPichamoorthy%26aufirst%3DN.%26aulast%3DBurma%26aufirst%3DS.%26atitle%3DThe%2520dual%2520PI3K%252FmTOR%2520inhibitor%2520NVP-BEZ235%2520is%2520a%2520potent%2520inhibitor%2520of%2520ATM-%2520and%2520DNA-PKcs-mediated%2520DNA%2520damage%2520responses%26jtitle%3DNeoplasia%26date%3D2012%26volume%3D14%26spage%3D34%26epage%3D43%26doi%3D10.1593%2Fneo.111512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarcsay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyiri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">Impact of lipophilic efficiency on compound quality</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1252</span>– <span class="NLM_lpage">1260</span>, <span class="refDoi"> DOI: 10.1021/jm201388p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201388p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVKjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1252-1260&author=A.+Tarcsayauthor=K.+Nyiriauthor=G.+M.+Keseru&title=Impact+of+lipophilic+efficiency+on+compound+quality&doi=10.1021%2Fjm201388p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of Lipophilic Efficiency on Compound Quality</span></div><div class="casAuthors">Tarcsay, Akos; Nyiri, Kinga; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1252-1260</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipophilic efficiency indexes such as LLE and LELP were suggested to support balanced optimization of potency and ADMET profile.  Here we investigated the performance of LLE and LELP on multiple data sets representing different stages of drug discovery including fragment and HTS hits and leads, development candidates, phase II compds., and launched drugs.  Analyzing their impact on ADME and safety properties and binding thermodn., we found that both LLE and LELP help identifying better quality compds.  LLE is sensible for the development stages but does not prefer fragment-type hits, while LELP has an advantage for this class of compds. and discriminates preferred starting points effectively.  Both LLE and LELP have significant impact on ADME and safety profiles; however, LELP outperforms LLE in risk assessment at least on the present data set.  On the basis of the results reported here, monitoring lipophilic efficiency metrics could contribute significantly to compd. quality and might improve the output of medicinal chem. programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxB8xs6-5DL7Vg90H21EOLACvtfcHk0lgW1PxUtdFkGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVKjsQ%253D%253D&md5=2536abef781f52806013016971c78bcb</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm201388p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201388p%26sid%3Dliteratum%253Aachs%26aulast%3DTarcsay%26aufirst%3DA.%26aulast%3DNyiri%26aufirst%3DK.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DImpact%2520of%2520lipophilic%2520efficiency%2520on%2520compound%2520quality%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1252%26epage%3D1260%26doi%3D10.1021%2Fjm201388p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, N. J.</span></span> <span> </span><span class="NLM_article-title">Validity of ligand efficiency metrics</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">618</span>, <span class="refDoi"> DOI: 10.1021/ml500146d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500146d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVShsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=616-618&author=C.+W.+Murrayauthor=D.+A.+Erlansonauthor=A.+L.+Hopkinsauthor=G.+M.+Keseruauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynoldsauthor=N.+J.+Richmond&title=Validity+of+ligand+efficiency+metrics&doi=10.1021%2Fml500146d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Validity of Ligand Efficiency Metrics</span></div><div class="casAuthors">Murray, Christopher W.; Erlanson, Daniel A.; Hopkins, Andrew L.; Keseru, Gyorgy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.; Richmond, Nicola J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">616-618</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A recent viewpoint article (Improving the plausibility of success with inefficient metrics. ACS Med. Chem. Lett.2014, 5, 2-5) argued that the std. definition of ligand efficiency (LE) is math. invalid.  In this viewpoint, we address this criticism and show categorically that the definition of LE is math. valid.  LE and other metrics such as lipophilic ligand efficiency (LLE) can be useful during the multiparameter optimization challenge faced by medicinal chemists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraJHYI4FCEJbVg90H21EOLACvtfcHk0lhUBFsYqynJeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVShsbs%253D&md5=5bc436490def9fa7af0f3e7ed241ee4e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fml500146d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500146d%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DRichmond%26aufirst%3DN.%2BJ.%26atitle%3DValidity%2520of%2520ligand%2520efficiency%2520metrics%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D616%26epage%3D618%26doi%3D10.1021%2Fml500146d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Free, S. M.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. W.</span></span> <span> </span><span class="NLM_article-title">A mathematical contribution to structure–activity studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1964</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1021/jm00334a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00334a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADyaF2cXkt1OltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1964&pages=395-399&author=S.+M.+Freeauthor=J.+W.+Wilson&title=A+mathematical+contribution+to+structure%E2%80%93activity+studies&doi=10.1021%2Fjm00334a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A mathematical contribution to structure-activity studies</span></div><div class="casAuthors">Free, Spencer M., Jr.; Wilson, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A math. technique is suggested as a means of describing structure-activity relation of a series of chem. analogs.  The data requirements included specific side chain arrangements and performance characteristics of all analogs tested.  Two examples illustrate the use of the additive math. model where the performance characteristics are measures of biol. activity.  The results rank the structural changes per position by estg. the amt. of biol. response attributed to each change.  The estimates are both pos. and neg.  Several uses for the math. soln. are suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRyTj3xI-aH7Vg90H21EOLACvtfcHk0lhUBFsYqynJeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXkt1OltbY%253D&md5=88fabb64d7a5635506a11418a2744bd6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm00334a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00334a001%26sid%3Dliteratum%253Aachs%26aulast%3DFree%26aufirst%3DS.%2BM.%26aulast%3DWilson%26aufirst%3DJ.%2BW.%26atitle%3DA%2520mathematical%2520contribution%2520to%2520structure%25E2%2580%2593activity%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1964%26volume%3D7%26spage%3D395%26epage%3D399%26doi%3D10.1021%2Fjm00334a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrecher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, G.</span></span> <span> </span><span class="NLM_article-title">Matrix-based multiparameter optimization of glucokinase activators: the discovery of AZD1092</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">779</span>, <span class="refDoi"> DOI: 10.1039/c1md00092f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1039%2Fc1md00092f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=775-779&author=M.+J.+Waringauthor=C.+Johnstoneauthor=D.+McKerrecherauthor=K.+G.+Pikeauthor=G.+Robb&title=Matrix-based+multiparameter+optimization+of+glucokinase+activators%3A+the+discovery+of+AZD1092&doi=10.1039%2Fc1md00092f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1039%2Fc1md00092f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00092f%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DC.%26aulast%3DMcKerrecher%26aufirst%3DD.%26aulast%3DPike%26aufirst%3DK.%2BG.%26aulast%3DRobb%26aufirst%3DG.%26atitle%3DMatrix-based%2520multiparameter%2520optimization%2520of%2520glucokinase%2520activators%253A%2520the%2520discovery%2520of%2520AZD1092%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D775%26epage%3D779%26doi%3D10.1039%2Fc1md00092f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freeman-Cook, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirico, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esler, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henegar, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houser, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limberakis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loomis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdande, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillion, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugarman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span> <span> </span><span class="NLM_article-title">Maximising lipophilic efficiency: the use of Free–Wilson analysis in the design of inhibitors of acetyl-CoA carboxylase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">942</span>, <span class="refDoi"> DOI: 10.1021/jm201503u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201503u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=935-942&author=K.+D.+Freeman-Cookauthor=P.+Amorauthor=S.+Baderauthor=L.+M.+Buzonauthor=S.+B.+Coffeyauthor=J.+W.+Corbettauthor=K.+J.+Diricoauthor=S.+D.+Doranauthor=R.+L.+Elliottauthor=W.+Eslerauthor=A.+Guzman-Perezauthor=K.+E.+Henegarauthor=J.+A.+Houserauthor=C.+S.+Jonesauthor=C.+Limberakisauthor=K.+Loomisauthor=K.+McPhersonauthor=S.+Murdandeauthor=K.+L.+Nelsonauthor=D.+Phillionauthor=B.+S.+Pierceauthor=W.+Songauthor=E.+Sugarmanauthor=S.+Tapleyauthor=M.+Tuauthor=Z.+Zhao&title=Maximising+lipophilic+efficiency%3A+the+use+of+Free%E2%80%93Wilson+analysis+in+the+design+of+inhibitors+of+acetyl-CoA+carboxylase&doi=10.1021%2Fjm201503u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm201503u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201503u%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman-Cook%26aufirst%3DK.%2BD.%26aulast%3DAmor%26aufirst%3DP.%26aulast%3DBader%26aufirst%3DS.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DCoffey%26aufirst%3DS.%2BB.%26aulast%3DCorbett%26aufirst%3DJ.%2BW.%26aulast%3DDirico%26aufirst%3DK.%2BJ.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DElliott%26aufirst%3DR.%2BL.%26aulast%3DEsler%26aufirst%3DW.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHenegar%26aufirst%3DK.%2BE.%26aulast%3DHouser%26aufirst%3DJ.%2BA.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DLoomis%26aufirst%3DK.%26aulast%3DMcPherson%26aufirst%3DK.%26aulast%3DMurdande%26aufirst%3DS.%26aulast%3DNelson%26aufirst%3DK.%2BL.%26aulast%3DPhillion%26aufirst%3DD.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DSugarman%26aufirst%3DE.%26aulast%3DTapley%26aufirst%3DS.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26atitle%3DMaximising%2520lipophilic%2520efficiency%253A%2520the%2520use%2520of%2520Free%25E2%2580%2593Wilson%2520analysis%2520in%2520the%2520design%2520of%2520inhibitors%2520of%2520acetyl-CoA%2520carboxylase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D935%26epage%3D942%26doi%3D10.1021%2Fjm201503u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, F.
W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snelson, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groombridge, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donald, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, S. N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morentin
Gutierrez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyte, A. C.</span></span> <span> </span><span class="NLM_article-title">Free–Wilson and structural approaches to co-optimizing human and rodent isoform potency for 11β-hydroxysteriod dehydrogenase type 1 (11β-HSD1) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10652</span>– <span class="NLM_lpage">10661</span>, <span class="refDoi"> DOI: 10.1021/jm3013163</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3013163" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10652-10661&author=F.%0AW.+Goldbergauthor=A.+G.+Leachauthor=J.+S.+Scottauthor=W.+L.+Snelsonauthor=S.+D.+Groombridgeauthor=C.+S.+Donaldauthor=S.+N.+L.+Bennettauthor=C.+Bodinauthor=P.+Morentin%0AGutierrezauthor=A.+C.+Gyte&title=Free%E2%80%93Wilson+and+structural+approaches+to+co-optimizing+human+and+rodent+isoform+potency+for+11%CE%B2-hydroxysteriod+dehydrogenase+type+1+%2811%CE%B2-HSD1%29+inhibitors&doi=10.1021%2Fjm3013163"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm3013163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3013163%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DF.%2BW.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DSnelson%26aufirst%3DW.%2BL.%26aulast%3DGroombridge%26aufirst%3DS.%2BD.%26aulast%3DDonald%26aufirst%3DC.%2BS.%26aulast%3DBennett%26aufirst%3DS.%2BN.%2BL.%26aulast%3DBodin%26aufirst%3DC.%26aulast%3DMorentin%2BGutierrez%26aufirst%3DP.%26aulast%3DGyte%26aufirst%3DA.%2BC.%26atitle%3DFree%25E2%2580%2593Wilson%2520and%2520structural%2520approaches%2520to%2520co-optimizing%2520human%2520and%2520rodent%2520isoform%2520potency%2520for%252011%25CE%25B2-hydroxysteriod%2520dehydrogenase%2520type%25201%2520%252811%25CE%25B2-HSD1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10652%26epage%3D10661%26doi%3D10.1021%2Fjm3013163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruston, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeritt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culshaw, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Good, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blades, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eden, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, S. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of AZD3147: A potent, selective dual inhibitor of mTORC1 and mTORC2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2326</span>– <span class="NLM_lpage">2349</span>, <span class="refDoi"> DOI: 10.1021/jm501778s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501778s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFeitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2326-2349&author=K.+G.+Pikeauthor=J.+Morrisauthor=L.+Rustonauthor=S.+L.+Passauthor=R.+Greenwoodauthor=E.+J.+Williamsauthor=J.+Demerittauthor=J.+D.+Culshawauthor=K.+Gillauthor=M.+Passauthor=M.+R.+V.+Finlayauthor=C.+J.+Goodauthor=C.+A.+Robertsauthor=G.+S.+Currieauthor=K.+Bladesauthor=J.+M.+Edenauthor=S.+E.+Pearson&title=Discovery+of+AZD3147%3A+A+potent%2C+selective+dual+inhibitor+of+mTORC1+and+mTORC2&doi=10.1021%2Fjm501778s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of AZD3147: A Potent, Selective Dual Inhibitor of mTORC1 and mTORC2</span></div><div class="casAuthors">Pike, Kurt G.; Morris, Jeff; Ruston, Linette; Pass, Sarah L.; Greenwood, Ryan; Williams, Emma J.; Demeritt, Julie; Culshaw, Janet D.; Gill, Kristy; Pass, Martin; Finlay, M. Raymond V.; Good, Catherine J.; Roberts, Craig A.; Currie, Gordon S.; Blades, Kevin; Eden, Jonathan M.; Pearson, Stuart E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2326-2349</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High throughput screening followed by a lead generation campaign uncovered a novel series of urea contg. morpholinopyrimidine compds. which act as potent and selective dual inhibitors of mTORC1 and mTORC2.  The authors describe the continued compd. optimization campaign for this series, in particular focused on identifying compds. with improved cellular potency, improved aq. soly., and good stability in human hepatocyte incubations.  Knowledge from empirical SAR investigations was combined with an understanding of the mol. interactions in the crystal lattice to improve both cellular potency and soly., and the composite parameters of LLE and pIC50-pSoly. were used to assess compd. quality and progress.  Predictive models were employed to efficiently mine the attractive chem. space identified resulting in the discovery of I (AZD3147), an extremely potent and selective dual inhibitor of mTORC1 and mTORC2 with physicochem. and pharmacokinetic properties suitable for development as a potential clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVFrPEX3khBbVg90H21EOLACvtfcHk0ljwuoawlvHycw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFeitL0%253D&md5=92d9596bf3c160bcde73fd9c586d6b84</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm501778s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501778s%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DK.%2BG.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DRuston%26aufirst%3DL.%26aulast%3DPass%26aufirst%3DS.%2BL.%26aulast%3DGreenwood%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DE.%2BJ.%26aulast%3DDemeritt%26aufirst%3DJ.%26aulast%3DCulshaw%26aufirst%3DJ.%2BD.%26aulast%3DGill%26aufirst%3DK.%26aulast%3DPass%26aufirst%3DM.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26aulast%3DGood%26aufirst%3DC.%2BJ.%26aulast%3DRoberts%26aufirst%3DC.%2BA.%26aulast%3DCurrie%26aufirst%3DG.%2BS.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DEden%26aufirst%3DJ.%2BM.%26aulast%3DPearson%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520AZD3147%253A%2520A%2520potent%252C%2520selective%2520dual%2520inhibitor%2520of%2520mTORC1%2520and%2520mTORC2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2326%26epage%3D2349%26doi%3D10.1021%2Fjm501778s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almond, A.</span></span> <span> </span><span class="NLM_article-title">Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4976</span>– <span class="NLM_lpage">4987</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.06.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.bmc.2013.06.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=23886813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCqt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=4976-4987&author=C.+D.+Blundellauthor=M.+J.+Packerauthor=A.+Almond&title=Quantification+of+free+ligand+conformational+preferences+by+NMR+and+their+relationship+to+the+bioactive+conformation&doi=10.1016%2Fj.bmc.2013.06.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation</span></div><div class="casAuthors">Blundell, Charles D.; Packer, Martin J.; Almond, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4976-4987</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Accurate unbound soln. 3D-structures of ligands provide unique opportunities for medicinal chem. and, in particular, a context to understand binding thermodn. and kinetics.  Previous methods of deriving these 3D-structures have had neither the accuracy nor resoln. needed for drug design and have not yet realized their potential.  Here, we describe and apply a NMR methodol. to the aminoglycoside streptomycin that can accurately quantify accessible 3D-space and rank the occupancy of obsd. conformers to a resoln. that enables medicinal chem. understanding and design.  Importantly, it is based upon conventional small mol. NMR techniques and can be performed in physiol.-relevant solvents.  The methodol. uses multiple datasets, an order of magnitude more exptl. data than previous NMR approaches and a dynamic model during refinement, is independent of computational chem. and avoids the problem of virtual conformations.  The refined set of soln. 3D-shapes for streptomycin can be grouped into two major families, of which the most populated is almost identical to the 30S ribosomal subunit bioactive shape.  We therefore propose that accurate unbound ligand soln. conformations may, in some cases, provide a subsidiary route to bioactive shape without crystallog.  This exptl. technique opens up new opportunities for drug design and more so when complemented with protein co-crystal structures, SAR data and pharmacophore modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUZZsawI_fmLVg90H21EOLACvtfcHk0ljwuoawlvHycw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCqt77K&md5=3ac32a01828e59160794384644aacbf4</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.06.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.06.056%26sid%3Dliteratum%253Aachs%26aulast%3DBlundell%26aufirst%3DC.%2BD.%26aulast%3DPacker%26aufirst%3DM.%2BJ.%26aulast%3DAlmond%26aufirst%3DA.%26atitle%3DQuantification%2520of%2520free%2520ligand%2520conformational%2520preferences%2520by%2520NMR%2520and%2520their%2520relationship%2520to%2520the%2520bioactive%2520conformation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D4976%26epage%3D4987%26doi%3D10.1016%2Fj.bmc.2013.06.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cadogan, E. D.</span></span> <span> </span><span class="NLM_article-title">Discovery and Preclinical Pharmacology of AZD0156: a First in Class Potent and Selective Inhibitor of Ataxia Telangiectasia Mutated (ATM) Kinase</span>.  <i>Abstracts of Papers, Annual Meeting of the American Association of Cancer Research, New Orleans, LA, 2016</i>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=E.+D.+Cadogan&title=Discovery+and+Preclinical+Pharmacology+of+AZD0156%3A+a+First+in+Class+Potent+and+Selective+Inhibitor+of+Ataxia+Telangiectasia+Mutated+%28ATM%29+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DCadogan%26aufirst%3DE.%2BD.%26atitle%3DDiscovery%2520and%2520Preclinical%2520Pharmacology%2520of%2520AZD0156%253A%2520a%2520First%2520in%2520Class%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520Ataxia%2520Telangiectasia%2520Mutated%2520%2528ATM%2529%2520Kinase%26jtitle%3DAbstracts%2520of%2520Papers%252C%2520Annual%2520Meeting%2520of%2520the%2520American%2520Association%2520of%2520Cancer%2520Research%252C%2520New%2520Orleans%252C%2520LA%252C%25202016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riches, L. C.</span>; <span class="NLM_string-name">Hughes, G.</span>; <span class="NLM_string-name">Jones, G. N.</span>; <span class="NLM_string-name">Garcia-Trinidad, A.</span>; <span class="NLM_string-name">Thomason, A. G.</span>; <span class="NLM_string-name">Gavine, P.</span>; <span class="NLM_string-name">Cui, A.</span>; <span class="NLM_string-name">O’Connor, M.</span>; <span class="NLM_string-name">Ling, S.</span>; <span class="NLM_string-name">Stott, J.</span>; <span class="NLM_string-name">Clark, R.</span>; <span class="NLM_string-name">Peel, S.</span>; <span class="NLM_string-name">Gill, P.</span>; <span class="NLM_string-name">Goodwin, L.</span>; <span class="NLM_string-name">Pike, K. G.</span>; <span class="NLM_string-name">Pass, M.</span>; <span class="NLM_string-name">Barlaam, B.</span>; <span class="NLM_string-name">Smith, G.</span>; <span class="NLM_string-name">Cadogan, E. B.</span></span> unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Riches%2C+L.+C.%3B+Hughes%2C+G.%3B+Jones%2C+G.+N.%3B+Garcia-Trinidad%2C+A.%3B+Thomason%2C+A.+G.%3B+Gavine%2C+P.%3B+Cui%2C+A.%3B+O%E2%80%99Connor%2C+M.%3B+Ling%2C+S.%3B+Stott%2C+J.%3B+Clark%2C+R.%3B+Peel%2C+S.%3B+Gill%2C+P.%3B+Goodwin%2C+L.%3B+Pike%2C+K.+G.%3B+Pass%2C+M.%3B+Barlaam%2C+B.%3B+Smith%2C+G.%3B+Cadogan%2C+E.+B.+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DRiches%26aufirst%3DL.%2BC." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barlaam, B. C.</span>; <span class="NLM_string-name">Pike, K. G.</span></span> <span> </span><span class="NLM_article-title">Imidazo[4,5-<i>c</i>]quinolin-2-one Compounds and Their Use in Treating Cancer</span>. WO patent <span class="NLM_patent">WO 2015170081</span>, Nov 12, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=B.+C.+Barlaam&author=K.+G.+Pike&title=Imidazo%5B4%2C5-c%5Dquinolin-2-one+Compounds+and+Their+Use+in+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarlaam%26aufirst%3DB.%2BC.%26atitle%3DImidazo%255B4%252C5-c%255Dquinolin-2-one%2520Compounds%2520and%2520Their%2520Use%2520in%2520Treating%2520Cancer%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellison, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahdesmaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhaskar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J.</span></span> <span> </span><span class="NLM_article-title">A reliable method for the delection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilizing multiplex PCR-based targeted next generation sequencing</span>. <i>BMC Clin. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">5</span>, <span class="refDoi"> DOI: 10.1186/s12907-015-0004-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1186%2Fs12907-015-0004-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=25859162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A280%3ADC%252BC2MjivVejuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=5&author=G.+Ellisonauthor=S.+Huangauthor=H.+Carrauthor=A.+Wallaceauthor=M.+Ahdesmakiauthor=S.+Bhaskarauthor=J.+Mills&title=A+reliable+method+for+the+delection+of+BRCA1+and+BRCA2+mutations+in+fixed+tumour+tissue+utilizing+multiplex+PCR-based+targeted+next+generation+sequencing&doi=10.1186%2Fs12907-015-0004-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing</span></div><div class="casAuthors">Ellison Gillian; Mills John; Huang Shuwen; Wallace Andrew; Bhaskar Sanjeev; Carr Hedley; Ahdesmaki Miika</div><div class="citationInfo"><span class="NLM_cas:title">BMC clinical pathology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5</span>
        ISSN:<span class="NLM_cas:issn">1472-6890</span>.
    </div><div class="casAbstract">BACKGROUND:  Germline mutations in BRCA1 or BRCA2 lead to a high lifetime probability of developing ovarian or breast cancer.  These genes can also be involved in the development of non-hereditary tumours as somatic BRCA1/2 pathogenic variants are found in some of these cancers.  Since patients with somatic BRCA pathogenic variants may benefit from treatment with poly ADP ribose polymerase inhibitors, it is important to be able to test for somatic changes in routinely available tumour samples.  Such samples are typically formalin-fixed paraffin-embedded (FFPE) tissue, where the extracted DNA tends to be highly fragmented and of limited quantity, making analysis of large genes such as BRCA1 and BRCA2 challenging.  This is made more difficult as somatic changes may be evident in only part of the sample, due to the presence of normal tissue.  METHODS:  We examined the feasibility of analysing DNA extracted from FFPE ovarian and breast tumour tissue to identify significant DNA variants in BRCA1/ BRCA2 using next generation sequencing methods that were sensitive enough to detect low level mutations, multiplexed to reduce the amount of DNA required and had short amplicon design.  The utility of two GeneRead DNAseq Targeted Exon Enrichment Panels with different designs targeting only BRCA1/2 exons, and the Ion AmpliSeq BRCA community panel, followed by library preparation and adaptor ligation using the TruSeq DNA PCR-Free HT Sample Preparation Kit and NGS analysis on the MiSeq were investigated.  RESULTS:  Using the GeneRead method, we successfully analysed over 76% of samples, with >95% coverage of BRCA1/2 coding regions and a mean average read depth of >1000-fold.  All mutations identified were confirmed where possible by Sanger sequencing or replication to eliminate the risk of false positive results due to artefacts within FFPE material.  Admixture experiments demonstrated that BRCA1/2 variants could be detected if present in >10% of the sample.  A sample subset was evaluated using the Ion AmpliSeq BRCA panel, achieving >99% coverage and sufficient read depth for a proportion of the samples.  CONCLUSIONS:  Detection of BRCA1/2 variants in fixed tissue is feasible, and could be performed prospectively to facilitate optimum treatment decisions for ovarian or breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1SMGX3K8vvcKL0FlyGHDofW6udTcc2eYWZ7HytyaGALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjivVejuw%253D%253D&md5=feb29e3176074b6ffb0ee903e86d7ed7</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1186%2Fs12907-015-0004-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12907-015-0004-6%26sid%3Dliteratum%253Aachs%26aulast%3DEllison%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DCarr%26aufirst%3DH.%26aulast%3DWallace%26aufirst%3DA.%26aulast%3DAhdesmaki%26aufirst%3DM.%26aulast%3DBhaskar%26aufirst%3DS.%26aulast%3DMills%26aufirst%3DJ.%26atitle%3DA%2520reliable%2520method%2520for%2520the%2520delection%2520of%2520BRCA1%2520and%2520BRCA2%2520mutations%2520in%2520fixed%2520tumour%2520tissue%2520utilizing%2520multiplex%2520PCR-based%2520targeted%2520next%2520generation%2520sequencing%26jtitle%3DBMC%2520Clin.%2520Pathol.%26date%3D2015%26volume%3D15%26spage%3D5%26doi%3D10.1186%2Fs12907-015-0004-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kowalski, K.</span>; <span class="NLM_string-name">Hansen, P.</span>; <span class="NLM_string-name">Dayton, B.</span>; <span class="NLM_string-name">Oladipupo, O.</span>; <span class="NLM_string-name">Thomas, E.</span>; <span class="NLM_string-name">Li, Y.</span>; <span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Overcoming Matrix-Based Interferences Using Multi-Extraction Techniques for LC-MS Analysis of AZD0156 and its Metabolite in Human Plasma</span>.  <i>65th American Society for Mass Spectrometry Annual Conference (ASMS 2017), Indianapolis, IN, 2017</i>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=K.+Kowalski&author=P.+Hansen&author=B.+Dayton&author=O.+Oladipupo&author=E.+Thomas&author=Y.+Li&author=Y.+Chen&title=Overcoming+Matrix-Based+Interferences+Using+Multi-Extraction+Techniques+for+LC-MS+Analysis+of+AZD0156+and+its+Metabolite+in+Human+Plasma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DKowalski%26aufirst%3DK.%26atitle%3DOvercoming%2520Matrix-Based%2520Interferences%2520Using%2520Multi-Extraction%2520Techniques%2520for%2520LC-MS%2520Analysis%2520of%2520AZD0156%2520and%2520its%2520Metabolite%2520in%2520Human%2520Plasma%26jtitle%3D65th%2520American%2520Society%2520for%2520Mass%2520Spectrometry%2520Annual%2520Conference%2520%2528ASMS%25202017%2529%252C%2520Indianapolis%252C%2520IN%252C%25202017%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <i>Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis</i>, <span class="NLM_edition">2nd</span> ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2000</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1002%2F0471220639" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=R.+A.+Copeland&title=Enzymes%3A+A+Practical+Introduction+to+Structure%2C+Mechanism%2C+and+Data+Analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2F0471220639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471220639%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEnzymes%253A%2520A%2520Practical%2520Introduction%2520to%2520Structure%252C%2520Mechanism%252C%2520and%2520Data%2520Analysis%26pub%3DWiley%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 33 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Cien Huang, Nina R. Filippone, Thomas Reiner, <span class="NLM_string-name hlFld-ContribAuthor">Sheryl Roberts</span>. </span><span class="cited-content_cbyCitation_article-title">Sensors and Inhibitors for the Detection of Ataxia Telangiectasia Mutated (ATM) Protein Kinase. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2021,</strong> <em>18 </em>
                                    (7)
                                     , 2470-2481. <a href="https://doi.org/10.1021/acs.molpharmaceut.1c00166" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.1c00166</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.1c00166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.1c00166%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DSensors%252Band%252BInhibitors%252Bfor%252Bthe%252BDetection%252Bof%252BAtaxia%252BTelangiectasia%252BMutated%252B%252528ATM%252529%252BProtein%252BKinase%26aulast%3DHuang%26aufirst%3DCien%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D01032021%26date%3D07052021%26date%3D06052021%26date%3D14062021%26volume%3D18%26issue%3D7%26spage%3D2470%26epage%3D2481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Amanda Van de Poël, Leticia Toledo-Sherman, Perla Breccia, Roger Cachope, Jennifer R. Bate, Ivan Angulo-Herrera, Grant Wishart, Kim L. Matthews, Sarah L. Martin, Marcus Peacock, Amy Barnard, Helen C. Cox, Graham Jones, George McAllister, Huw Vater, William Esmieu, Cole Clissold, Marieke Lamers, Philip Leonard, Rebecca E. Jarvis, Wesley Blackaby, Maria Eznarriaga, Ovadia Lazari, Dawn Yates, Mark Rose, Sung-Wook Jang, Ignacio Muñoz-Sanjuan, <span class="NLM_string-name hlFld-ContribAuthor">Celia Dominguez</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 5018-5036. <a href="https://doi.org/10.1021/acs.jmedchem.1c00114" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00114%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BExploration%252Bof%252BSelectivity%252Bfor%252BATM%252BInhibitors%252Bin%252BHuntington%2525E2%252580%252599s%252BDisease%26aulast%3DVan%2Bde%2BPo%25C3%25ABl%26aufirst%3DAmanda%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21012021%26date%3D30032021%26volume%3D64%26issue%3D8%26spage%3D5018%26epage%3D5036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Samuel H. Myers, Jose Antonio Ortega, <span class="NLM_string-name hlFld-ContribAuthor">Andrea Cavalli</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Lethality through the Lens of Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14151-14183. <a href="https://doi.org/10.1021/acs.jmedchem.0c00766" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00766</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00766%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252BLethality%252Bthrough%252Bthe%252BLens%252Bof%252BMedicinal%252BChemistry%26aulast%3DMyers%26aufirst%3DSamuel%2BH.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06052020%26date%3D02112020%26volume%3D63%26issue%3D23%26spage%3D14151%26epage%3D14183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Leticia Toledo-Sherman, Perla Breccia, Roger Cachope, Jennifer R. Bate, Ivan Angulo-Herrera, Grant Wishart, Kim L. Matthews, Sarah L. Martin, Helen C. Cox, George McAllister, Stephen D. Penrose, Huw Vater, William Esmieu, Amanda Van de Poël, Rhea Van de Bospoort, Annelieke Strijbosch, Marieke Lamers, Philip Leonard, Rebecca E. Jarvis, Wesley Blackaby, Karen Barnes, Maria Eznarriaga, Simon Dowler, Graham D. Smith, David F. Fischer, Ovadia Lazari, Dawn Yates, Mark Rose, Sung-Wook Jang, Ignacio Muñoz-Sanjuan, <span class="NLM_string-name hlFld-ContribAuthor">Celia Dominguez</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington’s Disease Models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (6)
                                     , 2988-3008. <a href="https://doi.org/10.1021/acs.jmedchem.8b01819" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01819</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01819%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BPotent%252Band%252BSelective%252BAtaxia%252BTelangiectasia-Mutated%252BInhibitors%252BSuitable%252Bfor%252Ba%252BProof-of-Concept%252BStudy%252Bin%252BHuntington%2525E2%252580%252599s%252BDisease%252BModels%26aulast%3DToledo-Sherman%26aufirst%3DLeticia%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D21112018%26date%3D19032019%26date%3D06032019%26volume%3D62%26issue%3D6%26spage%3D2988%26epage%3D3008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bernard Barlaam, Elaine Cadogan, Andrew Campbell, Nicola Colclough, Allan Dishington, Stephen Durant, Kristin Goldberg, Lorraine A. Hassall, Gareth D. Hughes, Philip A. MacFaul, Thomas M. McGuire, Martin Pass, Anil Patel, Stuart Pearson, Jens Petersen, Kurt G. Pike, Graeme Robb, Natalie Stratton, Guohong Xin, <span class="NLM_string-name hlFld-ContribAuthor">Baochang Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent, and Selective ATM Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (8)
                                     , 809-814. <a href="https://doi.org/10.1021/acsmedchemlett.8b00200" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00200%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BSeries%252Bof%252B3-Cinnoline%252BCarboxamides%252Bas%252BOrally%252BBioavailable%25252C%252BHighly%252BPotent%25252C%252Band%252BSelective%252BATM%252BInhibitors%26aulast%3DBarlaam%26aufirst%3DBernard%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D02052018%26date%3D13072018%26date%3D17072018%26date%3D13072018%26volume%3D9%26issue%3D8%26spage%3D809%26epage%3D814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey R.  Whiteaker</span>, <span class="hlFld-ContribAuthor ">Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Zhao</span>, <span class="hlFld-ContribAuthor ">Regine M.  Schoenherr</span>, <span class="hlFld-ContribAuthor ">Jacob J.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Ulianna  Voytovich</span>, <span class="hlFld-ContribAuthor ">Richard G.  Ivey</span>, <span class="hlFld-ContribAuthor ">Dongqing  Huang</span>, <span class="hlFld-ContribAuthor ">Chenwei  Lin</span>, <span class="hlFld-ContribAuthor ">Simona  Colantonio</span>, <span class="hlFld-ContribAuthor ">Tessa W.  Caceres</span>, <span class="hlFld-ContribAuthor ">Rhonda R.  Roberts</span>, <span class="hlFld-ContribAuthor ">Joseph G.  Knotts</span>, <span class="hlFld-ContribAuthor ">Jan A.  Kaczmarczyk</span>, <span class="hlFld-ContribAuthor ">Josip  Blonder</span>, <span class="hlFld-ContribAuthor ">Joshua J.  Reading</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Richardson</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Hewitt</span>, <span class="hlFld-ContribAuthor ">Sandra S.  Garcia-Buntley</span>, <span class="hlFld-ContribAuthor ">William  Bocik</span>, <span class="hlFld-ContribAuthor ">Tara  Hiltke</span>, <span class="hlFld-ContribAuthor ">Henry  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Elizabeth A.  Harrington</span>, <span class="hlFld-ContribAuthor ">J. Carl  Barrett</span>, <span class="hlFld-ContribAuthor ">Benedetta  Lombardi</span>, <span class="hlFld-ContribAuthor ">Paola  Marco-Casanova</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Pierce</span>, <span class="hlFld-ContribAuthor ">Amanda G.  Paulovich</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (15)
                                     , 3843. <a href="https://doi.org/10.3390/cancers13153843" title="DOI URL">https://doi.org/10.3390/cancers13153843</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13153843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13153843%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTargeted%252BMass%252BSpectrometry%252BEnables%252BQuantification%252Bof%252BNovel%252BPharmacodynamic%252BBiomarkers%252Bof%252BATM%252BKinase%252BInhibition%26aulast%3DWhiteaker%26aufirst%3DJeffrey%2BR.%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D15%26spage%3D3843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liliana  Raimundo</span>, <span class="hlFld-ContribAuthor ">Juliana  Calheiros</span>, <span class="hlFld-ContribAuthor ">Lucília  Saraiva</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (14)
                                     , 3438. <a href="https://doi.org/10.3390/cancers13143438" title="DOI URL">https://doi.org/10.3390/cancers13143438</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13143438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13143438%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DExploiting%252BDNA%252BDamage%252BRepair%252Bin%252BPrecision%252BCancer%252BTherapy%25253A%252BBRCA1%252Bas%252Ba%252BPrime%252BTherapeutic%252BTarget%26aulast%3DRaimundo%26aufirst%3DLiliana%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D14%26spage%3D3438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathew  Lozinski</span>, <span class="hlFld-ContribAuthor ">Nikola A.  Bowden</span>, <span class="hlFld-ContribAuthor ">Moira C.  Graves</span>, <span class="hlFld-ContribAuthor ">Michael  Fay</span>, <span class="hlFld-ContribAuthor ">Paul A.  Tooney</span>. </span><span class="cited-content_cbyCitation_article-title">DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets. </span><span class="cited-content_cbyCitation_journal-name">Cellular Oncology</span><span> <strong>2021,</strong> <em>107 </em><a href="https://doi.org/10.1007/s13402-021-00613-0" title="DOI URL">https://doi.org/10.1007/s13402-021-00613-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13402-021-00613-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13402-021-00613-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Oncology%26atitle%3DDNA%252Bdamage%252Brepair%252Bin%252Bglioblastoma%25253A%252Bcurrent%252Bperspectives%252Bon%252Bits%252Brole%252Bin%252Btumour%252Bprogression%25252C%252Btreatment%252Bresistance%252Band%252BPIKKing%252Bpotential%252Btherapeutic%252Btargets%26aulast%3DLozinski%26aufirst%3DMathew%26date%3D2021%26date%3D2021%26volume%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guillaume  Rieunier</span>, <span class="hlFld-ContribAuthor ">Xiaoning  Wu</span>, <span class="hlFld-ContribAuthor ">Letitia E.  Harris</span>, <span class="hlFld-ContribAuthor ">Jack V.  Mills</span>, <span class="hlFld-ContribAuthor ">Ashwin  Nandakumar</span>, <span class="hlFld-ContribAuthor ">Laura  Colling</span>, <span class="hlFld-ContribAuthor ">Elena  Seraia</span>, <span class="hlFld-ContribAuthor ">Stephanie B.  Hatch</span>, <span class="hlFld-ContribAuthor ">Daniel V.  Ebner</span>, <span class="hlFld-ContribAuthor ">Lisa K.  Folkes</span>, <span class="hlFld-ContribAuthor ">Ulrike  Weyer-Czernilofsky</span>, <span class="hlFld-ContribAuthor ">Thomas  Bogenrieder</span>, <span class="hlFld-ContribAuthor ">Anderson J.  Ryan</span>, <span class="hlFld-ContribAuthor ">Valentine M.  Macaulay</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2021,</strong> <em>81 </em>
                                    (8)
                                     , 2128-2141. <a href="https://doi.org/10.1158/0008-5472.CAN-20-2860" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-20-2860</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-20-2860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-20-2860%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DTargeting%252BIGF%252BPerturbs%252BGlobal%252BReplication%252Bthrough%252BRibonucleotide%252BReductase%252BDysfunction%26aulast%3DRieunier%26aufirst%3DGuillaume%26date%3D2021%26date%3D2021%26volume%3D81%26issue%3D8%26spage%3D2128%26epage%3D2141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer Q. J.  Zhang</span>, <span class="hlFld-ContribAuthor ">Sayanthooran  Saravanabavan</span>, <span class="hlFld-ContribAuthor ">Gopala K.  Rangan</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of Reducing Ataxia-Telangiectasia Mutated (ATM) in Experimental Autosomal Dominant Polycystic Kidney Disease. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2021,</strong> <em>10 </em>
                                    (3)
                                     , 532. <a href="https://doi.org/10.3390/cells10030532" title="DOI URL">https://doi.org/10.3390/cells10030532</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells10030532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells10030532%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DEffect%252Bof%252BReducing%252BAtaxia-Telangiectasia%252BMutated%252B%252528ATM%252529%252Bin%252BExperimental%252BAutosomal%252BDominant%252BPolycystic%252BKidney%252BDisease%26aulast%3DZhang%26aufirst%3DJennifer%2BQ.%2BJ.%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D3%26spage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin  Edginton‐White</span>, <span class="hlFld-ContribAuthor ">Constanze  Bonifer</span>. </span><span class="cited-content_cbyCitation_article-title">The transcriptional regulation of normal and malignant blood cell development. </span><span class="cited-content_cbyCitation_journal-name">The FEBS Journal</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.1111/febs.15735" title="DOI URL">https://doi.org/10.1111/febs.15735</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/febs.15735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffebs.15735%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FEBS%2520Journal%26atitle%3DThe%252Btranscriptional%252Bregulation%252Bof%252Bnormal%252Band%252Bmalignant%252Bblood%252Bcell%252Bdevelopment%26aulast%3DEdginton%25E2%2580%2590White%26aufirst%3DBenjamin%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nazanin K  Majd</span>, <span class="hlFld-ContribAuthor ">Timothy A  Yap</span>, <span class="hlFld-ContribAuthor ">Dimpy  Koul</span>, <span class="hlFld-ContribAuthor ">Veerakumar  Balasubramaniyan</span>, <span class="hlFld-ContribAuthor ">Xiaolong  Li</span>, <span class="hlFld-ContribAuthor ">Sabbir  Khan</span>, <span class="hlFld-ContribAuthor ">Katilin S  Gandy</span>, <span class="hlFld-ContribAuthor ">W K Alfred  Yung</span>, <span class="hlFld-ContribAuthor ">John F  de Groot</span>. </span><span class="cited-content_cbyCitation_article-title">The promise of DNA damage response inhibitors for the treatment of glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Neuro-Oncology Advances</span><span> <strong>2021,</strong> <em>3 </em>
                                    (1)
                                     <a href="https://doi.org/10.1093/noajnl/vdab015" title="DOI URL">https://doi.org/10.1093/noajnl/vdab015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/noajnl/vdab015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnoajnl%2Fvdab015%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuro-Oncology%2520Advances%26atitle%3DThe%252Bpromise%252Bof%252BDNA%252Bdamage%252Bresponse%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bglioblastoma%26aulast%3DMajd%26aufirst%3DNazanin%2BK%26date%3D2021%26date%3D2021%26volume%3D3%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuhui  Bao</span>, <span class="hlFld-ContribAuthor ">Xinjian  Liu</span>, <span class="hlFld-ContribAuthor ">Fang  Li</span>, <span class="hlFld-ContribAuthor ">Chuan-Yuan  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Limited MOMP, ATM, and their roles in carcinogenesis and cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Cell & Bioscience</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13578-020-00442-y" title="DOI URL">https://doi.org/10.1186/s13578-020-00442-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13578-020-00442-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13578-020-00442-y%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520%2526%2520Bioscience%26atitle%3DLimited%252BMOMP%25252C%252BATM%25252C%252Band%252Btheir%252Broles%252Bin%252Bcarcinogenesis%252Band%252Bcancer%252Btreatment%26aulast%3DBao%26aufirst%3DXuhui%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antje M.  Wengner</span>, <span class="hlFld-ContribAuthor ">Arne  Scholz</span>, <span class="hlFld-ContribAuthor ">Bernard  Haendler</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting DNA Damage Response in Prostate and Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (21)
                                     , 8273. <a href="https://doi.org/10.3390/ijms21218273" title="DOI URL">https://doi.org/10.3390/ijms21218273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21218273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21218273%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DTargeting%252BDNA%252BDamage%252BResponse%252Bin%252BProstate%252Band%252BBreast%252BCancer%26aulast%3DWengner%26aufirst%3DAntje%2BM.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D21%26spage%3D8273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles R.  Dunlop</span>, <span class="hlFld-ContribAuthor ">Yann  Wallez</span>, <span class="hlFld-ContribAuthor ">Timothy Isaac  Johnson</span>, <span class="hlFld-ContribAuthor ">Sandra  Bernaldo de Quirós Fernández</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Durant</span>, <span class="hlFld-ContribAuthor ">Elaine B.  Cadogan</span>, <span class="hlFld-ContribAuthor ">Alan  Lau</span>, <span class="hlFld-ContribAuthor ">Frances M.  Richards</span>, <span class="hlFld-ContribAuthor ">Duncan I.  Jodrell</span>. </span><span class="cited-content_cbyCitation_article-title">Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2020,</strong> <em>123 </em>
                                    (9)
                                     , 1424-1436. <a href="https://doi.org/10.1038/s41416-020-1016-2" title="DOI URL">https://doi.org/10.1038/s41416-020-1016-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41416-020-1016-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41416-020-1016-2%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DComplete%252Bloss%252Bof%252BATM%252Bfunction%252Baugments%252Breplication%252Bcatastrophe%252Binduced%252Bby%252BATR%252Binhibition%252Band%252Bgemcitabine%252Bin%252Bpancreatic%252Bcancer%252Bmodels%26aulast%3DDunlop%26aufirst%3DCharles%2BR.%26date%3D2020%26date%3D2020%26volume%3D123%26issue%3D9%26spage%3D1424%26epage%3D1436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srimadhavi  Ravi</span>, <span class="hlFld-ContribAuthor ">Sugata  Barui</span>, <span class="hlFld-ContribAuthor ">Sivapriya  Kirubakaran</span>, <span class="hlFld-ContribAuthor ">Parul  Duhan</span>, <span class="hlFld-ContribAuthor ">Kaushik  Bhowmik</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of Quinoline-3-Carboxamide Derivatives as Inhibitors of the ATM Kinase. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (23)
                                     , 2070-2079. <a href="https://doi.org/10.2174/1568026620666200731174216" title="DOI URL">https://doi.org/10.2174/1568026620666200731174216</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666200731174216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666200731174216%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252BQuinoline-3-Carboxamide%252BDerivatives%252Bas%252BInhibitors%252Bof%252Bthe%252BATM%252BKinase%26aulast%3DRavi%26aufirst%3DSrimadhavi%26date%3D2020%26volume%3D20%26issue%3D23%26spage%3D2070%26epage%3D2079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles A.  Kunos</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Radiosensitization Strategies in Uterine Cervix Cancer. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Radiation Oncology</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 281-290. <a href="https://doi.org/10.1016/j.semradonc.2020.05.001" title="DOI URL">https://doi.org/10.1016/j.semradonc.2020.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semradonc.2020.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semradonc.2020.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Radiation%2520Oncology%26atitle%3DNovel%252BRadiosensitization%252BStrategies%252Bin%252BUterine%252BCervix%252BCancer%26aulast%3DKunos%26aufirst%3DCharles%2BA.%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D281%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Selvaraj  Shyamsivappan</span>, <span class="hlFld-ContribAuthor ">Arjunan  Saravanan</span>, <span class="hlFld-ContribAuthor ">Raju  Vivek</span>, <span class="hlFld-ContribAuthor ">Thangaraj  Suresh</span>, <span class="hlFld-ContribAuthor ">Ramasamy  Shankar</span>, <span class="hlFld-ContribAuthor ">K. M.  Gothandam</span>, <span class="hlFld-ContribAuthor ">Palathurai Subramaniam  Mohan</span>. </span><span class="cited-content_cbyCitation_article-title">Novel phenyl and thiophene dispiro indenoquinoxaline pyrrolidine quinolones induced apoptosis
              via
              G1/S and G2/M phase cell cycle arrest in MCF-7 cells. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (35)
                                     , 15031-15045. <a href="https://doi.org/10.1039/D0NJ02588G" title="DOI URL">https://doi.org/10.1039/D0NJ02588G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ02588G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ02588G%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DNovel%252Bphenyl%252Band%252Bthiophene%252Bdispiro%252Bindenoquinoxaline%252Bpyrrolidine%252Bquinolones%252Binduced%252Bapoptosis%252Bvia%252BG1%25252FS%252Band%252BG2%25252FM%252Bphase%252Bcell%252Bcycle%252Barrest%252Bin%252BMCF-7%252Bcells%26aulast%3DShyamsivappan%26aufirst%3DSelvaraj%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D35%26spage%3D15031%26epage%3D15045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lijie  Xing</span>, <span class="hlFld-ContribAuthor ">Liang  Lin</span>, <span class="hlFld-ContribAuthor ">Tengteng  Yu</span>, <span class="hlFld-ContribAuthor ">Yuyin  Li</span>, <span class="hlFld-ContribAuthor ">Shih-Feng  Cho</span>, <span class="hlFld-ContribAuthor ">Jiye  Liu</span>, <span class="hlFld-ContribAuthor ">Kenneth  Wen</span>, <span class="hlFld-ContribAuthor ">Phillip A.  Hsieh</span>, <span class="hlFld-ContribAuthor ">Krista  Kinneer</span>, <span class="hlFld-ContribAuthor ">Nikhil  Munshi</span>, <span class="hlFld-ContribAuthor ">Kenneth C.  Anderson</span>, <span class="hlFld-ContribAuthor ">Yu-Tzu  Tai</span>. </span><span class="cited-content_cbyCitation_article-title">A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma. </span><span class="cited-content_cbyCitation_journal-name">Leukemia</span><span> <strong>2020,</strong> <em>34 </em>
                                    (8)
                                     , 2150-2162. <a href="https://doi.org/10.1038/s41375-020-0745-9" title="DOI URL">https://doi.org/10.1038/s41375-020-0745-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41375-020-0745-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41375-020-0745-9%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%26atitle%3DA%252Bnovel%252BBCMA%252BPBD-ADC%252Bwith%252BATM%25252FATR%25252FWEE1%252Binhibitors%252Bor%252Bbortezomib%252Binduce%252Bsynergistic%252Blethality%252Bin%252Bmultiple%252Bmyeloma%26aulast%3DXing%26aufirst%3DLijie%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3D8%26spage%3D2150%26epage%3D2162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beth  Williamson</span>, <span class="hlFld-ContribAuthor ">Nicola  Colclough</span>, <span class="hlFld-ContribAuthor ">Adrian John  Fretland</span>, <span class="hlFld-ContribAuthor ">Barry Christopher  Jones</span>, <span class="hlFld-ContribAuthor ">Rhys Dafydd Owen  Jones</span>, <span class="hlFld-ContribAuthor ">Dermot Francis  McGinnity</span>. </span><span class="cited-content_cbyCitation_article-title">Further Considerations Towards an Effective and Efficient Oncology Drug Discovery DMPK Strategy. </span><span class="cited-content_cbyCitation_journal-name">Current Drug Metabolism</span><span> <strong>2020,</strong> <em>21 </em>
                                    (2)
                                     , 145-162. <a href="https://doi.org/10.2174/1389200221666200312104837" title="DOI URL">https://doi.org/10.2174/1389200221666200312104837</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389200221666200312104837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389200221666200312104837%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Drug%2520Metabolism%26atitle%3DFurther%252BConsiderations%252BTowards%252Ban%252BEffective%252Band%252BEfficient%252BOncology%252BDrug%252BDiscovery%252BDMPK%252BStrategy%26aulast%3DWilliamson%26aufirst%3DBeth%26date%3D2020%26volume%3D21%26issue%3D2%26spage%3D145%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin F.  Lavin</span>, <span class="hlFld-ContribAuthor ">Abrey J.  Yeo</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical potential of ATM inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis</span><span> <strong>2020,</strong> <em>821 </em>, 111695. <a href="https://doi.org/10.1016/j.mrfmmm.2020.111695" title="DOI URL">https://doi.org/10.1016/j.mrfmmm.2020.111695</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mrfmmm.2020.111695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mrfmmm.2020.111695%26sid%3Dliteratum%253Aachs%26jtitle%3DMutation%2520Research%252FFundamental%2520and%2520Molecular%2520Mechanisms%2520of%2520Mutagenesis%26atitle%3DClinical%252Bpotential%252Bof%252BATM%252Binhibitors%26aulast%3DLavin%26aufirst%3DMartin%2BF.%26date%3D2020%26volume%3D821%26spage%3D111695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johan  Wernevik</span>, <span class="hlFld-ContribAuthor ">Fredrik  Bergström</span>, <span class="hlFld-ContribAuthor ">Anna  Novén</span>, <span class="hlFld-ContribAuthor ">Johan  Hulthe</span>, <span class="hlFld-ContribAuthor ">Linda  Fredlund</span>, <span class="hlFld-ContribAuthor ">Dan  Addison</span>, <span class="hlFld-ContribAuthor ">Jan  Holmgren</span>, <span class="hlFld-ContribAuthor ">Per-Erik  Strömstedt</span>, <span class="hlFld-ContribAuthor ">Erika  Rehnström</span>, <span class="hlFld-ContribAuthor ">Thomas  Lundbäck</span>. </span><span class="cited-content_cbyCitation_article-title">A Fully Integrated Assay Panel for Early Drug Metabolism and Pharmacokinetics Profiling. </span><span class="cited-content_cbyCitation_journal-name">ASSAY and Drug Development Technologies</span><span> <strong>2020,</strong> <em>18 </em>
                                    (4)
                                     , 157-179. <a href="https://doi.org/10.1089/adt.2020.970" title="DOI URL">https://doi.org/10.1089/adt.2020.970</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/adt.2020.970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fadt.2020.970%26sid%3Dliteratum%253Aachs%26jtitle%3DASSAY%2520and%2520Drug%2520Development%2520Technologies%26atitle%3DA%252BFully%252BIntegrated%252BAssay%252BPanel%252Bfor%252BEarly%252BDrug%252BMetabolism%252Band%252BPharmacokinetics%252BProfiling%26aulast%3DWernevik%26aufirst%3DJohan%26date%3D2020%26volume%3D18%26issue%3D4%26spage%3D157%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hannah L.  Smith</span>, <span class="hlFld-ContribAuthor ">Harriet  Southgate</span>, <span class="hlFld-ContribAuthor ">Deborah A.  Tweddle</span>, <span class="hlFld-ContribAuthor ">Nicola J.  Curtin</span>. </span><span class="cited-content_cbyCitation_article-title">DNA damage checkpoint kinases in cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Reviews in Molecular Medicine</span><span> <strong>2020,</strong> <em>22 </em><a href="https://doi.org/10.1017/erm.2020.3" title="DOI URL">https://doi.org/10.1017/erm.2020.3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1017/erm.2020.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1017%2Ferm.2020.3%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Reviews%2520in%2520Molecular%2520Medicine%26atitle%3DDNA%252Bdamage%252Bcheckpoint%252Bkinases%252Bin%252Bcancer%26aulast%3DSmith%26aufirst%3DHannah%2BL.%26date%3D2020%26date%3D2020%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joyce P.Y.  Mak</span>, <span class="hlFld-ContribAuthor ">Hoi Tang  Ma</span>, <span class="hlFld-ContribAuthor ">Randy Y.C.  Poon</span>. </span><span class="cited-content_cbyCitation_article-title">Synergism between ATM and PARP1 Inhibition Involves DNA Damage and Abrogating the G
              2
              DNA Damage Checkpoint. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2020,</strong> <em>19 </em>
                                    (1)
                                     , 123-134. <a href="https://doi.org/10.1158/1535-7163.MCT-19-0474" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-19-0474</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-19-0474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-19-0474%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DSynergism%252Bbetween%252BATM%252Band%252BPARP1%252BInhibition%252BInvolves%252BDNA%252BDamage%252Band%252BAbrogating%252Bthe%252BG%252B2%252BDNA%252BDamage%252BCheckpoint%26aulast%3DMak%26aufirst%3DJoyce%2BP.Y.%26date%3D2020%26date%3D2019%26volume%3D19%26issue%3D1%26spage%3D123%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masaya  Igase</span>, <span class="hlFld-ContribAuthor ">Shusaku  Shibutani</span>, <span class="hlFld-ContribAuthor ">Yosuke  Kurogouchi</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Fujiki</span>, <span class="hlFld-ContribAuthor ">Chung Chew  Hwang</span>, <span class="hlFld-ContribAuthor ">Matt  Coffey</span>, <span class="hlFld-ContribAuthor ">Shunsuke  Noguchi</span>, <span class="hlFld-ContribAuthor ">Yuki  Nemoto</span>, <span class="hlFld-ContribAuthor ">Takuya  Mizuno</span>. </span><span class="cited-content_cbyCitation_article-title">Combination Therapy with Reovirus and ATM Inhibitor Enhances Cell Death and Virus Replication in Canine Melanoma. </span><span class="cited-content_cbyCitation_journal-name">Molecular Therapy - Oncolytics</span><span> <strong>2019,</strong> <em>15 </em>, 49-59. <a href="https://doi.org/10.1016/j.omto.2019.08.003" title="DOI URL">https://doi.org/10.1016/j.omto.2019.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.omto.2019.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.omto.2019.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Therapy%2520-%2520Oncolytics%26atitle%3DCombination%252BTherapy%252Bwith%252BReovirus%252Band%252BATM%252BInhibitor%252BEnhances%252BCell%252BDeath%252Band%252BVirus%252BReplication%252Bin%252BCanine%252BMelanoma%26aulast%3DIgase%26aufirst%3DMasaya%26date%3D2019%26volume%3D15%26spage%3D49%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mei Hua  Jin</span>, <span class="hlFld-ContribAuthor ">Do-Youn  Oh</span>. </span><span class="cited-content_cbyCitation_article-title">ATM in DNA repair in cancer. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2019,</strong> <em>203 </em>, 107391. <a href="https://doi.org/10.1016/j.pharmthera.2019.07.002" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2019.07.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2019.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2019.07.002%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DATM%252Bin%252BDNA%252Brepair%252Bin%252Bcancer%26aulast%3DJin%26aufirst%3DMei%2BHua%26date%3D2019%26volume%3D203%26spage%3D107391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. Percy  Ivy</span>, <span class="hlFld-ContribAuthor ">Charles A.  Kunos</span>, <span class="hlFld-ContribAuthor ">Fernanda I.  Arnaldez</span>, <span class="hlFld-ContribAuthor ">Elise C.  Kohn</span>. </span><span class="cited-content_cbyCitation_article-title">Defining and targeting wild-type BRCA high-grade serous ovarian cancer: DNA repair and cell cycle checkpoints. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2019,</strong> <em>28 </em>
                                    (9)
                                     , 771-785. <a href="https://doi.org/10.1080/13543784.2019.1657403" title="DOI URL">https://doi.org/10.1080/13543784.2019.1657403</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2019.1657403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2019.1657403%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DDefining%252Band%252Btargeting%252Bwild-type%252BBRCA%252Bhigh-grade%252Bserous%252Bovarian%252Bcancer%25253A%252BDNA%252Brepair%252Band%252Bcell%252Bcycle%252Bcheckpoints%26aulast%3DIvy%26aufirst%3DS.%2BPercy%26date%3D2019%26date%3D2019%26volume%3D28%26issue%3D9%26spage%3D771%26epage%3D785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joshua L.  Justice</span>, <span class="hlFld-ContribAuthor ">Jason M.  Needham</span>, <span class="hlFld-ContribAuthor ">Sunnie R.  Thompson</span>, . </span><span class="cited-content_cbyCitation_article-title">BK Polyomavirus Activates the DNA Damage Response To Prolong S Phase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Virology</span><span> <strong>2019,</strong> <em>93 </em>
                                    (14)
                                     <a href="https://doi.org/10.1128/JVI.00130-19" title="DOI URL">https://doi.org/10.1128/JVI.00130-19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/JVI.00130-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FJVI.00130-19%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Virology%26atitle%3DBK%252BPolyomavirus%252BActivates%252Bthe%252BDNA%252BDamage%252BResponse%252BTo%252BProlong%252BS%252BPhase%26aulast%3DJustice%26aufirst%3DJoshua%2BL.%26date%3D2019%26volume%3D93%26issue%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicola  Colclough</span>, <span class="hlFld-ContribAuthor ">Kan  Chen</span>, <span class="hlFld-ContribAuthor ">Peter  Johnström</span>, <span class="hlFld-ContribAuthor ">Markus  Fridén</span>, <span class="hlFld-ContribAuthor ">Dermot F.  McGinnity</span>. </span><span class="cited-content_cbyCitation_article-title">Building on the success of osimertinib: achieving CNS exposure in oncology drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2019,</strong> <em>24 </em>
                                    (5)
                                     , 1067-1073. <a href="https://doi.org/10.1016/j.drudis.2019.01.015" title="DOI URL">https://doi.org/10.1016/j.drudis.2019.01.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2019.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2019.01.015%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DBuilding%252Bon%252Bthe%252Bsuccess%252Bof%252Bosimertinib%25253A%252Bachieving%252BCNS%252Bexposure%252Bin%252Boncology%252Bdrug%252Bdiscovery%26aulast%3DColclough%26aufirst%3DNicola%26date%3D2019%26volume%3D24%26issue%3D5%26spage%3D1067%26epage%3D1073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E.V.  Minten</span>, <span class="hlFld-ContribAuthor ">D.S.  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">DNA Repair: Translation to the Clinic. </span><span class="cited-content_cbyCitation_journal-name">Clinical Oncology</span><span> <strong>2019,</strong> <em>31 </em>
                                    (5)
                                     , 303-310. <a href="https://doi.org/10.1016/j.clon.2019.02.007" title="DOI URL">https://doi.org/10.1016/j.clon.2019.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.clon.2019.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.clon.2019.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Oncology%26atitle%3DDNA%252BRepair%25253A%252BTranslation%252Bto%252Bthe%252BClinic%26aulast%3DMinten%26aufirst%3DE.V.%26date%3D2019%26volume%3D31%26issue%3D5%26spage%3D303%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberto  Paredes</span>, <span class="hlFld-ContribAuthor ">Marion  Schneider</span>, <span class="hlFld-ContribAuthor ">Adam  Stevens</span>, <span class="hlFld-ContribAuthor ">Daniel J  White</span>, <span class="hlFld-ContribAuthor ">Andrew J K  Williamson</span>, <span class="hlFld-ContribAuthor ">Joanne  Muter</span>, <span class="hlFld-ContribAuthor ">Stella  Pearson</span>, <span class="hlFld-ContribAuthor ">James R  Kelly</span>, <span class="hlFld-ContribAuthor ">Kathleen  Connors</span>, <span class="hlFld-ContribAuthor ">Daniel H  Wiseman</span>, <span class="hlFld-ContribAuthor ">John A  Chadwick</span>, <span class="hlFld-ContribAuthor ">Harald  Löffler</span>, <span class="hlFld-ContribAuthor ">Hsiang Ying  Teng</span>, <span class="hlFld-ContribAuthor ">Simon  Lovell</span>, <span class="hlFld-ContribAuthor ">Richard  Unwin</span>, <span class="hlFld-ContribAuthor ">Henri J  van de Vrugt</span>, <span class="hlFld-ContribAuthor ">Helen  Smith</span>, <span class="hlFld-ContribAuthor ">Olga  Kustikova</span>, <span class="hlFld-ContribAuthor ">Axel  Schambach</span>, <span class="hlFld-ContribAuthor ">Tim C P  Somervaille</span>, <span class="hlFld-ContribAuthor ">Andrew  Pierce</span>, <span class="hlFld-ContribAuthor ">Anthony D  Whetton</span>, <span class="hlFld-ContribAuthor ">Stefan  Meyer</span>. </span><span class="cited-content_cbyCitation_article-title">EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 association. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2018,</strong> <em>46 </em>
                                    (15)
                                     , 7662-7674. <a href="https://doi.org/10.1093/nar/gky536" title="DOI URL">https://doi.org/10.1093/nar/gky536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gky536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgky536%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DEVI1%252Bcarboxy-terminal%252Bphosphorylation%252Bis%252BATM-mediated%252Band%252Bsustains%252Btranscriptional%252Bmodulation%252Band%252Bself-renewal%252Bvia%252Benhanced%252BCtBP1%252Bassociation%26aulast%3DParedes%26aufirst%3DRoberto%26date%3D2018%26date%3D2018%26volume%3D46%26issue%3D15%26spage%3D7662%26epage%3D7674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen T.  Durant</span>, <span class="hlFld-ContribAuthor ">Li  Zheng</span>, <span class="hlFld-ContribAuthor ">Yingchun  Wang</span>, <span class="hlFld-ContribAuthor ">Kan  Chen</span>, <span class="hlFld-ContribAuthor ">Lingli  Zhang</span>, <span class="hlFld-ContribAuthor ">Tianwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhenfan  Yang</span>, <span class="hlFld-ContribAuthor ">Lucy  Riches</span>, <span class="hlFld-ContribAuthor ">Antonio G.  Trinidad</span>, <span class="hlFld-ContribAuthor ">Jacqueline H. L.  Fok</span>, <span class="hlFld-ContribAuthor ">Tom  Hunt</span>, <span class="hlFld-ContribAuthor ">Kurt G.  Pike</span>, <span class="hlFld-ContribAuthor ">Joanne  Wilson</span>, <span class="hlFld-ContribAuthor ">Aaron  Smith</span>, <span class="hlFld-ContribAuthor ">Nicola  Colclough</span>, <span class="hlFld-ContribAuthor ">Venkatesh Pilla  Reddy</span>, <span class="hlFld-ContribAuthor ">Andrew  Sykes</span>, <span class="hlFld-ContribAuthor ">Annika  Janefeldt</span>, <span class="hlFld-ContribAuthor ">Peter  Johnström</span>, <span class="hlFld-ContribAuthor ">Katarina  Varnäs</span>, <span class="hlFld-ContribAuthor ">Akihiro  Takano</span>, <span class="hlFld-ContribAuthor ">Stephanie  Ling</span>, <span class="hlFld-ContribAuthor ">Jonathan  Orme</span>, <span class="hlFld-ContribAuthor ">Jonathan  Stott</span>, <span class="hlFld-ContribAuthor ">Caroline  Roberts</span>, <span class="hlFld-ContribAuthor ">Ian  Barrett</span>, <span class="hlFld-ContribAuthor ">Gemma  Jones</span>, <span class="hlFld-ContribAuthor ">Martine  Roudier</span>, <span class="hlFld-ContribAuthor ">Andrew  Pierce</span>, <span class="hlFld-ContribAuthor ">Jasmine  Allen</span>, <span class="hlFld-ContribAuthor ">Jenna  Kahn</span>, <span class="hlFld-ContribAuthor ">Amrita  Sule</span>, <span class="hlFld-ContribAuthor ">Jeremy  Karlin</span>, <span class="hlFld-ContribAuthor ">Anna  Cronin</span>, <span class="hlFld-ContribAuthor ">Melissa  Chapman</span>, <span class="hlFld-ContribAuthor ">Kristoffer  Valerie</span>, <span class="hlFld-ContribAuthor ">Ruth  Illingworth</span>, <span class="hlFld-ContribAuthor ">Martin  Pass</span>. </span><span class="cited-content_cbyCitation_article-title">The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. </span><span class="cited-content_cbyCitation_journal-name">Science Advances</span><span> <strong>2018,</strong> <em>4 </em>
                                    (6)
                                     , eaat1719. <a href="https://doi.org/10.1126/sciadv.aat1719" title="DOI URL">https://doi.org/10.1126/sciadv.aat1719</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/sciadv.aat1719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fsciadv.aat1719%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Advances%26atitle%3DThe%252Bbrain-penetrant%252Bclinical%252BATM%252Binhibitor%252BAZD1390%252Bradiosensitizes%252Band%252Bimproves%252Bsurvival%252Bof%252Bpreclinical%252Bbrain%252Btumor%252Bmodels%26aulast%3DDurant%26aufirst%3DStephen%2BT.%26date%3D2018%26date%3D2018%26volume%3D4%26issue%3D6%26spage%3Deaat1719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian  Hickson</span>, <span class="hlFld-ContribAuthor ">Kurt G.  Pike</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Durant</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting ATM for Cancer Therapy: Prospects for Drugging ATM. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 185-208. <a href="https://doi.org/10.1007/978-3-319-75836-7_8" title="DOI URL">https://doi.org/10.1007/978-3-319-75836-7_8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-75836-7_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-75836-7_8%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BATM%252Bfor%252BCancer%252BTherapy%25253A%252BProspects%252Bfor%252BDrugging%252BATM%26aulast%3DHickson%26aufirst%3DIan%26date%3D2018%26date%3D2018%26spage%3D185%26epage%3D208%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DTargeting%252Bthe%252BDNA%252BDamage%252BResponse%252Bfor%252BAnti-Cancer%252BTherapy%26aulast%3DPollard%26aufirst%3DJohn%26date%3D2018%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0028.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of LY294002 (<b>1</b>), KU-55933 (<b>2</b>), KU-59403 (<b>3</b>), and quinazoline <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>12</b>–<b>15</b>, <b>16</b>, and <b>18</b>–<b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1,3-diethyl 2-(ethoxymethylidene)propanedioate, EtOH, 80 °C, 4 h (84%); (b) Ph<sub>2</sub>O, 240 °C, 2.5 h (64%); (c) NaOH, EtOH, water, 75 °C, 2 h (89%); (d) SOCl<sub>2</sub>, DMF, 75 °C, 2 h, NH<sub>4</sub>OH (100%); (e) aryl boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 90 °C, 4 h (72%); (f) amine, DIPEA, DMA, 30–100 °C, 5–6h (44–72%); (g) trichloroisocyanuric acid, DBU, MeOH, rt, 0.25–2 h (56–70%); (h) MeI, TBAB, NaOH, DCM, water, rt, 2.5–24 h, (21–49%); (i) 3-(aminomethyl)pentane, DIPEA, DMA, 100 °C, 5 h (100%); (j) 2-fluoro-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 95 °C, 3 h (82%); (k) 2-(pyrrolidin-1-yl)ethan-1-amine, DIPEA, DMA, 34 °C, 1 h (80%); (l) (S)-1-(tetrahydro-2H-pyran-4-yl)ethanamine, DIPEA, DMA, 100 °C, 24 h (70%); (m) trichloroisocyanuric acid, DBU, MeOH, rt, 20 min (100%); (n) MeI, TBAB, NaOH, DCM, water, rt, 2.5 h, (98%); (o) aryl boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF:water, 90 °C, 2 h (37%); (p) tetrahydro-2<i>H</i>-pyran-4-amine, DIPEA, DMA, 100 °C, 24 h (78%); (q) trichloroisocyanuric acid, DBU, MeOH, rt, 15 min (98%); (r) MeI, TBAB, NaOH, DCM, water, rt, 24 h, (26%); (s) aryl boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 80–90 °C, 1.5–2 h (40–74%).</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>24</b>, <b>25</b>, and <b>27</b>–<b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) SOCl<sub>2</sub>, DMF, 80 °C, 4 h (70%); (b) 3-methoxycyclobutan-1-amine·HCl, DIPEA, DMA, 85 °C, 3 h (77%); (c) NaOH, EtOH, water, 40 °C, 2 h (81%); (d) DPPA, TEA, DMF, 60 °C, 2 h, (77%); (e) MeI, TBAB, NaOH, DCM, water, rt, 24 h, (75%); (f) (6-fluoropyridin-3-yl)boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 90 °C, 3 h; (g) amine, DMSO, 110 °C, 1–2 h (47–54%); (h) B<sub>2</sub>Pin<sub>2</sub>, (dppf)PdCl<sub>2</sub>, KOAc, dioxane, 80 °C, 2 h (76%); (i) aryl boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 80 °C, 2 h (17%); (j) (6-[[(<i>tert</i>-butoxy)carbonyl]amino]pyridin-3-yl)boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 100 °C, 3 h (70%); (k) 4-chlorobutanoyl chloride, DIPEA, DCM, rt, 16 h (66%); (l) TFA, DCM, rt, 30 min (99%); (m) dimethylamine, NaI, THF, 60 °C, 16 h, (19%); (n) arylboronic ester, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 80 °C, 2–6 h (22–62%).</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0013.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 1<i>H</i>-Imidazo[4,5-<i>c</i>]quinolin-2(3<i>H</i>)-ones by Hoffmann Rearrangement<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1,3-diethyl 2-(ethoxymethylidene)propanedioate, EtOH, 78 °C, 24 h (90%); (b) Ph<sub>2</sub>O, 240 °C, 1 h; (c) NaOH, EtOH, water, 75 °C, 1.5 h (96%); (d) SOCl<sub>2</sub>, DMF, 70 °C, 2 h, NH<sub>4</sub>OH (95%); (e) 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 100 °C, 5 h (72%); (f) tetrahydro-2<i>H</i>-pyran-4-amine·HCl, DIPEA, DMF, 80 °C, 16 h (19%); (g) trichloroisocyanuric acid, DBU, MeOH, rt, 30 min (87%); (h) DMFDMA, DMF, 80 °C, 1.5 h (43%) or iodopropane, NaH, DMF, 55 °C, 30 min, (9%); (i) oxetan-3-amine, DIPEA, DMA, 100 °C, 18 h (100%); (j) trichloroisocyanuric acid, DBU, MeOH, rt, 24 h (19%); (k) MeI, TBAB, NaOH, DCM, water, rt, 36 h, (92%); (l) boronic ester, dichloro [1,1′-bis(ditertbutylphosphino)ferrocene] palladium(II), K<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 1 h (58%); (m) 3-methoxycyclobutan-1-amine·HCl, DIPEA, DMA, 100 °C, 16 h (68%); (n) trichloroisocyanuric acid, DBU, MeOH, rt, 18 h (99%); (o) MeI, TBAB, NaOH, DCM, water, rt, 12 h, (75%); (p) arylboronate, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 80–90 °C, 2–3 h (36–75%); (q) (6-fluoropyridin-3-yl)boronic acid, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 90 °C, 4 h (86%); (r) alcohol, NaH, DMF or DMA, rt, 10 min -24 h (25–75%) (for <b>45</b> an additional step: TFA, DCM, rt, 1 h, was required); (s) (6-(3-bromopropoxy)pyridin-3-yl)boronic ester, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 90 °C, 1 h (27%); (t) MsCl, DIPEA, DMF, rt, 30 min; (u) morpholine, DIPEA rt (9% over 2 steps).</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0014.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 1<i>H</i>-Imidazo[4,5-<i>c</i>]quinolin-2(3<i>H</i>)-ones by Curtius Rearrangement<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) SOCl<sub>2</sub>, DMF, 75 °C, 16 h (83%); (b) amine, DIPEA, DMA, 80–90 °C, 1.5–16 h (83–97%); (c) NaOH, THF, MeOH, water, 60 °C, 1.5–3 h (95–100%); (d) DPPA, TEA, DMF, 60 °C, 1–16 h, (80–98%); (e) MeI, TBAB, NaOH, DCM, water, rt, 1–12 h or DMFDMA, DMF, 80 °C, 3 h (75–96%); (f) (6-fluoropyridin-3-yl)boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 100 °C, 3 h (87%); (g) 3-(piperidin-1-yl)propan-1-ol, NaH, THF, rt, 24 h (28%); (h) aryl boronic ester, Cs<sub>2</sub>CO<sub>3</sub>, X-phos-2Gen or Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 90–100 °C, 2–3 h (41–62%); (i) tetrahydro-2<i>H</i>-pyran-4-amine, DIPEA, DMF, 60 °C, 16 h (100%); (j) 2-(methoxymethyl)-5-boronic ester-pyridine Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 100 °C, 2 h (95%); (k) NaOH, THF, water, 60 °C, 4 h (92%); (l) DPPA, TEA, DMF, 60 °C, 7 h, (79%); (m) MeI, TBAB, NaOH, DCM, water, rt, 72 h (62%); (n) tetrahydro-2<i>H</i>-pyran-4-amine, DIPEA, DMF, 60 °C, 16 h (100%); (o) NaOH, MeOH, water, 70 °C, 2 h (86%); (p) DPPA, TEA, DMF, 60 °C, 2 h, (99%); (q) MeI, TBAB, NaOH, DCM, water, rt, 16 h (93%); (r) (6-fluoropyridin-3-yl)boronic acid, Cl<sub>4</sub>Na<sub>2</sub>Pd, DTBPPS, K<sub>2</sub>CO<sub>3</sub>, dioxane:water, 100 °C, 16 h (96%); (s) alcohol, NaH, DMA or DMF, rt to 50 °C, 2–16 h, (82–90%); (t) NADP, K<sub>2</sub>PO<sub>4</sub>, Codexis KRED, Codexis BVMO, 2-propanol, water, rt, 41 h (39%).</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0015.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <b>70</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1,3-diethyl 2-(ethoxymethylidene)propanedioate, EtOH, 80 °C, 4 h (90%); (b) Ph<sub>2</sub>O, 220 °C, 2 h (37%); (c) NaOH, EtOH, water, 100 °C, 0.5 h (92%); (d) SOCl<sub>2</sub>, DMF, 80 °C, 2 h, NH<sub>4</sub>OH (100%); (e) tetrahydro-2<i>H</i>-pyran-4-amine·HCl, DIPEA, DMA, rt, 18 h (37%); (f) trichloroisocyanuric acid, DBU, MeOH, rt, 30 min (75%); (g) MeI, TBAB, NaOH, DCM, water, rt, 12 h (75%); (h) boronic ester, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 90 °C, 2 h (28%).</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0016.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>74</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) diethyloxomalonate, aq EtOH, rt, 18 h (92%); (b) NaOH, EtOH, 78 °C, 50 min (81%); (c) SOCl<sub>2</sub>, 44 °C, 2 h, (97%); (d) TiCl<sub>4</sub>, nitrobenzene, 95 °C, 18 h then EtOH, H<sub>2</sub>SO<sub>4</sub>, 95 °C, 5 h (34%); (e) SOCl<sub>2</sub>, 75 °C, 3 h, (100%); (f) tetrahydro-2<i>H</i>-pyran-4-amine·HCl, TEA, THF, rt, 30 min (98%); (g) NaOH, MeOH, water, rt, 1 h; (h) DPPA, TEA, DMF, 60 °C, 3 h (60% over 2 steps); (i) DMFDMA, DMF, 80 °C, 4 h (91%); (j) boronic ester, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane:water, 80 °C, 2 h (8.5%).</p></p></figure><figure data-id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of basic quinoline carboxamide <b>16</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3a" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0003.jpeg" id="rightTab-GRAPHIC-d141e2105-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) In silico model of ATM with <b>36</b> bound into the ATP binding site. (b) In silico model of ATM with <b>38</b> bound into the ATP binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig3a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Relative energy for the conformational strain of a biaryl system as a function of dihedral with different substitution patterns, from quantum mechanics (DFT, B3LYP, 6-31G**).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0005.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of <b>70</b> and <b>74</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6a" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0006.jpeg" id="rightTab-GRAPHIC-d141e3184-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Predicted binding mode of <b>64</b> in ATM. (b) Solution conformation of <b>64</b> as determined by NMR (major isomer in green, minor isomer in gray).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig6a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7a" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0007.jpeg" id="rightTab-GRAPHIC-d141e3250-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) <b>64</b> potentiates the efficacy of irinotecan in an SW620 xenograft model. (b) <b>64</b> potentiates the efficacy of olaparib in a HBCx-10 patient derived tumor xenograft model. (c) Four out of 10 mice show tumor regressions in a HBCx-10 patient derived tumor xenograft model following treatment with olaparib (50 mg/kg PO QD). (d) Nine out of 10 mice show tumor regressions in a HBCx-10 patient derived tumor xenograft model following treatment with olaparib (50 mg/kg PO QD) and <b>64</b> (5 mg/kg PO QD days 1–3 weekly).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig7a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0008.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. PBPK simulation of steady state human exposure following a 6 mg daily oral dose of <b>64</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0009.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structure of <b>65</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/medium/jm-2017-01896w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0010.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Mean (+ standard deviation) plasma concentration (ng/mL) of <b>64</b> versus time at steady state following twice daily oral administration at the dose levels of 15, 30, 60, and 120 mg BID in patients with solid tumors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01896/20180504/images/large/jm-2017-01896w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01896&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10346" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10346" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 64 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartek, J.</span></span> <span> </span><span class="NLM_article-title">The DNA damage response in human biology and disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">1071</span>– <span class="NLM_lpage">1078</span>, <span class="refDoi"> DOI: 10.1038/nature08467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1038%2Fnature08467" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=1071-1078&author=S.+P.+Jacksonauthor=J.+Bartek&title=The+DNA+damage+response+in+human+biology+and+disease&doi=10.1038%2Fnature08467"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature08467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08467%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DBartek%26aufirst%3DJ.%26atitle%3DThe%2520DNA%2520damage%2520response%2520in%2520human%2520biology%2520and%2520disease%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D1071%26epage%3D1078%26doi%3D10.1038%2Fnature08467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ciccia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elledge, S. J.</span></span> <span> </span><span class="NLM_article-title">The DNA damage response: making it safe to play with knives</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2010.09.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.molcel.2010.09.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=20965415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCjtr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=179-204&author=A.+Cicciaauthor=S.+J.+Elledge&title=The+DNA+damage+response%3A+making+it+safe+to+play+with+knives&doi=10.1016%2Fj.molcel.2010.09.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The DNA Damage Response: Making It Safe to Play with Knives</span></div><div class="casAuthors">Ciccia, Alberto; Elledge, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-204</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Damage to our genetic material is an ongoing threat to both our ability to faithfully transmit genetic information to our offspring as well as our own survival.  To respond to these threats, eukaryotes have evolved the DNA damage response (DDR).  The DDR is a complex signal transduction pathway that has the ability to sense DNA damage and transduce this information to the cell to influence cellular responses to DNA damage.  Cells possess an arsenal of enzymic tools capable of remodeling and repairing DNA; however, their activities must be tightly regulated in a temporal, spatial, and DNA lesion-appropriate fashion to optimize repair and prevent unnecessary and potentially deleterious alterations in the structure of DNA during normal cellular processes.  This review will focus on how the DDR controls DNA repair and the phenotypic consequences of defects in these crit. regulatory functions in mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofclv-VUxTXLVg90H21EOLACvtfcHk0liN-wCIixnpEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCjtr7P&md5=71d5ed7d3a82d9b395877510bbe4df03</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2010.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2010.09.019%26sid%3Dliteratum%253Aachs%26aulast%3DCiccia%26aufirst%3DA.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520DNA%2520damage%2520response%253A%2520making%2520it%2520safe%2520to%2520play%2520with%2520knives%26jtitle%3DMol.%2520Cell%26date%3D2010%26volume%3D40%26spage%3D179%26epage%3D204%26doi%3D10.1016%2Fj.molcel.2010.09.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoeijmakers, J. H.</span></span> <span> </span><span class="NLM_article-title">Genome maintenance mechanisms for preventing cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>411</i></span>,  <span class="NLM_fpage">366</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1038/35077232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1038%2F35077232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=11357144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVSjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=366-374&author=J.+H.+Hoeijmakers&title=Genome+maintenance+mechanisms+for+preventing+cancer&doi=10.1038%2F35077232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Genome maintenance mechanisms for preventing cancer</span></div><div class="casAuthors">Hoeijmakers, Jan H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">6835</span>),
    <span class="NLM_cas:pages">366-374</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with 67 refs.  The early notion that cancer is caused by mutations in genes crit. for the control of cell growth implied that genome stability is important for preventing oncogenesis.  During the past decade, knowledge about the mechanisms by which genes erode and the mol. machinery designed to counteract this time-dependent genetic degeneration has increased markedly.  At the same time, it has become apparent that inherited or acquired deficiencies in genome maintenance systems contribute significantly to the onset of cancer.  This review summarizes the main DNA caretaking systems and their impact on genome stability and carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCLg3z9y6ZD7Vg90H21EOLACvtfcHk0liL2nK76AGADw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVSjs74%253D&md5=7ef77f478c786849b0ec44a9d3c5bd28</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F35077232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35077232%26sid%3Dliteratum%253Aachs%26aulast%3DHoeijmakers%26aufirst%3DJ.%2BH.%26atitle%3DGenome%2520maintenance%2520mechanisms%2520for%2520preventing%2520cancer%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D366%26epage%3D374%26doi%3D10.1038%2F35077232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeggo, P. A.</span></span> <span> </span><span class="NLM_article-title">DNA Double-strand break repair in a cellular context</span>. <i>Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1016/j.clon.2014.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.clon.2014.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=24630811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A280%3ADC%252BC2crjvFOlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=243-249&author=A.+Shibataauthor=P.+A.+Jeggo&title=DNA+Double-strand+break+repair+in+a+cellular+context&doi=10.1016%2Fj.clon.2014.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">DNA double-strand break repair in a cellular context</span></div><div class="casAuthors">Shibata A; Jeggo P A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical oncology (Royal College of Radiologists (Great Britain))</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">243-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Substantial insight into the mechanisms responding to DNA double-strand breaks has been gained from molecular, biochemical and structural approaches.  Attention is now focusing on understanding the interplay between the pathways, how they interface through the cell cycle and the communication with other DNA transactions, such as replication and transcription.  Understanding these aspects will facilitate an assessment of how cancer cells have modified these processes to achieve unlimited proliferative capacity and adaptability, and pave the way to identify targets suitable for therapy.  Here, we briefly overview the processes responding to double-strand breaks and discuss our current understanding of their interplay in a cellular context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlKWntb1MSj8-crCu0nI_sfW6udTcc2eYbA05yM3EaGrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crjvFOlsw%253D%253D&md5=4c933f2b2ae6393845f266f2d8336ee7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.clon.2014.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clon.2014.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DShibata%26aufirst%3DA.%26aulast%3DJeggo%26aufirst%3DP.%2BA.%26atitle%3DDNA%2520Double-strand%2520break%2520repair%2520in%2520a%2520cellular%2520context%26jtitle%3DClin.%2520Oncol.%26date%3D2014%26volume%3D26%26spage%3D243%26epage%3D249%26doi%3D10.1016%2Fj.clon.2014.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Radhakrishnan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jette, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lees-Miller, S. P.</span></span> <span> </span><span class="NLM_article-title">Non-homologous end joining: emerging themes and unanswered questions</span>. <i>DNA Repair</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/j.dnarep.2014.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.dnarep.2014.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=24582502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlSks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2014&pages=2-8&author=S.+K.+Radhakrishnanauthor=N.+Jetteauthor=S.+P.+Lees-Miller&title=Non-homologous+end+joining%3A+emerging+themes+and+unanswered+questions&doi=10.1016%2Fj.dnarep.2014.01.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Non-homologous end joining: Emerging themes and unanswered questions</span></div><div class="casAuthors">Radhakrishnan, Sarvan Kumar; Jette, Nicholas; Lees-Miller, Susan P.</div><div class="citationInfo"><span class="NLM_cas:title">DNA Repair</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2-8</span>CODEN:
                <span class="NLM_cas:coden">DRNEAR</span>;
        ISSN:<span class="NLM_cas:issn">1568-7864</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Non-homologous end joining (NHEJ) is the major pathway for the repair of ionizing radiation induced DNA double strand breaks in human cells.  Here, we discuss current insights into the mechanism of NHEJ and the interplay between NHEJ and other pathways for repair of IR-induced DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquSMYUuuBAkrVg90H21EOLACvtfcHk0liL2nK76AGADw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlSks74%253D&md5=bde81e38cc6cda0d04bc8c66473be237</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.dnarep.2014.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dnarep.2014.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DRadhakrishnan%26aufirst%3DS.%2BK.%26aulast%3DJette%26aufirst%3DN.%26aulast%3DLees-Miller%26aufirst%3DS.%2BP.%26atitle%3DNon-homologous%2520end%2520joining%253A%2520emerging%2520themes%2520and%2520unanswered%2520questions%26jtitle%3DDNA%2520Repair%26date%3D2014%26volume%3D17%26spage%3D2%26epage%3D8%26doi%3D10.1016%2Fj.dnarep.2014.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, M. J.</span></span> <span> </span><span class="NLM_article-title">Targeting the DNA damage response</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2015.10.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.molcel.2015.10.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2015&pages=547-560&author=M.+J.+O%E2%80%99Connor&title=Targeting+the+DNA+damage+response&doi=10.1016%2Fj.molcel.2015.10.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2015.10.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2015.10.040%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BJ.%26atitle%3DTargeting%2520the%2520DNA%2520damage%2520response%26jtitle%3DMol.%2520Cell%26date%3D2015%26volume%3D60%26spage%3D547%26epage%3D560%26doi%3D10.1016%2Fj.molcel.2015.10.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiloh, Y.</span></span> <span> </span><span class="NLM_article-title">Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart</span>. <i>Annu. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1146/annurev.genet.31.1.635</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1146%2Fannurev.genet.31.1.635" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1997&pages=635-662&author=Y.+Shiloh&title=Ataxia-telangiectasia+and+the+Nijmegen+breakage+syndrome%3A+related+disorders+but+genes+apart&doi=10.1146%2Fannurev.genet.31.1.635"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1146%2Fannurev.genet.31.1.635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.genet.31.1.635%26sid%3Dliteratum%253Aachs%26aulast%3DShiloh%26aufirst%3DY.%26atitle%3DAtaxia-telangiectasia%2520and%2520the%2520Nijmegen%2520breakage%2520syndrome%253A%2520related%2520disorders%2520but%2520genes%2520apart%26jtitle%3DAnnu.%2520Rev.%2520Genet.%26date%3D1997%26volume%3D31%26spage%3D635%26epage%3D662%26doi%3D10.1146%2Fannurev.genet.31.1.635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fruman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span> <span> </span><span class="NLM_article-title">Phosphoinositide kinases</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">507</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.67.1.481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1146%2Fannurev.biochem.67.1.481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=9759495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFOmsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1998&pages=481-507&author=D.+A.+Frumanauthor=R.+E.+Meyersauthor=L.+C.+Cantley&title=Phosphoinositide+kinases&doi=10.1146%2Fannurev.biochem.67.1.481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphoinositide kinases</span></div><div class="casAuthors">Fruman, David A.; Meyers, Rachel E.; Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">481-507</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 153 refs.  Several phosphorylated derivs. of phosphatidylinositol, collectively termed phosphoinositides, have been identified in eukaryotic cells from yeast to mammals.  Phosphoinositides are involved in the regulation of diverse cellular processes, including proliferation, survival, cytoskeletal organization, vesicle trafficking, glucose transport, and platelet function.  The enzymes that phosphorylate phosphatidylinositol and its derivs. are termed phosphoinositide kinases.  Recent advances have challenged previous hypotheses about the substrate selectivity of different phosphoinositide kinase families.  Here we re-examine the pathways of phosphoinositide synthesis and the enzymes involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMU_JFi14u3bVg90H21EOLACvtfcHk0libmleMzvZJwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFOmsb4%253D&md5=0b2fece266a4fc3f1b2a38b1693665c2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.67.1.481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.67.1.481%26sid%3Dliteratum%253Aachs%26aulast%3DFruman%26aufirst%3DD.%2BA.%26aulast%3DMeyers%26aufirst%3DR.%2BE.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DPhosphoinositide%2520kinases%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1998%26volume%3D67%26spage%3D481%26epage%3D507%26doi%3D10.1146%2Fannurev.biochem.67.1.481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiloh, Y.</span></span> <span> </span><span class="NLM_article-title">ATM and related protein kinases: safeguarding genome integrity</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1038/nrc1011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1038%2Fnrc1011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=12612651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFGhtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=155-168&author=Y.+Shiloh&title=ATM+and+related+protein+kinases%3A+safeguarding+genome+integrity&doi=10.1038%2Fnrc1011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">ATM and related protein kinases: safeguarding genome integrity</span></div><div class="casAuthors">Shiloh, Yosef</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">155-168</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Maintenance of genome stability is essential for avoiding the passage to neoplasia.  The DNA-damage response - a cornerstone of genome stability - occurs by a swift transduction of the DNA-damage signal to many cellular pathways.  A prime example is the cellular response to DNA double-strand breaks, which activate the ATM protein kinase that, in turn, modulates numerous signaling pathways.  ATM mutations lead to the cancer-predisposing genetic disorder ataxia-telangiectasia (A-T).  Understanding ATM's mode of action provides new insights into the assocn. between defective responses to DNA damage and cancer, and brings us closer to resolving the issue of cancer predisposition in some A-T carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6rldvrvSuQLVg90H21EOLACvtfcHk0libmleMzvZJwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFGhtr4%253D&md5=2d84325b04979dad3e33155fefa421e6</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrc1011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1011%26sid%3Dliteratum%253Aachs%26aulast%3DShiloh%26aufirst%3DY.%26atitle%3DATM%2520and%2520related%2520protein%2520kinases%253A%2520safeguarding%2520genome%2520integrity%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D155%26epage%3D168%26doi%3D10.1038%2Fnrc1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ditch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paull, T. T.</span></span> <span> </span><span class="NLM_article-title">The ATM protein kinase and cellular redox signaling: beyond the DNA damage response</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2011.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.tibs.2011.10.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=15-22&issue=1&author=S.+Ditchauthor=T.+T.+Paull&title=The+ATM+protein+kinase+and+cellular+redox+signaling%3A+beyond+the+DNA+damage+response&doi=10.1016%2Fj.tibs.2011.10.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2011.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2011.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DDitch%26aufirst%3DS.%26aulast%3DPaull%26aufirst%3DT.%2BT.%26atitle%3DThe%2520ATM%2520protein%2520kinase%2520and%2520cellular%2520redox%2520signaling%253A%2520beyond%2520the%2520DNA%2520damage%2520response%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2012%26volume%3D37%26issue%3D1%26spage%3D15%26epage%3D22%26doi%3D10.1016%2Fj.tibs.2011.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korabecny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nepovimova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodny, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moravcova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanzlikova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span> <span> </span><span class="NLM_article-title">The development of ataxia telangiectasia mutated kinase inhibitors</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">811</span>, <span class="refDoi"> DOI: 10.2174/1389557514666140820123656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.2174%2F1389557514666140820123656" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=805-811&author=M.+Andrsauthor=J.+Korabecnyauthor=E.+Nepovimovaauthor=D.+Junauthor=Z.+Hodnyauthor=S.+Moravcovaauthor=H.+Hanzlikovaauthor=K.+Kuca&title=The+development+of+ataxia+telangiectasia+mutated+kinase+inhibitors&doi=10.2174%2F1389557514666140820123656"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F1389557514666140820123656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557514666140820123656%26sid%3Dliteratum%253Aachs%26aulast%3DAndrs%26aufirst%3DM.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DHodny%26aufirst%3DZ.%26aulast%3DMoravcova%26aufirst%3DS.%26aulast%3DHanzlikova%26aufirst%3DH.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DThe%2520development%2520of%2520ataxia%2520telangiectasia%2520mutated%2520kinase%2520inhibitors%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2014%26volume%3D14%26spage%3D805%26epage%3D811%26doi%3D10.2174%2F1389557514666140820123656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paull, T. T.</span></span> <span> </span><span class="NLM_article-title">ATM Activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>308</i></span> (<span class="NLM_issue">5721</span>),  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">554</span>, <span class="refDoi"> DOI: 10.1126/science.1108297</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1126%2Fscience.1108297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=15790808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlOjt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2005&pages=551-554&issue=5721&author=J.+H.+Leeauthor=T.+T.+Paull&title=ATM+Activation+by+DNA+double-strand+breaks+through+the+Mre11-Rad50-Nbs1+complex&doi=10.1126%2Fscience.1108297"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">ATM Activation by DNA Double-Strand Breaks Through the Mre11-Rad50-Nbs1 Complex</span></div><div class="casAuthors">Lee, Ji-Hoon; Paull, Tanya T.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">5721</span>),
    <span class="NLM_cas:pages">551-554</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The ataxia-telangiectasia mutated (ATM) kinase signals the presence of DNA double-strand breaks in mammalian cells by phosphorylating proteins that initiate cell-cycle arrest, apoptosis, and DNA repair.  We show that the Mre11-Rad50-Nbs1 (MRN) complex acts as a double-strand break sensor for ATM and recruits ATM to broken DNA mols.  Inactive ATM dimers were activated in vitro with DNA in the presence of MRN, leading to phosphorylation of the downstream cellular targets p53 and Chk2.  ATM autophosphorylation was not required for monomerization of ATM by MRN.  The unwinding of DNA ends by MRN was essential for ATM stimulation, which is consistent with the central role of single-stranded DNA as an evolutionarily conserved signal for DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSkz54bE4FN7Vg90H21EOLACvtfcHk0libmleMzvZJwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlOjt7k%253D&md5=5b62f8c0fbcf0605d7c34257c383528a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.1108297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1108297%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DPaull%26aufirst%3DT.%2BT.%26atitle%3DATM%2520Activation%2520by%2520DNA%2520double-strand%2520breaks%2520through%2520the%2520Mre11-Rad50-Nbs1%2520complex%26jtitle%3DScience%26date%3D2005%26volume%3D308%26issue%3D5721%26spage%3D551%26epage%3D554%26doi%3D10.1126%2Fscience.1108297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bakkenist, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastan, M. B.</span></span> <span> </span><span class="NLM_article-title">DNA Damage activates ATM through intermolecular autophosphorylation and dimer dissociation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>421</i></span>,  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1038/nature01368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1038%2Fnature01368" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2003&pages=499-506&author=C.+J.+Bakkenistauthor=M.+B.+Kastan&title=DNA+Damage+activates+ATM+through+intermolecular+autophosphorylation+and+dimer+dissociation&doi=10.1038%2Fnature01368"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature01368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01368%26sid%3Dliteratum%253Aachs%26aulast%3DBakkenist%26aufirst%3DC.%2BJ.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26atitle%3DDNA%2520Damage%2520activates%2520ATM%2520through%2520intermolecular%2520autophosphorylation%2520and%2520dimer%2520dissociation%26jtitle%3DNature%26date%3D2003%26volume%3D421%26spage%3D499%26epage%3D506%26doi%3D10.1038%2Fnature01368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurimasa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D. J.</span></span> <span> </span><span class="NLM_article-title">ATM Phosphorylates histone H2AX in response to DNA double-strand breaks</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span> (<span class="NLM_issue">45</span>),  <span class="NLM_fpage">42462</span>– <span class="NLM_lpage">42467</span>, <span class="refDoi"> DOI: 10.1074/jbc.C100466200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1074%2Fjbc.C100466200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=11571274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVGmsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=42462-42467&issue=45&author=S.+Burmaauthor=B.+P.+Chenauthor=M.+Murphyauthor=A.+Kurimasaauthor=D.+J.+Chen&title=ATM+Phosphorylates+histone+H2AX+in+response+to+DNA+double-strand+breaks&doi=10.1074%2Fjbc.C100466200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">ATM phosphorylates histone H2AX in response to DNA double-strand breaks</span></div><div class="casAuthors">Burma, Sandeep; Chen, Benjamin P.; Murphy, Michael; Kurimasa, Akihiro; Chen, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">42462-42467</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A very early step in the response of mammalian cells to DNA double-strand breaks is the phosphorylation of histone H2AX at serine 139 at the sites of DNA damage.  Although the phosphatidylinositol 3-kinases, DNA-PK (DNA-dependent protein kinase), ATM (ataxia telangiectasia mutated), and ATR (ATM and Rad3-related), have all been implicated in H2AX phosphorylation, the specific kinase involved has not yet been identified.  To definitively identify the specific kinase(s) that phosphorylates H2AX in vivo, we have utilized DNA-PKcs-/- and Atm-/- cell lines and mouse embryonic fibroblasts.  We find that H2AX phosphorylation and nuclear focus formation are normal in DNA-PKcs-/- cells and severely compromised in Atm-/- cells.  We also find that ATM can phosphorylate H2AX in vitro and that ectopic expression of ATM in Atm-/- fibroblasts restores H2AX phosphorylation in vivo.  The minimal H2AX phosphorylation in Atm-/- fibroblasts can be abolished by low concns. of wortmannin suggesting that DNA-PK, rather than ATR, is responsible for low levels of H2AX phosphorylation in the absence of ATM.  Our results clearly establish ATM as the major kinase involved in the phosphorylation of H2AX and suggest that ATM is one of the earliest kinases to be activated in the cellular response to double-strand breaks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoILtTZr6r8mbVg90H21EOLACvtfcHk0lgiX9NPEZUoxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVGmsb4%253D&md5=9264731343a6ae15ddd675ac43edefa3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C100466200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C100466200%26sid%3Dliteratum%253Aachs%26aulast%3DBurma%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DB.%2BP.%26aulast%3DMurphy%26aufirst%3DM.%26aulast%3DKurimasa%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DD.%2BJ.%26atitle%3DATM%2520Phosphorylates%2520histone%2520H2AX%2520in%2520response%2520to%2520DNA%2520double-strand%2520breaks%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D45%26spage%3D42462%26epage%3D42467%26doi%3D10.1074%2Fjbc.C100466200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scully, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, A.</span></span> <span> </span><span class="NLM_article-title">Double strand break repair functions of histone H2AX</span>. <i>Mutat. Res., Fundam. Mol. Mech. Mutagen.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>750</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1016/j.mrfmmm.2013.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.mrfmmm.2013.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=23916969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlKrtb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=750&publication_year=2013&pages=5-14&issue=1%E2%80%932&author=R.+Scullyauthor=A.+Xie&title=Double+strand+break+repair+functions+of+histone+H2AX&doi=10.1016%2Fj.mrfmmm.2013.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Double strand break repair functions of histone H2AX</span></div><div class="casAuthors">Scully, Ralph; Xie, Anyong</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">750</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">5-14</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Chromosomal double strand breaks provoke an extensive reaction in neighboring chromatin, characterized by phosphorylation of histone H2AX on serine 139 of its C-terminal tail (to form "γH2AX").  The γH2AX response contributes to the repair of double strand breaks encountered in a variety of different contexts, including those induced by ionizing radiation, physiol. programmed breaks that characterize normal immune cell development and the pathol. exposure of DNA ends triggered by telomere dysfunction.  γH2AX also participates in the evolutionarily conserved process of sister chromatid recombination, a homologous recombination pathway involved in the suppression of genomic instability during DNA replication and directly implicated in tumor suppression.  At a biochem. level, the γH2AX response provides a compelling example of how the "histone code" is adapted to the regulation of double strand break repair.  Here, we review progress in research aimed at understanding how γH2AX contributes to double strand break repair in mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe08jJUUxRfLVg90H21EOLACvtfcHk0lgiX9NPEZUoxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlKrtb3O&md5=48675a7db433aaf7b93efe7c119548ba</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.mrfmmm.2013.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrfmmm.2013.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DScully%26aufirst%3DR.%26aulast%3DXie%26aufirst%3DA.%26atitle%3DDouble%2520strand%2520break%2520repair%2520functions%2520of%2520histone%2520H2AX%26jtitle%3DMutat.%2520Res.%252C%2520Fundam.%2520Mol.%2520Mech.%2520Mutagen.%26date%3D2013%26volume%3D750%26issue%3D1%25E2%2580%25932%26spage%3D5%26epage%3D14%26doi%3D10.1016%2Fj.mrfmmm.2013.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyal, l.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taya, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smorodinsky, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prives, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiss, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiloh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziv, Y.</span></span> <span> </span><span class="NLM_article-title">Enhanced phosporylation of p53 by ATM in response to DNA damage</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">5383</span>),  <span class="NLM_fpage">1674</span>– <span class="NLM_lpage">1677</span>, <span class="refDoi"> DOI: 10.1126/science.281.5383.1674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1126%2Fscience.281.5383.1674" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=1674-1677&issue=5383&author=S.+Baninauthor=l.+Moyalauthor=S.-Y.+Shiehauthor=Y.+Tayaauthor=C.+W.+Andersonauthor=L.+Chessaauthor=N.+I.+Smorodinskyauthor=C.+Privesauthor=Y.+Reissauthor=Y.+Shilohauthor=Y.+Ziv&title=Enhanced+phosporylation+of+p53+by+ATM+in+response+to+DNA+damage&doi=10.1126%2Fscience.281.5383.1674"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.281.5383.1674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.281.5383.1674%26sid%3Dliteratum%253Aachs%26aulast%3DBanin%26aufirst%3DS.%26aulast%3DMoyal%26aufirst%3Dl.%26aulast%3DShieh%26aufirst%3DS.-Y.%26aulast%3DTaya%26aufirst%3DY.%26aulast%3DAnderson%26aufirst%3DC.%2BW.%26aulast%3DChessa%26aufirst%3DL.%26aulast%3DSmorodinsky%26aufirst%3DN.%2BI.%26aulast%3DPrives%26aufirst%3DC.%26aulast%3DReiss%26aufirst%3DY.%26aulast%3DShiloh%26aufirst%3DY.%26aulast%3DZiv%26aufirst%3DY.%26atitle%3DEnhanced%2520phosporylation%2520of%2520p53%2520by%2520ATM%2520in%2520response%2520to%2520DNA%2520damage%26jtitle%3DScience%26date%3D1998%26volume%3D281%26issue%3D5383%26spage%3D1674%26epage%3D1677%26doi%3D10.1126%2Fscience.281.5383.1674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elledge, S. J.</span></span> <span> </span><span class="NLM_article-title">Linkage of ATM to cell cycle regulation by the Chk2 protein kinase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>282</i></span> (<span class="NLM_issue">5395</span>),  <span class="NLM_fpage">1893</span>– <span class="NLM_lpage">1897</span>, <span class="refDoi"> DOI: 10.1126/science.282.5395.1893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1126%2Fscience.282.5395.1893" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=1893-1897&issue=5395&author=S.+Matsuokaauthor=M.+Huangauthor=S.+J.+Elledge&title=Linkage+of+ATM+to+cell+cycle+regulation+by+the+Chk2+protein+kinase&doi=10.1126%2Fscience.282.5395.1893"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.282.5395.1893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.282.5395.1893%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuoka%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DLinkage%2520of%2520ATM%2520to%2520cell%2520cycle%2520regulation%2520by%2520the%2520Chk2%2520protein%2520kinase%26jtitle%3DScience%26date%3D1998%26volume%3D282%26issue%3D5395%26spage%3D1893%26epage%3D1897%26doi%3D10.1126%2Fscience.282.5395.1893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marine, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozano, G.</span></span> <span> </span><span class="NLM_article-title">Mdm2-Mediated ubiquitylation: p53 and beyond</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1038/cdd.2009.68</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1038%2Fcdd.2009.68" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=19498444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=93-102&issue=1&author=J.-C.+Marineauthor=G.+Lozano&title=Mdm2-Mediated+ubiquitylation%3A+p53+and+beyond&doi=10.1038%2Fcdd.2009.68"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mdm2-mediated ubiquitylation: p53 and beyond</span></div><div class="casAuthors">Marine, J.-C.; Lozano, G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-102</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The really interesting genes (RING)-finger-contg. oncoprotein, Mdm2, is a promising drug target for cancer therapy.  A key Mdm2 function is to promote ubiquitylation and proteasomal-dependent degrdn. of the tumor suppressor protein p53.  Recent reports provide novel important insights into Mdm2-mediated regulation of p53 and how the phys. and functional interactions between these two proteins are regulated.  Moreover, a p53-independent role of Mdm2 has recently been confirmed by genetic data.  These advances and their potential implications for the development of new cancer therapeutic strategies form the focus of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmHYHeLCnS3LVg90H21EOLACvtfcHk0ljfU4bU6NIAww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnurvE&md5=1930cf89eeaa86d3db3f7f94640c8cc8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2009.68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2009.68%26sid%3Dliteratum%253Aachs%26aulast%3DMarine%26aufirst%3DJ.-C.%26aulast%3DLozano%26aufirst%3DG.%26atitle%3DMdm2-Mediated%2520ubiquitylation%253A%2520p53%2520and%2520beyond%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2010%26volume%3D17%26issue%3D1%26spage%3D93%26epage%3D102%26doi%3D10.1038%2Fcdd.2009.68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kastan, M.</span></span> <span> </span><span class="NLM_article-title">Ataxia-telangiectasia-broad implications for a rare disorder</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>333</i></span>,  <span class="NLM_fpage">622</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1056/NEJM199509073331014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1056%2FNEJM199509073331014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=1995&pages=622-663&author=M.+Kastan&title=Ataxia-telangiectasia-broad+implications+for+a+rare+disorder&doi=10.1056%2FNEJM199509073331014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1056%2FNEJM199509073331014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199509073331014%26sid%3Dliteratum%253Aachs%26aulast%3DKastan%26aufirst%3DM.%26atitle%3DAtaxia-telangiectasia-broad%2520implications%2520for%2520a%2520rare%2520disorder%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1995%26volume%3D333%26spage%3D622%26epage%3D663%26doi%3D10.1056%2FNEJM199509073331014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moding, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirsch, D. G.</span></span> <span> </span><span class="NLM_article-title">Strategies for optimizing the response of cancer and normal tissues to radiation</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1038/nrd4003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1038%2Fnrd4003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=23812271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVaiu7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=526-542&author=E.+J.+Modingauthor=M.+B.+Kastanauthor=D.+G.+Kirsch&title=Strategies+for+optimizing+the+response+of+cancer+and+normal+tissues+to+radiation&doi=10.1038%2Fnrd4003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for optimizing the response of cancer and normal tissues to radiation</span></div><div class="casAuthors">Moding, Everett J.; Kastan, Michael B.; Kirsch, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">526-542</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Approx. 50% of all patients with cancer receive radiation therapy at some point during the course of their treatment, and the majority of these patients are treated with curative intent.  Despite recent advances in the planning of radiation treatment and the delivery of image-guided radiation therapy, acute toxicity and potential long-term side effects often limit the ability to deliver a sufficient dose of radiation to control tumors locally.  In the past two decades, a better understanding of the hallmarks of cancer and the discovery of specific signalling pathways by which cells respond to radiation have provided new opportunities to design molecularly targeted therapies to increase the therapeutic window of radiation therapy.  Here, we review efforts to develop approaches that could improve outcomes with radiation therapy by increasing the probability of tumor cure or by decreasing normal tissue toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou7EQIkMMxvrVg90H21EOLACvtfcHk0ljfU4bU6NIAww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVaiu7zK&md5=f7a6b5ed442870ec03086ded64a28fc5</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrd4003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4003%26sid%3Dliteratum%253Aachs%26aulast%3DModing%26aufirst%3DE.%2BJ.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26aulast%3DKirsch%26aufirst%3DD.%2BG.%26atitle%3DStrategies%2520for%2520optimizing%2520the%2520response%2520of%2520cancer%2520and%2520normal%2520tissues%2520to%2520radiation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D526%26epage%3D542%26doi%3D10.1038%2Fnrd4003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cremona, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, A.</span></span> <span> </span><span class="NLM_article-title">ATM Signaling and cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">3351</span>– <span class="NLM_lpage">3360</span>, <span class="refDoi"> DOI: 10.1038/onc.2013.275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1038%2Fonc.2013.275" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=3351-3360&issue=26&author=C.+A.+Cremonaauthor=A.+Behrens&title=ATM+Signaling+and+cancer&doi=10.1038%2Fonc.2013.275"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fonc.2013.275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2013.275%26sid%3Dliteratum%253Aachs%26aulast%3DCremona%26aufirst%3DC.%2BA.%26aulast%3DBehrens%26aufirst%3DA.%26atitle%3DATM%2520Signaling%2520and%2520cancer%26jtitle%3DOncogene%26date%3D2014%26volume%3D33%26issue%3D26%26spage%3D3351%26epage%3D3360%26doi%3D10.1038%2Fonc.2013.275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkaria, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eshleman, J. S.</span></span> <span> </span><span class="NLM_article-title">ATM as a target for novel radiosensitizers</span>. <i>Semin. Radiat. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1053/srao.2001.26030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1053%2Fsrao.2001.26030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=11677656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A280%3ADC%252BD3MrntFChsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=316-327&author=J.+N.+Sarkariaauthor=J.+S.+Eshleman&title=ATM+as+a+target+for+novel+radiosensitizers&doi=10.1053%2Fsrao.2001.26030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">ATM as a target for novel radiosensitizers</span></div><div class="casAuthors">Sarkaria J N; Eshleman J S</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in radiation oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">316-27</span>
        ISSN:<span class="NLM_cas:issn">1053-4296</span>.
    </div><div class="casAbstract">DNA damage checkpoints are complex signal transduction pathways that are critical for normal cellular recovery following potentially lethal genotoxic insults.  The ataxia-telangiectasia mutated (ATM) protein kinase is a critical component in these pathways and integrates the cellular response to damage by phosphorylating key proteins involved in cell cycle regulation and DNA repair.  Lack of normal ATM function in the inherited ataxia-telangiectasia (A-T) syndrome results in a pleiotropic clinical syndrome characterized by a marked increased risk of cancer and profound hypersensitivity to ionizing radiation.  Cells derived from patients with A-T share some of these attributes with genomic instability, loss of normal cell cycle arrest pathways, defects in DNA repair and increased radiation sensitivity.  The radiosensitivity of A-T cells suggests that pharmacological inhibitors of the ATM kinase should be effective radiosensitizing agents.  In fact, caffeine inhibits ATM kinase activity at concentrations that result in an A-T-like phenotype with loss of cell cycle checkpoints and hypersensitivity to ionizing radiation.  Although the clinical use of caffeine as a radiosensitizer is limited by potentially lethal systemic toxicities, more potent methyl xanthines may selectively inhibit the ATM pathway at clinically achievable levels.  Interestingly, caffeine and other methyl xanthines preferentially radiosensitize cells that lack normal p53 function.  Because p53 is commonly inactivated in epithelial malignancies, this suggests that small molecule inhibitors of ATM might selectively sensitize the majority of tumors to the lethal effects of ionizing radiation while sparing normal tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQH5CDYZIko7sNIRw0GKUoEfW6udTcc2eYvBlXY4stJnbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MrntFChsw%253D%253D&md5=238687773f51a0bf55ae6c6dbee78cec</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1053%2Fsrao.2001.26030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fsrao.2001.26030%26sid%3Dliteratum%253Aachs%26aulast%3DSarkaria%26aufirst%3DJ.%2BN.%26aulast%3DEshleman%26aufirst%3DJ.%2BS.%26atitle%3DATM%2520as%2520a%2520target%2520for%2520novel%2520radiosensitizers%26jtitle%3DSemin.%2520Radiat.%2520Oncol.%26date%3D2001%26volume%3D11%26spage%3D316%26epage%3D327%26doi%3D10.1053%2Fsrao.2001.26030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">590</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2009.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.ctrv.2009.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=19635647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=590-596&author=Y.+Zhuauthor=J.+Huauthor=Y.+Huauthor=W.+Liu&title=Targeting+DNA+repair+pathways%3A+a+novel+approach+to+reduce+cancer+therapeutic+resistance&doi=10.1016%2Fj.ctrv.2009.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting DNA repair pathways: A novel approach to reduce cancer therapeutic resistance</span></div><div class="casAuthors">Zhu, Yongjian; Hu, Jue; Hu, Yiduo; Liu, Weiguo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">590-596</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Increased chemo-resistance and radio-resistance of cancer cells is a major obstacle in the treatment and management of malignant cancers.  An important mechanism that underlies the development of such therapeutic resistance is that cancer cells recognize DNA lesions induced by DNA-damaging agents and by ionizing radiation, and repair these lesions by activating various DNA repair pathways.  Therefore, Use of pharmacol. agents that can inhibit certain DNA repair pathways in cancer cells has the potential for enhancing the targeted cytotoxicity of anticancer treatments and reversing the assocd. therapeutic resistance assocd. with DNA repair; such agents, offering a promising opportunity to achieve better therapeutic efficacy.  Here we review the major DNA repair pathways and discuss recent advances in the development of novel inhibitors of DNA repair pathways; many of these agents are under preclin./clin. investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbMZUKq5LyO7Vg90H21EOLACvtfcHk0lhEN20-0Y44fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt73M&md5=f5a39c6da606a9dbfd82775e70e88c34</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2009.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2009.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DTargeting%2520DNA%2520repair%2520pathways%253A%2520a%2520novel%2520approach%2520to%2520reduce%2520cancer%2520therapeutic%2520resistance%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2009%26volume%3D35%26spage%3D590%26epage%3D596%26doi%3D10.1016%2Fj.ctrv.2009.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. C.</span></span> <span> </span><span class="NLM_article-title">Targeted cancer therapies based on the inhibition of DNA strand break repair</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">7816</span>– <span class="NLM_lpage">7824</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1210879</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1038%2Fsj.onc.1210879" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=7816-7824&author=M.+J.+O%E2%80%99Connorauthor=N.+M.+Martinauthor=G.+C.+Smith&title=Targeted+cancer+therapies+based+on+the+inhibition+of+DNA+strand+break+repair&doi=10.1038%2Fsj.onc.1210879"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210879%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BJ.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26aulast%3DSmith%26aufirst%3DG.%2BC.%26atitle%3DTargeted%2520cancer%2520therapies%2520based%2520on%2520the%2520inhibition%2520of%2520DNA%2520strand%2520break%2520repair%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D7816%26epage%3D7824%26doi%3D10.1038%2Fsj.onc.1210879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hollick, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigoreau, L. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cano-Soumillac, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockcroft, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frigerio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golding, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guiard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardcastle, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hummersone, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menear, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ord, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, R. J.</span></span> <span> </span><span class="NLM_article-title">Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1958</span>– <span class="NLM_lpage">1972</span>, <span class="refDoi"> DOI: 10.1021/jm061121y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061121y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1958-1972&author=J.+J.+Hollickauthor=L.+J.+M.+Rigoreauauthor=C.+Cano-Soumillacauthor=X.+Cockcroftauthor=N.+J.+Curtinauthor=M.+Frigerioauthor=B.+T.+Goldingauthor=S.+Guiardauthor=I.+R.+Hardcastleauthor=I.+Hicksonauthor=M.+G.+Hummersoneauthor=K.+A.+Menearauthor=N.+M.+B.+Martinauthor=I.+Matthewsauthor=D.+R.+Newellauthor=R.+Ordauthor=C.+J.+Richardsonauthor=G.+C.+M.+Smithauthor=R.+J.+Griffin&title=Pyranone%2C+thiopyranone%2C+and+pyridone+inhibitors+of+phosphatidylinositol+3-kinase+related+kinases.+Structure-activity+relationships+for+DNA-dependent+protein+kinase+inhibition%2C+and+identification+of+the+first+potent+and+selective+inhibitor+of+the+ataxia+telangiectasia+mutated+kinase&doi=10.1021%2Fjm061121y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm061121y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061121y%26sid%3Dliteratum%253Aachs%26aulast%3DHollick%26aufirst%3DJ.%2BJ.%26aulast%3DRigoreau%26aufirst%3DL.%2BJ.%2BM.%26aulast%3DCano-Soumillac%26aufirst%3DC.%26aulast%3DCockcroft%26aufirst%3DX.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DFrigerio%26aufirst%3DM.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGuiard%26aufirst%3DS.%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DHummersone%26aufirst%3DM.%2BG.%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DMartin%26aufirst%3DN.%2BM.%2BB.%26aulast%3DMatthews%26aufirst%3DI.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DOrd%26aufirst%3DR.%26aulast%3DRichardson%26aufirst%3DC.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26atitle%3DPyranone%252C%2520thiopyranone%252C%2520and%2520pyridone%2520inhibitors%2520of%2520phosphatidylinositol%25203-kinase%2520related%2520kinases.%2520Structure-activity%2520relationships%2520for%2520DNA-dependent%2520protein%2520kinase%2520inhibition%252C%2520and%2520identification%2520of%2520the%2520first%2520potent%2520and%2520selective%2520inhibitor%2520of%2520the%2520ataxia%2520telangiectasia%2520mutated%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1958%26epage%3D1972%26doi%3D10.1021%2Fjm061121y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. C. M.</span>; <span class="NLM_string-name">Martin, N. M. B.</span>; <span class="NLM_string-name">Jackson, S. P.</span>; <span class="NLM_string-name">O’Connor, M. J.</span>; <span class="NLM_string-name">Lau, A. Y. K.</span>; <span class="NLM_string-name">Cockcroft, X. -L. F.</span>; <span class="NLM_string-name">Matthews, I. T. W.</span>; <span class="NLM_string-name">Menear, K. A.</span>; <span class="NLM_string-name">Rigoreau, L. J. M.</span>; <span class="NLM_string-name">Hummersone, M. G.</span>; <span class="NLM_string-name">Girffin, R. J.</span></span> <span> </span><span class="NLM_article-title">Pyranones Useful as ATM Protein Kinase Inhibitors</span>. WO patent <span class="NLM_patent">WO 2003070726</span>, Aug 28, <span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=G.+C.+M.+Smith&author=N.+M.+B.+Martin&author=S.+P.+Jackson&author=M.+J.+O%E2%80%99Connor&author=A.+Y.+K.+Lau&author=X.+-L.+F.+Cockcroft&author=I.+T.+W.+Matthews&author=K.+A.+Menear&author=L.+J.+M.+Rigoreau&author=M.+G.+Hummersone&author=R.+J.+Girffin&title=Pyranones+Useful+as+ATM+Protein+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26atitle%3DPyranones%2520Useful%2520as%2520ATM%2520Protein%2520Kinase%2520Inhibitors%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hickson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reaper, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. C. M.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">9152</span>– <span class="NLM_lpage">9159</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-2727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1158%2F0008-5472.CAN-04-2727" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=9152-9159&author=I.+Hicksonauthor=Y.+Zhaoauthor=C.+J.+Richardsonauthor=S.+J.+Greenauthor=N.+M.+B.+Martinauthor=A.+I.+Orrauthor=P.+M.+Reaperauthor=S.+P.+Jacksonauthor=N.+J.+Curtinauthor=G.+C.+M.+Smith&title=Identification+and+characterization+of+a+novel+and+specific+inhibitor+of+the+ataxia-telangiectasia+mutated+kinase+ATM&doi=10.1158%2F0008-5472.CAN-04-2727"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-2727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-2727%26sid%3Dliteratum%253Aachs%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DRichardson%26aufirst%3DC.%2BJ.%26aulast%3DGreen%26aufirst%3DS.%2BJ.%26aulast%3DMartin%26aufirst%3DN.%2BM.%2BB.%26aulast%3DOrr%26aufirst%3DA.%2BI.%26aulast%3DReaper%26aufirst%3DP.%2BM.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520novel%2520and%2520specific%2520inhibitor%2520of%2520the%2520ataxia-telangiectasia%2520mutated%2520kinase%2520ATM%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D9152%26epage%3D9159%26doi%3D10.1158%2F0008-5472.CAN-04-2727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batey, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slade, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, N. J.</span></span> <span> </span><span class="NLM_article-title">Preclinical evaluation of a novel ATM inhibitor, KU-59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">959</span>– <span class="NLM_lpage">967</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-12-0707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1158%2F1535-7163.MCT-12-0707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=23512991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVOksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=959-967&issue=6&author=M.+A.+Bateyauthor=Y.+Zhaoauthor=S.+Kyleauthor=C.+Richardsonauthor=A.+Sladeauthor=N.+M.+Martinauthor=A.+Lauauthor=D.+R.+Newellauthor=N.+J.+Curtin&title=Preclinical+evaluation+of+a+novel+ATM+inhibitor%2C+KU-59403%2C+in+vitro+and+in+vivo+in+p53+functional+and+dysfunctional+models+of+human+cancer&doi=10.1158%2F1535-7163.MCT-12-0707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Evaluation of a Novel ATM Inhibitor, KU59403, In Vitro and In Vivo in p53 Functional and Dysfunctional Models of Human Cancer</span></div><div class="casAuthors">Batey, Michael A.; Zhao, Yan; Kyle, Suzanne; Richardson, Caroline; Slade, Andrew; Martin, Niall M. B.; Lau, Alan; Newell, David R.; Curtin, Nicola J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">959-967</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Ataxia telangiectasia mutated (ATM) kinase signals DNA double-strand breaks (DSB) to cell-cycle arrest via p53 and DNA repair.  ATM-defective cells are sensitive to DSB-inducing agents, making ATM an attractive target for anticancer chemo- and radiosensitization.  KU59403 is an ATM inhibitor with the potency, selectivity, and soly. for advanced preclin. evaluation.  KU59403 was not cytotoxic to human cancer cell lines (SW620, LoVo, HCT116, and MDA-MB-231) per se but significantly increased the cytotoxicity of topoisomerase I and II poisons: camptothecin, etoposide, and doxorubicin.  Chemo- and radiosensitization by ATM inhibition was not p53-dependent.  Following administration to mice, KU59403 distributed to tissues and concns. exceeding those required for in vitro activity were maintained for at least 4 h in tumor xenografts.  KU59403 significantly enhanced the antitumor activity of topoisomerase poisons in mice bearing human colon cancer xenografts (SW620 and HCT116) at doses that were nontoxic alone and well-tolerated in combination.  Chemosensitization was both dose- and schedule-dependent.  KU59403 represents a major advance in ATM inhibitor development, being the 1st compd. to show good tissue distribution and significant chemosensitization in in vivo models of human cancer, without major toxicity.  KU59403 provides the 1st proof-of-principle preclin. data to support the future clin. development of ATM inhibitors.  Mol Cancer Ther; 12(6); 959-67. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNlMwHzEdbQrVg90H21EOLACvtfcHk0ljpUucg1yM44A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVOksL8%253D&md5=82771364eb5cd8a3baf13e5cd48b5389</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0707%26sid%3Dliteratum%253Aachs%26aulast%3DBatey%26aufirst%3DM.%2BA.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DKyle%26aufirst%3DS.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DSlade%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26atitle%3DPreclinical%2520evaluation%2520of%2520a%2520novel%2520ATM%2520inhibitor%252C%2520KU-59403%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520in%2520p53%2520functional%2520and%2520dysfunctional%2520models%2520of%2520human%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26issue%3D6%26spage%3D959%26epage%3D967%26doi%3D10.1158%2F1535-7163.MCT-12-0707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suryadevara, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbrook, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemoff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, R. K.</span></span> <span> </span><span class="NLM_article-title">Optimization of a novel series of ataxia-telangiectasia mutated kinase inhibitors as potential radiosensitizing agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">559</span>– <span class="NLM_lpage">577</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01092</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01092" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGnsr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=559-577&author=J.+Minauthor=K.+Guoauthor=P.+K.+Suryadevaraauthor=F.+Zhuauthor=G.+Holbrookauthor=Y.+Chenauthor=C.+Feauauthor=B.+M.+Youngauthor=A.+Lemoffauthor=M.+C.+Connellyauthor=M.+B.+Kastanauthor=R.+K.+Guy&title=Optimization+of+a+novel+series+of+ataxia-telangiectasia+mutated+kinase+inhibitors+as+potential+radiosensitizing+agents&doi=10.1021%2Facs.jmedchem.5b01092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents</span></div><div class="casAuthors">Min, Jaeki; Guo, Kexiao; Suryadevara, Praveen K.; Zhu, Fangyi; Holbrook, Gloria; Chen, Yizhe; Feau, Clementine; Young, Brandon M.; Lemoff, Andrew; Connelly, Michele C.; Kastan, Michael B.; Guy, R. Kiplin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">559-577</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We previously reported a novel inhibitor of the ataxia-telangiectasia mutated (ATM) kinase, which is a target for novel radiosensitizing drugs.  While our initial lead, compd. 4, was relatively potent and nontoxic, it exhibited poor stability to oxidative metab. and relatively poor selectivity against other kinases.  The current study focused on balancing potency and selectivity with metabolic stability through structural modification to the metabolized site on the quinazoline core.  We performed extensive structure-activity and structure-property relationship studies on this quinazoline ATM kinase inhibitor in order to identify structural variants with enhanced selectivity and metabolic stability.  We show that, while the C-7-methoxy group is essential for potency, replacing the C-6-methoxy group considerably improves metabolic stability without affecting potency.  Promising analogs 20, 27g, and 27n were selected based on in vitro pharmacol. and evaluated in murine pharmacokinetic and tolerability studies.  Compd. 27g possessed significantly improve pharmacokinetics relative to that of 4.  Compd. 27g was also significantly more selective against other kinases than 4.  Therefore, 27g is a good candidate for further development as a potential radiosensitizer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl6-cCkwsTybVg90H21EOLACvtfcHk0ljpUucg1yM44A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGnsr%252FF&md5=bc4edb4fdd0aa77689e3acc34278a836</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01092%26sid%3Dliteratum%253Aachs%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DK.%26aulast%3DSuryadevara%26aufirst%3DP.%2BK.%26aulast%3DZhu%26aufirst%3DF.%26aulast%3DHolbrook%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DFeau%26aufirst%3DC.%26aulast%3DYoung%26aufirst%3DB.%2BM.%26aulast%3DLemoff%26aufirst%3DA.%26aulast%3DConnelly%26aufirst%3DM.%2BC.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26atitle%3DOptimization%2520of%2520a%2520novel%2520series%2520of%2520ataxia-telangiectasia%2520mutated%2520kinase%2520inhibitors%2520as%2520potential%2520radiosensitizing%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D559%26epage%3D577%26doi%3D10.1021%2Facs.jmedchem.5b01092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degorce, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlaam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadogan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dishington, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducray, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassall, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lach, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouvry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomason, A. G.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel 3-quinoline carboxamides as potent, selective and orally bioavailable inhibitors of ataxia telangiectasia mutated (ATM) kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6281</span>– <span class="NLM_lpage">6292</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00519</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6281-6292&author=S.+L.+Degorceauthor=B.+Barlaamauthor=E.+Cadoganauthor=A.+Dishingtonauthor=R.+Ducrayauthor=S.+C.+Glossopauthor=L.+A.+Hassallauthor=F.+Lachauthor=A.+Lauauthor=T.+M.+McGuireauthor=T.+Nowakauthor=G.+Ouvryauthor=K.+G.+Pikeauthor=A.+G.+Thomason&title=Discovery+of+novel+3-quinoline+carboxamides+as+potent%2C+selective+and+orally+bioavailable+inhibitors+of+ataxia+telangiectasia+mutated+%28ATM%29+kinase&doi=10.1021%2Facs.jmedchem.6b00519"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00519%26sid%3Dliteratum%253Aachs%26aulast%3DDegorce%26aufirst%3DS.%2BL.%26aulast%3DBarlaam%26aufirst%3DB.%26aulast%3DCadogan%26aufirst%3DE.%26aulast%3DDishington%26aufirst%3DA.%26aulast%3DDucray%26aufirst%3DR.%26aulast%3DGlossop%26aufirst%3DS.%2BC.%26aulast%3DHassall%26aufirst%3DL.%2BA.%26aulast%3DLach%26aufirst%3DF.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DMcGuire%26aufirst%3DT.%2BM.%26aulast%3DNowak%26aufirst%3DT.%26aulast%3DOuvry%26aufirst%3DG.%26aulast%3DPike%26aufirst%3DK.%2BG.%26aulast%3DThomason%26aufirst%3DA.%2BG.%26atitle%3DDiscovery%2520of%2520novel%25203-quinoline%2520carboxamides%2520as%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520inhibitors%2520of%2520ataxia%2520telangiectasia%2520mutated%2520%2528ATM%2529%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6281%26epage%3D6292%26doi%3D10.1021%2Facs.jmedchem.6b00519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karlin, J.</span>; <span class="NLM_string-name">Allen, J.</span>; <span class="NLM_string-name">Odedra, R.</span>; <span class="NLM_string-name">Hughes, G.</span>; <span class="NLM_string-name">Farrington, P.</span>; <span class="NLM_string-name">Ducray, R.</span>; <span class="NLM_string-name">Ouvry, G.</span>; <span class="NLM_string-name">Degorce, S.</span>; <span class="NLM_string-name">Wilson, J.</span>; <span class="NLM_string-name">Smith, A.</span>; <span class="NLM_string-name">Patel, B.</span>; <span class="NLM_string-name">Thomason, A.</span>; <span class="NLM_string-name">Vincent, J.</span>; <span class="NLM_string-name">Colclough, N.</span>; <span class="NLM_string-name">Ahmad, S. F.</span>; <span class="NLM_string-name">Beckta, J. M.</span>; <span class="NLM_string-name">Tokarz, M.</span>; <span class="NLM_string-name">Mukhopadhyay, N. D.</span>; <span class="NLM_string-name">Barlaam, B.</span>; <span class="NLM_string-name">Pike, K. G.</span>; <span class="NLM_string-name">Cadogan, E.</span>; <span class="NLM_string-name">Pass, M.</span>; <span class="NLM_string-name">Valerie, K.</span>; <span class="NLM_string-name">Durant, S.</span></span>, <span> </span><span class="NLM_article-title">Blood–Brain Barrier penetrating ATM Inhibitor Radio-Sensitizes Intracranial Gliomas in Mice</span>.  <i>Abstracts of Papers, Annual Meeting of the American Association of Cancer Research, New Orleans, LA, 2006</i>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Karlin&author=J.+Allen&author=R.+Odedra&author=G.+Hughes&author=P.+Farrington&author=R.+Ducray&author=G.+Ouvry&author=S.+Degorce&author=J.+Wilson&author=A.+Smith&author=B.+Patel&author=A.+Thomason&author=J.+Vincent&author=N.+Colclough&author=S.+F.+Ahmad&author=J.+M.+Beckta&author=M.+Tokarz&author=N.+D.+Mukhopadhyay&author=B.+Barlaam&author=K.+G.+Pike&author=E.+Cadogan&author=M.+Pass&author=K.+Valerie&author=S.+Durant&title=Blood%E2%80%93Brain+Barrier+penetrating+ATM+Inhibitor+Radio-Sensitizes+Intracranial+Gliomas+in+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DKarlin%26aufirst%3DJ.%26atitle%3DBlood%25E2%2580%2593Brain%2520Barrier%2520penetrating%2520ATM%2520Inhibitor%2520Radio-Sensitizes%2520Intracranial%2520Gliomas%2520in%2520Mice%26jtitle%3DAbstracts%2520of%2520Papers%252C%2520Annual%2520Meeting%2520of%2520the%2520American%2520Association%2520of%2520Cancer%2520Research%252C%2520New%2520Orleans%252C%2520LA%252C%25202006%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. G.</span>, <span class="NLM_string-name">Barlaam, B.</span>; <span class="NLM_string-name">Colclough, N.</span>; <span class="NLM_string-name">McGuire, T. M.</span>; <span class="NLM_string-name">Cadogan, E.</span>; <span class="NLM_string-name">Pass, M.</span>; <span class="NLM_string-name">Hassall, L. A.</span>; <span class="NLM_string-name">Hawkins, J.</span>; <span class="NLM_string-name">Holmes, J.</span>; <span class="NLM_string-name">Dishington, A.</span>; <span class="NLM_string-name">Robb, G.</span>; <span class="NLM_string-name">Ducray, R.</span>; <span class="NLM_string-name">Ouvry, G.</span>; <span class="NLM_string-name">Degorce, S. L.</span>; <span class="NLM_string-name">Lau, A.</span>; <span class="NLM_string-name">MacFaul, P.</span>; <span class="NLM_string-name">Hughes, G.</span></span> <span> </span><span class="NLM_article-title">Identifying High Quality, Potent and Selective Inhibitors of ATM Kinase: Discovery of AZD0156</span>.  <i>RSC-SCI Kinase 2016, Nottingham, UK, 2016</i>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=K.+G.+Pike&author=B.+Barlaam&author=N.+Colclough&author=T.+M.+McGuire&author=E.+Cadogan&author=M.+Pass&author=L.+A.+Hassall&author=J.+Hawkins&author=J.+Holmes&author=A.+Dishington&author=G.+Robb&author=R.+Ducray&author=G.+Ouvry&author=S.+L.+Degorce&author=A.+Lau&author=P.+MacFaul&author=G.+Hughes&title=Identifying+High+Quality%2C+Potent+and+Selective+Inhibitors+of+ATM+Kinase%3A+Discovery+of+AZD0156"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DK.%2BG.%26atitle%3DIdentifying%2520High%2520Quality%252C%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520ATM%2520Kinase%253A%2520Discovery%2520of%2520AZD0156%26jtitle%3DRSC-SCI%2520Kinase%25202016%252C%2520Nottingham%252C%2520UK%252C%25202016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Redfern, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palethorpe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegl, P. K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strang, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camm, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, T. G.</span></span> <span> </span><span class="NLM_article-title">Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development</span>. <i>Cardiovasc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/S0008-6363(02)00846-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2FS0008-6363%2802%2900846-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=12667944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit12gsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2003&pages=32-45&author=W.+S.+Redfernauthor=L.+Carlssonauthor=A.+S.+Davisauthor=W.+G.+Lynchauthor=I.+MacKenzieauthor=S.+Palethorpeauthor=P.+K.+S.+Sieglauthor=I.+Strangauthor=A.+T.+Sullivanauthor=R.+Wallisauthor=A.+J.+Cammauthor=T.+G.+Hammond&title=Relationships+between+preclinical+cardiac+electrophysiology%2C+clinical+QT+interval+prolongation+and+torsade+de+pointes+for+a+broad+range+of+drugs%3A+evidence+for+a+provisional+safety+margin+in+drug+development&doi=10.1016%2FS0008-6363%2802%2900846-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development</span></div><div class="casAuthors">Redfern, W. S.; Carlsson, L.; Davis, A. S.; Lynch, W. G.; MacKenzie, I.; Palethorpe, S.; Siegl, P. K. S.; Strang, I.; Sullivan, A. T.; Wallis, R.; Camm, A. J.; Hammond, T. G.</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-45</span>CODEN:
                <span class="NLM_cas:coden">CVREAU</span>;
        ISSN:<span class="NLM_cas:issn">0008-6363</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review discussing attempts to det. the relative value of preclin. cardiac electrophysiol. data (in vitro and in vivo) for predicting risk of torsades de pointes (TdP) in clin. use.  Published data on human ether-a-go-go-related gene-encoded voltage-dependent potassium channel (hERG) (or IKr) activity, cardiac action potential duration (at 90% repolarization; APD90), and QT prolongation in dogs were compared against QT effects and reports of TdP in humans for 100 drugs.  These data were set against the free plasma concns. attained during clin. use (effective therapeutic plasma concns.; ETPCunbound).  The drugs were divided into five categories: (1) Class Ia and III antiarrhythmics; (2) withdrawn from market due to TdP; (3) measurable incidence/numerous reports of TdP in humans; (4) isolated reports of TdP in humans; (5) no reports of TdP in humans.  Data from hERG (or IKr) assays in addn. to ETPCunbound data were available for 52 drugs.  For Category 1 drugs, data for hERG/IKr IC50, APD90, QTc in animals and QTc in humans were generally close to or superimposed on the ETPCunbound values.  This relationship was uncoupled in the other categories, with more complex relationships between the data.  In Category 1 (except amiodarone), the ratios between hERG/IKr IC50 and ETPCunbound (max) ranged 0.1-31-fold.  Similar ranges were obtained for drugs in Category 2 (0.31-13-fold) and Category 3 (0.03-35-fold).  A large spread was found for Category 4 drugs (0.13-35,700-fold); this category embraced an assortment of mechanisms ranging from drugs which may well be affecting IKr currents in clin. use (e.g., sparfloxacin) to others such as nifedipine (35,700-fold) where channel block is not involved.  Finally, for the majority of Category 5 drugs there was a >30-fold sepn. between hERG/IKr activity and ETPCunbound values, with the notable exception of verapamil (1.7-fold), which is free from QT prolongation in man; this is probably explained by its multiple interactions with cardiac ion channels.  The dataset confirms the widely held belief that most drugs assocd. with TdP in humans are also assocd. with hERG K+ channel block at concns. close to or superimposed upon the free plasma concns. found in clin. use.  A 30-fold margin between Cmax and hERG IC50 may suffice for drugs currently undergoing clin. evaluation, but for future drug discovery programs, pharmaceutical companies should consider increasing this margin, particularly for drugs aimed at nondebilitating diseases.  However, interactions with multiple cardiac ion channels can either mitigate or exacerbate the prolongation of APD and QT that would ensue from block of IKr currents alone, and delay of repolarization per se is not necessarily torsadogenic.  Clearly, an integrated assessment of in vitro and in vivo data is required in order to predict the torsadogenic risk of a new candidate drug in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkpRDUH0rhyrVg90H21EOLACvtfcHk0lgVTOkb76DL_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit12gsb8%253D&md5=a236c07febd2e05fe70e61604619bf2e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0008-6363%2802%2900846-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0008-6363%252802%252900846-5%26sid%3Dliteratum%253Aachs%26aulast%3DRedfern%26aufirst%3DW.%2BS.%26aulast%3DCarlsson%26aufirst%3DL.%26aulast%3DDavis%26aufirst%3DA.%2BS.%26aulast%3DLynch%26aufirst%3DW.%2BG.%26aulast%3DMacKenzie%26aufirst%3DI.%26aulast%3DPalethorpe%26aufirst%3DS.%26aulast%3DSiegl%26aufirst%3DP.%2BK.%2BS.%26aulast%3DStrang%26aufirst%3DI.%26aulast%3DSullivan%26aufirst%3DA.%2BT.%26aulast%3DWallis%26aufirst%3DR.%26aulast%3DCamm%26aufirst%3DA.%2BJ.%26aulast%3DHammond%26aufirst%3DT.%2BG.%26atitle%3DRelationships%2520between%2520preclinical%2520cardiac%2520electrophysiology%252C%2520clinical%2520QT%2520interval%2520prolongation%2520and%2520torsade%2520de%2520pointes%2520for%2520a%2520broad%2520range%2520of%2520drugs%253A%2520evidence%2520for%2520a%2520provisional%2520safety%2520margin%2520in%2520drug%2520development%26jtitle%3DCardiovasc.%2520Res.%26date%3D2003%26volume%3D58%26spage%3D32%26epage%3D45%26doi%3D10.1016%2FS0008-6363%2802%2900846-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leahy, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arundel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakey, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, M.</span></span> <span> </span><span class="NLM_article-title">Physiologic based pharmacokinetic modeling and QSAR</span>. <i>Bioactive Compd. Des.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADyaK2sXivFOmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&pages=147-151&author=D.+E.+Leahyauthor=P.+A.+Arundelauthor=G.+E.+Blakeyauthor=M.+Rowland&title=Physiologic+based+pharmacokinetic+modeling+and+QSAR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Physiologic based pharmacokinetic modeling and QSAR</span></div><div class="casAuthors">Leahy, D. E.; Arundel, P. A.; Blakey, G. E.; Rowland, M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioactive Compound Design</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">147-151</span>CODEN:
                <span class="NLM_cas:coden">63SXAI</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Bios Scientific Publishers</span>)
        </div><div class="casAbstract">A preliminary anal. of tissue pharmacokinetic data generated in rat for a series of 5-alkyl-5-Et barbituric acids is reported.  The anal. partially supports the hypothesis that the whole animal pharmacokinetic profile can be simulated from a knowledge of physiol. parameters such as tissue vols. and blood flows, combined with the key solute dependent properties such as tissue partition coeffs.  In addn., physiol. parameters are shown to be simply dependent on phys. properties such as lipophilicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrsVa9zOrR5bVg90H21EOLACvtfcHk0ljJX2behDpXPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFOmsQ%253D%253D&md5=9d8528b3ad5990f2b43e645297c6ba97</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeahy%26aufirst%3DD.%2BE.%26aulast%3DArundel%26aufirst%3DP.%2BA.%26aulast%3DBlakey%26aufirst%3DG.%2BE.%26aulast%3DRowland%26aufirst%3DM.%26atitle%3DPhysiologic%2520based%2520pharmacokinetic%2520modeling%2520and%2520QSAR%26jtitle%3DBioactive%2520Compd.%2520Des.%26date%3D1996%26spage%3D147%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nestorov, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aarons, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arundel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, M.</span></span> <span> </span><span class="NLM_article-title">Lumping of whole-body physiologically based pharmacokinetic models</span>. <i>J. Pharmacokinet. Biopharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1023/A:1023272707390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1023%2FA%3A1023272707390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=9773391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVGqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1998&pages=21-46&issue=1&author=I.+A.+Nestorovauthor=L.+J.+Aaronsauthor=P.+A.+Arundelauthor=M.+Rowland&title=Lumping+of+whole-body+physiologically+based+pharmacokinetic+models&doi=10.1023%2FA%3A1023272707390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Lumping of whole-body physiologically based pharmacokinetic models</span></div><div class="casAuthors">Nestorov, Ivan A.; Aarons, Leon J.; Arundel, Philip A.; Rowland, Malcolm</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacokinetics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-46</span>CODEN:
                <span class="NLM_cas:coden">JPBPBJ</span>;
        ISSN:<span class="NLM_cas:issn">0090-466X</span>.
    
            (<span class="NLM_cas:orgname">Plenum Publishing Corp.</span>)
        </div><div class="casAbstract">Lumping is a common pragmatic approach aimed at the redn. of whole-body physiol. based pharmacokinetic (PBPK) model dimensionality and complexity.  Incorrect lumping is equiv. to model misspecification with all the neg. consequences to the subsequent model implementation.  Proper lumping should guarantee that no useful information about the kinetics of the underlying processes is lost.  To enforce this guarantee, formal std. lumping procedures and techniques need to be defined and implemented.  This study examines the lumping process from a system theory point of view, which provides a formal basis for the derivation of principles and std. procedures of lumping.  The lumping principle in PBPK modeling is defined as follows: Only tissues with identical model specification, and occupying identical positions in the system structure should be lumped together at each lumping iteration.  In order to lump together serial tissues, they should have similar or close time consts.  In order to lump together serial tissues, they should equilibrate very rapidly with one another.  The lumping procedure should include the following stages: (i) tissue specification conversion (when tissues with different model specifications are to be lumped together); (ii) classification of the tissues into classes with significantly different kinetics, according to the basic principle of lumping above; (iii) calcn. of the parameters of the lumped compartments; (i.v.) simulation of the lumped system; (v) lumping of the exptl. data; and (vi) verification of the lumped model.  The use of the lumping principles and procedures to be adopted is illustrated with an example of a commonly implemented whole-body physiol. based pharmacokinetic model structure to characterize the pharmacokinetics of a homologous series of barbiturates in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVeHN8G_f36LVg90H21EOLACvtfcHk0ljJX2behDpXPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVGqu7s%253D&md5=cd1dda43fc8597d9235001fd2a4bdf01</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023272707390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023272707390%26sid%3Dliteratum%253Aachs%26aulast%3DNestorov%26aufirst%3DI.%2BA.%26aulast%3DAarons%26aufirst%3DL.%2BJ.%26aulast%3DArundel%26aufirst%3DP.%2BA.%26aulast%3DRowland%26aufirst%3DM.%26atitle%3DLumping%2520of%2520whole-body%2520physiologically%2520based%2520pharmacokinetic%2520models%26jtitle%3DJ.%2520Pharmacokinet.%2520Biopharmaceutics%26date%3D1998%26volume%3D26%26issue%3D1%26spage%3D21%26epage%3D46%26doi%3D10.1023%2FA%3A1023272707390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGinnity, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, R. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of human pharmacokinetics, therapeutic dose and exposure predictions using marketed oral drugs</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.2174/138920007780866799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.2174%2F138920007780866799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=17584017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsl2jtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=463-479&author=D.+F.+McGinnityauthor=J.+Collingtonauthor=R.+P.+Austinauthor=R.+J.+Riley&title=Evaluation+of+human+pharmacokinetics%2C+therapeutic+dose+and+exposure+predictions+using+marketed+oral+drugs&doi=10.2174%2F138920007780866799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of human pharmacokinetics, therapeutic dose and exposure predictions using marketed oral drugs</span></div><div class="casAuthors">McGinnity, D. F.; Collington, J.; Austin, R. P.; Riley, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-479</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">In this article approaches to predict human pharmacokinetics (PK) are discussed and the capability of the exemplified methodologies to est. individual PK parameters and therapeutic dose for a set of marketed oral drugs has been assessed.  For a set of 63 drugs where the min. efficacious concn. (MEC) and human PK were known, the clin. dose was shown to be well predicted or in some cases over-estd. using a simple one-compartment oral PK model.  For a subset of these drugs, in vitro potency against the primary human targets was gathered, and compared to the obsd. MEC.  When cor. for plasma protein binding, the MEC of the majority of compds. was ≤ 3 fold over the resp. in vitro target potency value.  A series of in vitro and in vivo expts. were conducted to predict the human PK parameters.  Metabolic clearance was generally predicted well from human hepatocytes.  Interestingly, for this compd. set, allometry or glomerular filtration rate (GFR) ratio methods appeared to be applicable for renal CL even where CLrenal > GFR.  For ∼90% of compds. studied, the predicted CL using in vitro-in vivo (IVIV) extrapolation together with a CLrenal est., where appropriate, was within 2-fold of that obsd. clin.  Encouragingly vol. of distribution at steady state (Vss) estd. in preclin. species (rat and dog) when cor. for plasma protein binding, predicted human Vss successfully on the majority of occasions - 73% of compds. within 2-fold.  In this lab., absorption estd. from oral rat PK studies was lower than the obsd. human absorption for most drugs, even when soly. and permeability appeared not to be limiting.  Preliminary data indicate absorption in the dog may be more representative of human for compds. absorbed via the transcellular pathway.  Using predicted PK and MEC values estd. from in vitro potency assays there was a good correlation between predicted and obsd. dose.  This anal. suggests that for oral therapies, human PK parameters and clin. dose can be estd. from a consideration of data obtained from in vitro screens using human derived material and in vivo animal studies.  The benefits and limitations of this holistic approach to PK and dose prediction within the drug discovery process are exemplified and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdbfKDFLO_UrVg90H21EOLACvtfcHk0ljJX2behDpXPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsl2jtL4%253D&md5=765bdc4b870b660e813e36ae3719ddb5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F138920007780866799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920007780866799%26sid%3Dliteratum%253Aachs%26aulast%3DMcGinnity%26aufirst%3DD.%2BF.%26aulast%3DCollington%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DR.%2BP.%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26atitle%3DEvaluation%2520of%2520human%2520pharmacokinetics%252C%2520therapeutic%2520dose%2520and%2520exposure%2520predictions%2520using%2520marketed%2520oral%2520drugs%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2007%26volume%3D8%26spage%3D463%26epage%3D479%26doi%3D10.2174%2F138920007780866799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atsumi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takakusa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, O.</span></span> <span> </span><span class="NLM_article-title">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1970</span>– <span class="NLM_lpage">1977</span>, <span class="refDoi"> DOI: 10.1124/dmd.109.027797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1124%2Fdmd.109.027797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=19487250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1970-1977&issue=9&author=S.+Nakayamaauthor=R.+Atsumiauthor=H.+Takakusaauthor=Y.+Kobayashiauthor=A.+Kuriharaauthor=Y.+Nagaiauthor=D.+Nakaiauthor=O.+Okazaki&title=A+zone+classification+system+for+risk+assessment+of+idiosyncratic+drug+toxicity+using+daily+dose+and+covalent+binding&doi=10.1124%2Fdmd.109.027797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span></div><div class="casAuthors">Nakayama, Shintaro; Atsumi, Ryo; Takakusa, Hideo; Kobayashi, Yoshimasa; Kurihara, Atsushi; Nagai, Yoko; Nakai, Daisuke; Okazaki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1970-1977</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The risk of idiosyncratic drug toxicity (IDT) is of great concern to the pharmaceutical industry.  Current hypotheses based on retrospective studies suggest that the occurrence of IDT is related to covalent binding and daily dose.  The authors detd. the covalent binding of 42 radiolabeled drugs in three test systems (human liver microsomes and hepatocytes in vitro and rat liver in vivo) to assess the risk of IDT.  On the basis of safety profiles given in official documentation, tested drugs were classified into the safety categories of safe, warning, black box warning, and withdrawn.  The covalent binding in each of the three test systems did not distinguish the safety categories clearly.  However, when the log-normalized covalent binding was plotted against the log-normalized daily dose, the distribution of the plot in the safety categories became clear.  An ordinal logistic regression anal. indicated that both covalent binding and daily dose were significantly correlated with safety category and that covalent binding in hepatocytes was the best predictor among the three systems.  When two sepn. lines were drawn on the correlation graph between covalent binding in human hepatocytes and daily dose by a regression anal. to create three zones, 30 of 37 tested drugs were located in zones corresponding to their resp. classified safety categories.  In conclusion, the authors established a zone classification system using covalent binding in human hepatocytes and daily dose for the risk assessment of IDTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtahZPkNJ3JbVg90H21EOLACvtfcHk0ljpAQDB2sXGTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO&md5=425119e0451fc50ec6ca95d5e3fe5fd3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.027797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.027797%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DAtsumi%26aufirst%3DR.%26aulast%3DTakakusa%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DKurihara%26aufirst%3DA.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DNakai%26aufirst%3DD.%26aulast%3DOkazaki%26aufirst%3DO.%26atitle%3DA%2520zone%2520classification%2520system%2520for%2520risk%2520assessment%2520of%2520idiosyncratic%2520drug%2520toxicity%2520using%2520daily%2520dose%2520and%2520covalent%2520binding%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26issue%3D9%26spage%3D1970%26epage%3D1977%26doi%3D10.1124%2Fdmd.109.027797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borlak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, W.</span></span> <span> </span><span class="NLM_article-title">High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1002/hep.26208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1002%2Fhep.26208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=23258593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVaisrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2013&pages=388-396&author=M.+Chenauthor=J.+Borlakauthor=W.+Tong&title=High+lipophilicity+and+high+daily+dose+of+oral+medications+are+associated+with+significant+risk+for+drug-induced+liver+injury&doi=10.1002%2Fhep.26208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury</span></div><div class="casAuthors">Chen, Minjun; Borlak, Juergen; Tong, Weida</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">388-396</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Drug-induced liver injury (DILI) is a leading cause of drug failure in clin. trials and a major reason for drug withdrawals from the market.  Although there is evidence that dosages of ≥100 mg/day are assocd. with increased risk for hepatotoxicity, many drugs are safe at such dosages.  There is an unmet need to predict risk for DILI more reliably, and lipophilicity might be a contributing factor.  We analyzed the combined factors of daily dose and lipophilicity for 164 US Food and Drug Administration-approved oral medications and obsd. high risk for hepatotoxicity (odds ratio [OR], 14.05; P < 0.001) for drugs given at dosages ≥100 mg/day and octanol-water partition coeff. (logP) ≥3.  This defined the "rule-of-two.".  Similar results were obtained for an independent set of 179 oral medications with 85% of the rule-of-two positives being assocd. with hepatotoxicity (OR, 3.89; P < 0.01).  Using the World Health Organization's Anatomical Therapeutic Chem. classification system, the rule-of-two performed best in predicting DILI in seven therapeutic categories.  Among 15 rule-of-two positives, 14 were withdrawn from hepatotoxic drugs, and one was over-the-counter medication labeled for liver injury.  We addnl. examd. drug pairs that have similar chem. structures and act on the same mol. target but differ in their potential for DILI.  Again, the rule-of-two predicted hepatotoxicity reliably.  Finally, the rule-of-two was applied to clin. case studies to identify hepatotoxic drugs in complex comedication regimes to further demonstrate its use.  Conclusion: Apart from dose, lipophilicity contributes significantly to risk for hepatotoxicity.  Applying the rule-of-two is an appropriate means of estg. risk for DILI compared with dose alone. (HEPATOl. 2013).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1EE02L_JCdLVg90H21EOLACvtfcHk0ljpAQDB2sXGTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVaisrrM&md5=a88e02ff29653bdeee53b59a4da46d06</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fhep.26208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26208%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DM.%26aulast%3DBorlak%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DW.%26atitle%3DHigh%2520lipophilicity%2520and%2520high%2520daily%2520dose%2520of%2520oral%2520medications%2520are%2520associated%2520with%2520significant%2520risk%2520for%2520drug-induced%2520liver%2520injury%26jtitle%3DHepatology%26date%3D2013%26volume%3D58%26spage%3D388%26epage%3D396%26doi%3D10.1002%2Fhep.26208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swindell, A. C.</span></span> <span> </span><span class="NLM_article-title">Guidance in the setting of drug particle size specification to minimize variability in absorption</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1795</span>– <span class="NLM_lpage">1798</span>, <span class="refDoi"> DOI: 10.1023/A:1016068705255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1023%2FA%3A1016068705255" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1996&pages=1795-1798&author=K.+C.+Johnsonauthor=A.+C.+Swindell&title=Guidance+in+the+setting+of+drug+particle+size+specification+to+minimize+variability+in+absorption&doi=10.1023%2FA%3A1016068705255"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1023%2FA%3A1016068705255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1016068705255%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DK.%2BC.%26aulast%3DSwindell%26aufirst%3DA.%2BC.%26atitle%3DGuidance%2520in%2520the%2520setting%2520of%2520drug%2520particle%2520size%2520specification%2520to%2520minimize%2520variability%2520in%2520absorption%26jtitle%3DPharm.%2520Res.%26date%3D1996%26volume%3D13%26spage%3D1795%26epage%3D1798%26doi%3D10.1023%2FA%3A1016068705255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilgers, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biermacher, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sims, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palandra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosley, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shobe, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, P. S.</span></span> <span> </span><span class="NLM_article-title">Predicting oral absorption of drugs: a case study with a novel class of antimicrobial agents</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1155</span>, <span class="refDoi"> DOI: 10.1023/A:1025084527878</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1023%2FA%3A1025084527878" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2003&pages=1149-1155&issue=8&author=A.+R.+Hilgersauthor=D.+P.+Smithauthor=J.+J.+Biermacherauthor=J.+S.+Dayauthor=J.+L.+Jensenauthor=S.+M.+Simsauthor=W.+J.+Adamsauthor=J.+M.+Friisauthor=J.+Palandraauthor=J.+D.+Hosleyauthor=E.+M.+Shobeauthor=P.+S.+Burton&title=Predicting+oral+absorption+of+drugs%3A+a+case+study+with+a+novel+class+of+antimicrobial+agents&doi=10.1023%2FA%3A1025084527878"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1023%2FA%3A1025084527878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1025084527878%26sid%3Dliteratum%253Aachs%26aulast%3DHilgers%26aufirst%3DA.%2BR.%26aulast%3DSmith%26aufirst%3DD.%2BP.%26aulast%3DBiermacher%26aufirst%3DJ.%2BJ.%26aulast%3DDay%26aufirst%3DJ.%2BS.%26aulast%3DJensen%26aufirst%3DJ.%2BL.%26aulast%3DSims%26aufirst%3DS.%2BM.%26aulast%3DAdams%26aufirst%3DW.%2BJ.%26aulast%3DFriis%26aufirst%3DJ.%2BM.%26aulast%3DPalandra%26aufirst%3DJ.%26aulast%3DHosley%26aufirst%3DJ.%2BD.%26aulast%3DShobe%26aufirst%3DE.%2BM.%26aulast%3DBurton%26aufirst%3DP.%2BS.%26atitle%3DPredicting%2520oral%2520absorption%2520of%2520drugs%253A%2520a%2520case%2520study%2520with%2520a%2520novel%2520class%2520of%2520antimicrobial%2520agents%26jtitle%3DPharm.%2520Res.%26date%3D2003%26volume%3D20%26issue%3D8%26spage%3D1149%26epage%3D1155%26doi%3D10.1023%2FA%3A1025084527878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gelder, J.</span></span> <span> </span><span class="NLM_article-title">Developability assessment of clinical drug products with maximum absorbable doses</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>427</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">260</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1016/j.ijpharm.2012.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.ijpharm.2012.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=22349050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtF2hsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2012&pages=260-269&issue=2&author=X.+Dingauthor=J.+P.+Roseauthor=J.+Van+Gelder&title=Developability+assessment+of+clinical+drug+products+with+maximum+absorbable+doses&doi=10.1016%2Fj.ijpharm.2012.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Developability assessment of clinical drug products with maximum absorbable doses</span></div><div class="casAuthors">Ding, Xuan; Rose, John P.; Van Gelder, Jan</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">427</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">260-269</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Maximum absorbable dose refers to the max. amt. of an orally administered drug that can be absorbed in the gastrointestinal tract.  Maximum absorbable dose, or Dabs, has proved to be an important parameter for quantifying the absorption potential of drug candidates.  The purpose of this work is to validate the use of Dabs in a developability assessment context, and to establish appropriate protocol and interpretation criteria for this application.  Three methods for calcg. Dabs were compared by assessing how well the methods predicted the absorption limit for a set of real clin. candidates.  Dabs was calcd. for these clin. candidates by means of a simple equation and two computer simulation programs, GastroPlus and an program developed at Eli Lilly and Company.  Results from single dose escalation studies in Phase I clin. trials were analyzed to identify the max. absorbable doses for these compds.  Compared to the clin. results, the equation and both simulation programs provide conservative ests. of Dabs, but in general Dabs from the computer simulations are more accurate, which may find obvious advantage for the simulations in developability assessment.  Computer simulations also revealed the complex behavior assocd. with absorption satn. and suggested in most cases that the Dabs limit is not likely to be achieved in a typical clin. dose range.  On the basis of the validation findings, an approach is proposed for assessing absorption potential, and best practices are discussed for the use of Dabs ests. to inform clin. formulation development strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-tXMDaAGuRbVg90H21EOLACvtfcHk0lhlogiVZ84MRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtF2hsbk%253D&md5=0dd141927adc493e6343fd8ec3e3fbae</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2012.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2012.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DX.%26aulast%3DRose%26aufirst%3DJ.%2BP.%26aulast%3DVan%2BGelder%26aufirst%3DJ.%26atitle%3DDevelopability%2520assessment%2520of%2520clinical%2520drug%2520products%2520with%2520maximum%2520absorbable%2520doses%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2012%26volume%3D427%26issue%3D2%26spage%3D260%26epage%3D269%26doi%3D10.1016%2Fj.ijpharm.2012.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sjogren, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westergren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanisch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindfors, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennernas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahamsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannergren, C.</span></span> <span> </span><span class="NLM_article-title">In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">679</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2013.05.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.ejps.2013.05.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=23727464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSlsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=679-698&author=E.+Sjogrenauthor=J.+Westergrenauthor=I.+Grantauthor=G.+Hanischauthor=L.+Lindforsauthor=H.+Lennernasauthor=B.+Abrahamssonauthor=C.+Tannergren&title=In+silico+predictions+of+gastrointestinal+drug+absorption+in+pharmaceutical+product+development%3A+application+of+the+mechanistic+absorption+model+GI-Sim&doi=10.1016%2Fj.ejps.2013.05.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: Application of the mechanistic absorption model GI-Sim</span></div><div class="casAuthors">Sjogren, Erik; Westergren, Jan; Grant, Iain; Hanisch, Gunilla; Lindfors, Lennart; Lennernas, Hans; Abrahamsson, Bertil; Tannergren, Christer</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">679-698</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Oral drug delivery is the predominant administration route for a major part of the pharmaceutical products used worldwide.  Further understanding and improvement of gastrointestinal drug absorption predictions is currently a highly prioritized area of research within the pharmaceutical industry.  The fraction absorbed (fabs) of an oral dose after administration of a solid dosage form is a key parameter in the estn. of the in vivo performance of an orally administrated drug formulation.  This study discloses an evaluation of the predictive performance of the mechanistic physiol. based absorption model GI-Sim.  GI-Sim deploys a compartmental gastrointestinal absorption and transit model as well as algorithms describing permeability, dissoln. rate, salt effects, partitioning into micelles, particle and micelle drifting in the aq. boundary layer, particle growth and amorphous or cryst. pptn.  Twelve APIs with reported or expected absorption limitations in humans, due to permeability, dissoln. and/or soly., were investigated.  Predictions of the intestinal absorption for different doses and formulations were performed based on physicochem. and biopharmaceutical properties, such as soly. in buffer and simulated intestinal fluid, mol. wt., pKa, diffusivity and mol. d., measured or estd. human effective permeability and particle size distribution.  The performance of GI-Sim was evaluated by comparing predicted plasma concn.-time profiles along with oral pharmacokinetic parameters originating from clin. studies in healthy individuals.  The capability of GI-Sim to correctly predict impact of dose and particle size as well as the in vivo performance of nanoformulations was also investigated.  The overall predictive performance of GI-Sim was good as >95% of the predicted pharmacokinetic parameters (Cmax and AUC) were within a 2-fold deviation from the clin. observations and the predicted plasma AUC was within one std. deviation of the obsd. mean plasma AUC in 74% of the simulations.  GI-Sim was also able to correctly capture the trends in dose- and particle size dependent absorption for the study drugs with soly. and dissoln. limited absorption, resp.  In addn., GI-Sim was also shown to be able to predict the increase in absorption and plasma exposure achieved with nanoformulations.  Based on the results, the performance of GI-Sim was shown to be suitable for early risk assessment as well as to guide decision making in pharmaceutical formulation development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriPOOmNPmHhrVg90H21EOLACvtfcHk0lhlogiVZ84MRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSlsr%252FJ&md5=b6eb6e66b7642463fd1191cfe3bdbc51</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2013.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2013.05.019%26sid%3Dliteratum%253Aachs%26aulast%3DSjogren%26aufirst%3DE.%26aulast%3DWestergren%26aufirst%3DJ.%26aulast%3DGrant%26aufirst%3DI.%26aulast%3DHanisch%26aufirst%3DG.%26aulast%3DLindfors%26aufirst%3DL.%26aulast%3DLennernas%26aufirst%3DH.%26aulast%3DAbrahamsson%26aufirst%3DB.%26aulast%3DTannergren%26aufirst%3DC.%26atitle%3DIn%2520silico%2520predictions%2520of%2520gastrointestinal%2520drug%2520absorption%2520in%2520pharmaceutical%2520product%2520development%253A%2520application%2520of%2520the%2520mechanistic%2520absorption%2520model%2520GI-Sim%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D49%26spage%3D679%26epage%3D698%26doi%3D10.1016%2Fj.ejps.2013.05.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, A. W.</span></span> <span> </span><span class="NLM_article-title">On the action of bromine in alkaline solution on amides</span>. <i>Ber. Dtsch. Chem. Ges.</i> <span class="NLM_year" style="font-weight: bold;">1881</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2725</span>– <span class="NLM_lpage">2736</span>, (title translated from “Ueber die Einwirkung des Broms in alkalischer Lösung auf Amide”). <span class="refDoi"> DOI: 10.1002/cber.188101402242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1002%2Fcber.188101402242" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1881&pages=2725-2736&author=A.+W.+Hofmann&title=On+the+action+of+bromine+in+alkaline+solution+on+amides&doi=10.1002%2Fcber.188101402242"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fcber.188101402242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.188101402242%26sid%3Dliteratum%253Aachs%26aulast%3DHofmann%26aufirst%3DA.%2BW.%26atitle%3DOn%2520the%2520action%2520of%2520bromine%2520in%2520alkaline%2520solution%2520on%2520amides%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%26date%3D1881%26volume%3D14%26spage%3D2725%26epage%3D2736%26doi%3D10.1002%2Fcber.188101402242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyaura, N.</span></span> <span> </span><span class="NLM_article-title">Palladium(0)-catalyzed cross-coupling reaction of alkoxydiboron with haloarenes: a direct procedure for arylboronic esters</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7508</span>– <span class="NLM_lpage">7510</span>, <span class="refDoi"> DOI: 10.1021/jo00128a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00128a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=7508-7510&author=T.+Ishiyamaauthor=M.+Murataauthor=N.+Miyaura&title=Palladium%280%29-catalyzed+cross-coupling+reaction+of+alkoxydiboron+with+haloarenes%3A+a+direct+procedure+for+arylboronic+esters&doi=10.1021%2Fjo00128a024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters</span></div><div class="casAuthors">Ishiyama, Tatsuo; Murata, Miki; Miyaura, Norio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7508-10</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The palladium-catalyzed cross-coupling reaction of the pinacol ester of diboronic acid I with haloarenes gave a direct procedure for arylboronic esters II (Ar = aryl) from aryl halides in a range of 60-98%.  The reaction was catalyzed by PdCl2(dppf) (3 mol %) at 80° in the presence of KOAc (3 equiv) in DMSO and available with various functional groups such as nitrile, cyanide, ester, and carbonyl groups.  The trans-ArPd(II)(OAc)(PPh3)2 intermediate was isolated and characterized to propose the catalytic cycle involving the transmetalation between the phenylpalladium(II) acetate complex and I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobehJBGFjDH7Vg90H21EOLACvtfcHk0lhlogiVZ84MRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D&md5=2666902270ec1efc5742480b133f1255</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjo00128a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00128a024%26sid%3Dliteratum%253Aachs%26aulast%3DIshiyama%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DMiyaura%26aufirst%3DN.%26atitle%3DPalladium%25280%2529-catalyzed%2520cross-coupling%2520reaction%2520of%2520alkoxydiboron%2520with%2520haloarenes%253A%2520a%2520direct%2520procedure%2520for%2520arylboronic%2520esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D7508%26epage%3D7510%26doi%3D10.1021%2Fjo00128a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Page, K. M.</span></span> <span> </span><span class="NLM_article-title">Validation of early human dose prediction: a key metric for compound crogression in drug discovery</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.5b00840</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.5b00840" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGrs7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=609-620&issue=2&author=K.+M.+Page&title=Validation+of+early+human+dose+prediction%3A+a+key+metric+for+compound+crogression+in+drug+discovery&doi=10.1021%2Facs.molpharmaceut.5b00840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of Early Human Dose Prediction: A Key Metric for Compound Progression in Drug Discovery</span></div><div class="casAuthors">Page, Ken M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">609-620</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human dose prediction is increasingly recognized as an important parameter in Drug Discovery.  Validation of a method using only in vitro and predicted parameters incorporated into a PK model was undertaken by predicting human dose and free Cmax for a no. of marketed drugs and AZ Development compds.  Doses were compared to those most relevant to marketed drugs or to clin. administered doses of AZ compds. normalized either to predicted Cmin or Cmax values.  Av. (AFE) and abs. av. (AAFE) fold-error anal. showed that best predictions were obtained using a QSAR model as the source of Vss, with Fabs set to 1 for acids and 0.5 for all other ion classes; for clearance prediction no binding correction to the well stirred model (WSM) was used for bases, while it was set to Fup/Fup0.5 for all other ion classes.  Using this combination of methods, predicted doses for 45 to 68% of the Cmin- and Cmax-normalized and marketed drug data sets were within 3-fold of the obsd. values, while 82 to 92% of these data sets were within 10-fold.  This method for early human dose prediction is able to rank, identify, and flag risks or optimization opportunities for future development compds. within 10 days of first synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT--CfNq9EGLVg90H21EOLACvtfcHk0lis1huoyLCkXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGrs7%252FO&md5=612ece6c4e2729ab4694b0ae168e4cba</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.5b00840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.5b00840%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DK.%2BM.%26atitle%3DValidation%2520of%2520early%2520human%2520dose%2520prediction%253A%2520a%2520key%2520metric%2520for%2520compound%2520crogression%2520in%2520drug%2520discovery%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2016%26volume%3D13%26issue%3D2%26spage%3D609%26epage%3D620%26doi%3D10.1021%2Facs.molpharmaceut.5b00840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Volume of distribution in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5691</span>– <span class="NLM_lpage">5698</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00201</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00201" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFSlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5691-5698&author=D.+A.+Smithauthor=K.+Beaumontauthor=T.+S.+Maurerauthor=L.+Di&title=Volume+of+distribution+in+drug+design&doi=10.1021%2Facs.jmedchem.5b00201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Volume of Distribution in Drug Design</span></div><div class="casAuthors">Smith, Dennis A.; Beaumont, Kevin; Maurer, Tristan S.; Di, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5691-5698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Vol. of distribution is one of the most important pharmacokinetic properties of a drug candidate.  It is a major determinant of half-life and dosing frequency of a drug.  For a similar log P, a basic mol. will tend to exhibit higher vol. of distribution than a neutral mol.  Acids often exhibit low vols. of distribution.  Although a design strategy against vol. of distribution can be advantageous in achieving desirable dosing regimen, it must be well-directed in order to avoid detrimental effects to other important properties.  Strategies to increase vol. of distribution include adding lipophilicity and introducing basic functional groups in a way that does not increase metabolic clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP7QwgPahf4bVg90H21EOLACvtfcHk0lis1huoyLCkXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFSlsb0%253D&md5=2c7289b3602a8edef2d9ef0e6a82e483</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00201%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DVolume%2520of%2520distribution%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5691%26epage%3D5698%26doi%3D10.1021%2Facs.jmedchem.5b00201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caravatti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guagnano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoepfer, J.</span></span> <span> </span><span class="NLM_article-title">Entry into a new class of protein kinase inhibitors by pseudo ring design</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">900</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.12.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.bmcl.2007.12.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=18248988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=897-900&author=P.+Furetauthor=G.+Caravattiauthor=V.+Guagnanoauthor=M.+Langauthor=T.+Meyerauthor=J.+Schoepfer&title=Entry+into+a+new+class+of+protein+kinase+inhibitors+by+pseudo+ring+design&doi=10.1016%2Fj.bmcl.2007.12.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Entry into a new class of protein kinase inhibitors by pseudo ring design</span></div><div class="casAuthors">Furet, Pascal; Caravatti, Giorgio; Guagnano, Vito; Lang, Marc; Meyer, Thomas; Schoepfer, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">897-900</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A pyrimidin-4-yl-urea motif forming a pseudo ring by intramol. hydrogen bonding has been designed to mimic the pyrido[2,3-d]pyrimidin-7-one core structure of a well-established class of protein kinase inhibitors.  Potent inhibition of a no. of protein kinases was obtained with the first prototype compd. synthesized to probe the design concept.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5MZZKS4I03LVg90H21EOLACvtfcHk0lis1huoyLCkXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWksb0%253D&md5=989b4bb7f1d5177be45d4edf31290de5</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.041%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DCaravatti%26aufirst%3DG.%26aulast%3DGuagnano%26aufirst%3DV.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DSchoepfer%26aufirst%3DJ.%26atitle%3DEntry%2520into%2520a%2520new%2520class%2520of%2520protein%2520kinase%2520inhibitors%2520by%2520pseudo%2520ring%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D897%26epage%3D900%26doi%3D10.1016%2Fj.bmcl.2007.12.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maira, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brueggen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritsch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brachmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chene, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pover, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoemaker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Echeverría, C.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammailian target of rapamycin inhibitor with potent in vivo antitumor activity</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1851</span>– <span class="NLM_lpage">1863</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=18606717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&issue=7&author=S.+M.+Mairaauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Cheneauthor=A.+De+Poverauthor=K.+Schoemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+Garc%C3%ADa-Echeverr%C3%ADa&title=Identification+and+characterization+of+NVP-BEZ235%2C+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammailian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity&doi=10.1158%2F1535-7163.MCT-08-0017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span></div><div class="casAuthors">Maira, Sauveur-Michel; Stauffer, Frederic; Brueggen, Josef; Furet, Pascal; Schnell, Christian; Fritsch, Christine; Brachmann, Saskia; Chene, Patrick; De Pover, Alain; Schoemaker, Kevin; Fabbro, Doriano; Gabriel, Daniela; Simonen, Marjo; Murphy, Leon; Finan, Peter; Sellers, William; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1851-1863</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells, providing unique opportunities for anticancer therapeutic intervention.  NVP-BEZ235 is an imidazo[4,5-c]quinoline deriv. that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.  In cellular settings using human tumor cell lines, this mol. is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest.  The cellular activity of NVP-BEZ235 translates well in in vivo models of human cancer.  Thus, the compd. was well tolerated, displayed disease stasis when administered orally, and enhanced the efficacy of other anticancer agents when used in in vivo combination studies.  Ex vivo pharmacokinetic/pharmacodynamic analyses of tumor tissues showed a time-dependent correlation between compd. concn. and PI3K/Akt pathway inhibition.  Collectively, the preclin. data show that NVP-BEZ235 is a potent dual PI3K/mTOR modulator with favorable pharmaceutical properties.  NVP-BEZ235 is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyO784qv52vrVg90H21EOLACvtfcHk0lis1huoyLCkXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D&md5=5b1979e134dd12065198d86dbc11ce15</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarc%25C3%25ADa-Echeverr%25C3%25ADa%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520NVP-BEZ235%252C%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammailian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26issue%3D7%26spage%3D1851%26epage%3D1863%26doi%3D10.1158%2F1535-7163.MCT-08-0017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gil del Alcazar, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardebeck, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomimatsu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachoo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habib, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burma, S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1235</span>– <span class="NLM_lpage">1248</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-1607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1158%2F1078-0432.CCR-13-1607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=24366691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC2cXks1Ohurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1235-1248&issue=5&author=C.+R.+Gil+del+Alcazarauthor=M.+C.+Hardebeckauthor=B.+Mukherjeeauthor=N.+Tomimatsuauthor=X.+Gaoauthor=J.+Yanauthor=X.-J.+Xieauthor=R.+Bachooauthor=L.+Liauthor=A.+A.+Habibauthor=S.+Burma&title=Inhibition+of+DNA+double-strand+break+repair+by+the+dual+PI3K%2FmTOR+inhibitor+NVP-BEZ235+as+a+strategy+for+radiosensitization+of+glioblastoma&doi=10.1158%2F1078-0432.CCR-13-1607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of DNA Double-Strand Break Repair by the Dual PI3K/mTOR Inhibitor NVP-BEZ235 as a Strategy for Radiosensitization of Glioblastoma</span></div><div class="casAuthors">Gil del Alcazar, Carlos Rodrigo; Hardebeck, Molly Catherine; Mukherjee, Bipasha; Tomimatsu, Nozomi; Gao, Xiaohuan; Yan, Jingsheng; Xie, Xian-Jin; Bachoo, Robert; Li, Li; Habib, Amyn A.; Burma, Sandeep</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1235-1248</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Inhibitors of the DNA damage response (DDR) have great potential for radiosensitization of numerous cancers, including glioblastomas, which are extremely radio- and chemoresistant brain tumors.  Currently, there are no DNA double-strand break (DSB) repair inhibitors that have been successful in treating glioblastoma.  Our lab. previously demonstrated that the dual phosphoinositide 3-kinase/mTOR inhibitor NVP-BEZ235 can potently inhibit the two central DDR kinases, DNA-dependent protein kinase catalytic subunit (DNA-PKcs) and ataxia-telangiectasia mutated (ATM), in vitro.  Here, we tested whether NVP-BEZ235 could also inhibit ATM and DNA-PKcs in tumors in vivo and assessed its potential as a radio- and chemosensitizer in preclin. mouse glioblastoma models.  Exptl. Design: The radiosensitizing effect of NVP-BEZ235 was tested by following tumor growth in s.c. and orthotopic glioblastoma models.  Tumors were generated using the radioresistant U87-vIII glioma cell line and GBM9 neurospheres in nude mice.  These tumors were then treated with ionizing radiation and/or NVP-BEZ235 and analyzed for DNA-PKcs and ATM activation, DSB repair inhibition, and attenuation of growth.  Results: NVP-BEZ235 potently inhibited both DNA-PKcs and ATM kinases and attenuated the repair of ionizing radiation-induced DNA damage in tumors.  This resulted in striking tumor radiosensitization, which extended the survival of brain tumor-bearing mice.  Notably, tumors displayed a higher DSB-load when compared with normal brain tissue.  NVP-BEZ235 also sensitized a subset of s.c. tumors to temozolomide, a drug routinely used concurrently with ionizing radiation for the treatment of glioblastoma.  Conclusions: These results demonstrate that it may be possible to significantly improve glioblastoma therapy by combining ionizing radiation with potent and bioavailable DNA repair inhibitors such as NVP-BEZ235.  Clin Cancer Res; 20(5); 1235-48. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU7klfy2L_M7Vg90H21EOLACvtfcHk0ljca1tzmfWvcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXks1Ohurg%253D&md5=22c4c555e6d11d3ea1b426ce7bb261c7</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-1607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-1607%26sid%3Dliteratum%253Aachs%26aulast%3DGil%2Bdel%2BAlcazar%26aufirst%3DC.%2BR.%26aulast%3DHardebeck%26aufirst%3DM.%2BC.%26aulast%3DMukherjee%26aufirst%3DB.%26aulast%3DTomimatsu%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DX.-J.%26aulast%3DBachoo%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHabib%26aufirst%3DA.%2BA.%26aulast%3DBurma%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520DNA%2520double-strand%2520break%2520repair%2520by%2520the%2520dual%2520PI3K%252FmTOR%2520inhibitor%2520NVP-BEZ235%2520as%2520a%2520strategy%2520for%2520radiosensitization%2520of%2520glioblastoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26issue%3D5%26spage%3D1235%26epage%3D1248%26doi%3D10.1158%2F1078-0432.CCR-13-1607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomimatsu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amancherla, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichamoorthy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burma, S.</span></span> <span> </span><span class="NLM_article-title">The dual PI3K/mTOR inhibitor NVP-BEZ235 is a potent inhibitor of ATM- and DNA-PKcs-mediated DNA damage responses</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1593/neo.111512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1593%2Fneo.111512" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=34-43&author=B.+Mukherjeeauthor=N.+Tomimatsuauthor=K.+Amancherlaauthor=C.+V.+Camachoauthor=N.+Pichamoorthyauthor=S.+Burma&title=The+dual+PI3K%2FmTOR+inhibitor+NVP-BEZ235+is+a+potent+inhibitor+of+ATM-+and+DNA-PKcs-mediated+DNA+damage+responses&doi=10.1593%2Fneo.111512"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1593%2Fneo.111512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.111512%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DB.%26aulast%3DTomimatsu%26aufirst%3DN.%26aulast%3DAmancherla%26aufirst%3DK.%26aulast%3DCamacho%26aufirst%3DC.%2BV.%26aulast%3DPichamoorthy%26aufirst%3DN.%26aulast%3DBurma%26aufirst%3DS.%26atitle%3DThe%2520dual%2520PI3K%252FmTOR%2520inhibitor%2520NVP-BEZ235%2520is%2520a%2520potent%2520inhibitor%2520of%2520ATM-%2520and%2520DNA-PKcs-mediated%2520DNA%2520damage%2520responses%26jtitle%3DNeoplasia%26date%3D2012%26volume%3D14%26spage%3D34%26epage%3D43%26doi%3D10.1593%2Fneo.111512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarcsay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyiri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">Impact of lipophilic efficiency on compound quality</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1252</span>– <span class="NLM_lpage">1260</span>, <span class="refDoi"> DOI: 10.1021/jm201388p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201388p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVKjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1252-1260&author=A.+Tarcsayauthor=K.+Nyiriauthor=G.+M.+Keseru&title=Impact+of+lipophilic+efficiency+on+compound+quality&doi=10.1021%2Fjm201388p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of Lipophilic Efficiency on Compound Quality</span></div><div class="casAuthors">Tarcsay, Akos; Nyiri, Kinga; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1252-1260</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipophilic efficiency indexes such as LLE and LELP were suggested to support balanced optimization of potency and ADMET profile.  Here we investigated the performance of LLE and LELP on multiple data sets representing different stages of drug discovery including fragment and HTS hits and leads, development candidates, phase II compds., and launched drugs.  Analyzing their impact on ADME and safety properties and binding thermodn., we found that both LLE and LELP help identifying better quality compds.  LLE is sensible for the development stages but does not prefer fragment-type hits, while LELP has an advantage for this class of compds. and discriminates preferred starting points effectively.  Both LLE and LELP have significant impact on ADME and safety profiles; however, LELP outperforms LLE in risk assessment at least on the present data set.  On the basis of the results reported here, monitoring lipophilic efficiency metrics could contribute significantly to compd. quality and might improve the output of medicinal chem. programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxB8xs6-5DL7Vg90H21EOLACvtfcHk0ljca1tzmfWvcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVKjsQ%253D%253D&md5=2536abef781f52806013016971c78bcb</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm201388p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201388p%26sid%3Dliteratum%253Aachs%26aulast%3DTarcsay%26aufirst%3DA.%26aulast%3DNyiri%26aufirst%3DK.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DImpact%2520of%2520lipophilic%2520efficiency%2520on%2520compound%2520quality%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1252%26epage%3D1260%26doi%3D10.1021%2Fjm201388p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, N. J.</span></span> <span> </span><span class="NLM_article-title">Validity of ligand efficiency metrics</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">618</span>, <span class="refDoi"> DOI: 10.1021/ml500146d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500146d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVShsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=616-618&author=C.+W.+Murrayauthor=D.+A.+Erlansonauthor=A.+L.+Hopkinsauthor=G.+M.+Keseruauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynoldsauthor=N.+J.+Richmond&title=Validity+of+ligand+efficiency+metrics&doi=10.1021%2Fml500146d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Validity of Ligand Efficiency Metrics</span></div><div class="casAuthors">Murray, Christopher W.; Erlanson, Daniel A.; Hopkins, Andrew L.; Keseru, Gyorgy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.; Richmond, Nicola J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">616-618</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A recent viewpoint article (Improving the plausibility of success with inefficient metrics. ACS Med. Chem. Lett.2014, 5, 2-5) argued that the std. definition of ligand efficiency (LE) is math. invalid.  In this viewpoint, we address this criticism and show categorically that the definition of LE is math. valid.  LE and other metrics such as lipophilic ligand efficiency (LLE) can be useful during the multiparameter optimization challenge faced by medicinal chemists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraJHYI4FCEJbVg90H21EOLACvtfcHk0lhjCA5ua4L2cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVShsbs%253D&md5=5bc436490def9fa7af0f3e7ed241ee4e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fml500146d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500146d%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DRichmond%26aufirst%3DN.%2BJ.%26atitle%3DValidity%2520of%2520ligand%2520efficiency%2520metrics%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D616%26epage%3D618%26doi%3D10.1021%2Fml500146d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Free, S. M.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. W.</span></span> <span> </span><span class="NLM_article-title">A mathematical contribution to structure–activity studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1964</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1021/jm00334a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00334a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADyaF2cXkt1OltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1964&pages=395-399&author=S.+M.+Freeauthor=J.+W.+Wilson&title=A+mathematical+contribution+to+structure%E2%80%93activity+studies&doi=10.1021%2Fjm00334a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A mathematical contribution to structure-activity studies</span></div><div class="casAuthors">Free, Spencer M., Jr.; Wilson, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A math. technique is suggested as a means of describing structure-activity relation of a series of chem. analogs.  The data requirements included specific side chain arrangements and performance characteristics of all analogs tested.  Two examples illustrate the use of the additive math. model where the performance characteristics are measures of biol. activity.  The results rank the structural changes per position by estg. the amt. of biol. response attributed to each change.  The estimates are both pos. and neg.  Several uses for the math. soln. are suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRyTj3xI-aH7Vg90H21EOLACvtfcHk0lhjCA5ua4L2cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXkt1OltbY%253D&md5=88fabb64d7a5635506a11418a2744bd6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm00334a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00334a001%26sid%3Dliteratum%253Aachs%26aulast%3DFree%26aufirst%3DS.%2BM.%26aulast%3DWilson%26aufirst%3DJ.%2BW.%26atitle%3DA%2520mathematical%2520contribution%2520to%2520structure%25E2%2580%2593activity%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1964%26volume%3D7%26spage%3D395%26epage%3D399%26doi%3D10.1021%2Fjm00334a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrecher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, G.</span></span> <span> </span><span class="NLM_article-title">Matrix-based multiparameter optimization of glucokinase activators: the discovery of AZD1092</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">779</span>, <span class="refDoi"> DOI: 10.1039/c1md00092f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1039%2Fc1md00092f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=775-779&author=M.+J.+Waringauthor=C.+Johnstoneauthor=D.+McKerrecherauthor=K.+G.+Pikeauthor=G.+Robb&title=Matrix-based+multiparameter+optimization+of+glucokinase+activators%3A+the+discovery+of+AZD1092&doi=10.1039%2Fc1md00092f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1039%2Fc1md00092f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00092f%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DC.%26aulast%3DMcKerrecher%26aufirst%3DD.%26aulast%3DPike%26aufirst%3DK.%2BG.%26aulast%3DRobb%26aufirst%3DG.%26atitle%3DMatrix-based%2520multiparameter%2520optimization%2520of%2520glucokinase%2520activators%253A%2520the%2520discovery%2520of%2520AZD1092%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D775%26epage%3D779%26doi%3D10.1039%2Fc1md00092f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freeman-Cook, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirico, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esler, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henegar, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houser, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limberakis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loomis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdande, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillion, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugarman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span> <span> </span><span class="NLM_article-title">Maximising lipophilic efficiency: the use of Free–Wilson analysis in the design of inhibitors of acetyl-CoA carboxylase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">942</span>, <span class="refDoi"> DOI: 10.1021/jm201503u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201503u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=935-942&author=K.+D.+Freeman-Cookauthor=P.+Amorauthor=S.+Baderauthor=L.+M.+Buzonauthor=S.+B.+Coffeyauthor=J.+W.+Corbettauthor=K.+J.+Diricoauthor=S.+D.+Doranauthor=R.+L.+Elliottauthor=W.+Eslerauthor=A.+Guzman-Perezauthor=K.+E.+Henegarauthor=J.+A.+Houserauthor=C.+S.+Jonesauthor=C.+Limberakisauthor=K.+Loomisauthor=K.+McPhersonauthor=S.+Murdandeauthor=K.+L.+Nelsonauthor=D.+Phillionauthor=B.+S.+Pierceauthor=W.+Songauthor=E.+Sugarmanauthor=S.+Tapleyauthor=M.+Tuauthor=Z.+Zhao&title=Maximising+lipophilic+efficiency%3A+the+use+of+Free%E2%80%93Wilson+analysis+in+the+design+of+inhibitors+of+acetyl-CoA+carboxylase&doi=10.1021%2Fjm201503u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm201503u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201503u%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman-Cook%26aufirst%3DK.%2BD.%26aulast%3DAmor%26aufirst%3DP.%26aulast%3DBader%26aufirst%3DS.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DCoffey%26aufirst%3DS.%2BB.%26aulast%3DCorbett%26aufirst%3DJ.%2BW.%26aulast%3DDirico%26aufirst%3DK.%2BJ.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DElliott%26aufirst%3DR.%2BL.%26aulast%3DEsler%26aufirst%3DW.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHenegar%26aufirst%3DK.%2BE.%26aulast%3DHouser%26aufirst%3DJ.%2BA.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DLoomis%26aufirst%3DK.%26aulast%3DMcPherson%26aufirst%3DK.%26aulast%3DMurdande%26aufirst%3DS.%26aulast%3DNelson%26aufirst%3DK.%2BL.%26aulast%3DPhillion%26aufirst%3DD.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DSugarman%26aufirst%3DE.%26aulast%3DTapley%26aufirst%3DS.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26atitle%3DMaximising%2520lipophilic%2520efficiency%253A%2520the%2520use%2520of%2520Free%25E2%2580%2593Wilson%2520analysis%2520in%2520the%2520design%2520of%2520inhibitors%2520of%2520acetyl-CoA%2520carboxylase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D935%26epage%3D942%26doi%3D10.1021%2Fjm201503u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, F.
W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snelson, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groombridge, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donald, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, S. N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morentin
Gutierrez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyte, A. C.</span></span> <span> </span><span class="NLM_article-title">Free–Wilson and structural approaches to co-optimizing human and rodent isoform potency for 11β-hydroxysteriod dehydrogenase type 1 (11β-HSD1) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10652</span>– <span class="NLM_lpage">10661</span>, <span class="refDoi"> DOI: 10.1021/jm3013163</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3013163" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10652-10661&author=F.%0AW.+Goldbergauthor=A.+G.+Leachauthor=J.+S.+Scottauthor=W.+L.+Snelsonauthor=S.+D.+Groombridgeauthor=C.+S.+Donaldauthor=S.+N.+L.+Bennettauthor=C.+Bodinauthor=P.+Morentin%0AGutierrezauthor=A.+C.+Gyte&title=Free%E2%80%93Wilson+and+structural+approaches+to+co-optimizing+human+and+rodent+isoform+potency+for+11%CE%B2-hydroxysteriod+dehydrogenase+type+1+%2811%CE%B2-HSD1%29+inhibitors&doi=10.1021%2Fjm3013163"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm3013163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3013163%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DF.%2BW.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DSnelson%26aufirst%3DW.%2BL.%26aulast%3DGroombridge%26aufirst%3DS.%2BD.%26aulast%3DDonald%26aufirst%3DC.%2BS.%26aulast%3DBennett%26aufirst%3DS.%2BN.%2BL.%26aulast%3DBodin%26aufirst%3DC.%26aulast%3DMorentin%2BGutierrez%26aufirst%3DP.%26aulast%3DGyte%26aufirst%3DA.%2BC.%26atitle%3DFree%25E2%2580%2593Wilson%2520and%2520structural%2520approaches%2520to%2520co-optimizing%2520human%2520and%2520rodent%2520isoform%2520potency%2520for%252011%25CE%25B2-hydroxysteriod%2520dehydrogenase%2520type%25201%2520%252811%25CE%25B2-HSD1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10652%26epage%3D10661%26doi%3D10.1021%2Fjm3013163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruston, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeritt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culshaw, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Good, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blades, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eden, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, S. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of AZD3147: A potent, selective dual inhibitor of mTORC1 and mTORC2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2326</span>– <span class="NLM_lpage">2349</span>, <span class="refDoi"> DOI: 10.1021/jm501778s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501778s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFeitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2326-2349&author=K.+G.+Pikeauthor=J.+Morrisauthor=L.+Rustonauthor=S.+L.+Passauthor=R.+Greenwoodauthor=E.+J.+Williamsauthor=J.+Demerittauthor=J.+D.+Culshawauthor=K.+Gillauthor=M.+Passauthor=M.+R.+V.+Finlayauthor=C.+J.+Goodauthor=C.+A.+Robertsauthor=G.+S.+Currieauthor=K.+Bladesauthor=J.+M.+Edenauthor=S.+E.+Pearson&title=Discovery+of+AZD3147%3A+A+potent%2C+selective+dual+inhibitor+of+mTORC1+and+mTORC2&doi=10.1021%2Fjm501778s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of AZD3147: A Potent, Selective Dual Inhibitor of mTORC1 and mTORC2</span></div><div class="casAuthors">Pike, Kurt G.; Morris, Jeff; Ruston, Linette; Pass, Sarah L.; Greenwood, Ryan; Williams, Emma J.; Demeritt, Julie; Culshaw, Janet D.; Gill, Kristy; Pass, Martin; Finlay, M. Raymond V.; Good, Catherine J.; Roberts, Craig A.; Currie, Gordon S.; Blades, Kevin; Eden, Jonathan M.; Pearson, Stuart E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2326-2349</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High throughput screening followed by a lead generation campaign uncovered a novel series of urea contg. morpholinopyrimidine compds. which act as potent and selective dual inhibitors of mTORC1 and mTORC2.  The authors describe the continued compd. optimization campaign for this series, in particular focused on identifying compds. with improved cellular potency, improved aq. soly., and good stability in human hepatocyte incubations.  Knowledge from empirical SAR investigations was combined with an understanding of the mol. interactions in the crystal lattice to improve both cellular potency and soly., and the composite parameters of LLE and pIC50-pSoly. were used to assess compd. quality and progress.  Predictive models were employed to efficiently mine the attractive chem. space identified resulting in the discovery of I (AZD3147), an extremely potent and selective dual inhibitor of mTORC1 and mTORC2 with physicochem. and pharmacokinetic properties suitable for development as a potential clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVFrPEX3khBbVg90H21EOLACvtfcHk0lhAC_TuwZLnbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFeitL0%253D&md5=92d9596bf3c160bcde73fd9c586d6b84</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm501778s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501778s%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DK.%2BG.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DRuston%26aufirst%3DL.%26aulast%3DPass%26aufirst%3DS.%2BL.%26aulast%3DGreenwood%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DE.%2BJ.%26aulast%3DDemeritt%26aufirst%3DJ.%26aulast%3DCulshaw%26aufirst%3DJ.%2BD.%26aulast%3DGill%26aufirst%3DK.%26aulast%3DPass%26aufirst%3DM.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26aulast%3DGood%26aufirst%3DC.%2BJ.%26aulast%3DRoberts%26aufirst%3DC.%2BA.%26aulast%3DCurrie%26aufirst%3DG.%2BS.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DEden%26aufirst%3DJ.%2BM.%26aulast%3DPearson%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520AZD3147%253A%2520A%2520potent%252C%2520selective%2520dual%2520inhibitor%2520of%2520mTORC1%2520and%2520mTORC2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2326%26epage%3D2349%26doi%3D10.1021%2Fjm501778s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almond, A.</span></span> <span> </span><span class="NLM_article-title">Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4976</span>– <span class="NLM_lpage">4987</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.06.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1016%2Fj.bmc.2013.06.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=23886813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCqt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=4976-4987&author=C.+D.+Blundellauthor=M.+J.+Packerauthor=A.+Almond&title=Quantification+of+free+ligand+conformational+preferences+by+NMR+and+their+relationship+to+the+bioactive+conformation&doi=10.1016%2Fj.bmc.2013.06.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation</span></div><div class="casAuthors">Blundell, Charles D.; Packer, Martin J.; Almond, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4976-4987</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Accurate unbound soln. 3D-structures of ligands provide unique opportunities for medicinal chem. and, in particular, a context to understand binding thermodn. and kinetics.  Previous methods of deriving these 3D-structures have had neither the accuracy nor resoln. needed for drug design and have not yet realized their potential.  Here, we describe and apply a NMR methodol. to the aminoglycoside streptomycin that can accurately quantify accessible 3D-space and rank the occupancy of obsd. conformers to a resoln. that enables medicinal chem. understanding and design.  Importantly, it is based upon conventional small mol. NMR techniques and can be performed in physiol.-relevant solvents.  The methodol. uses multiple datasets, an order of magnitude more exptl. data than previous NMR approaches and a dynamic model during refinement, is independent of computational chem. and avoids the problem of virtual conformations.  The refined set of soln. 3D-shapes for streptomycin can be grouped into two major families, of which the most populated is almost identical to the 30S ribosomal subunit bioactive shape.  We therefore propose that accurate unbound ligand soln. conformations may, in some cases, provide a subsidiary route to bioactive shape without crystallog.  This exptl. technique opens up new opportunities for drug design and more so when complemented with protein co-crystal structures, SAR data and pharmacophore modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUZZsawI_fmLVg90H21EOLACvtfcHk0lhAC_TuwZLnbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCqt77K&md5=3ac32a01828e59160794384644aacbf4</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.06.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.06.056%26sid%3Dliteratum%253Aachs%26aulast%3DBlundell%26aufirst%3DC.%2BD.%26aulast%3DPacker%26aufirst%3DM.%2BJ.%26aulast%3DAlmond%26aufirst%3DA.%26atitle%3DQuantification%2520of%2520free%2520ligand%2520conformational%2520preferences%2520by%2520NMR%2520and%2520their%2520relationship%2520to%2520the%2520bioactive%2520conformation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D4976%26epage%3D4987%26doi%3D10.1016%2Fj.bmc.2013.06.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cadogan, E. D.</span></span> <span> </span><span class="NLM_article-title">Discovery and Preclinical Pharmacology of AZD0156: a First in Class Potent and Selective Inhibitor of Ataxia Telangiectasia Mutated (ATM) Kinase</span>.  <i>Abstracts of Papers, Annual Meeting of the American Association of Cancer Research, New Orleans, LA, 2016</i>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=E.+D.+Cadogan&title=Discovery+and+Preclinical+Pharmacology+of+AZD0156%3A+a+First+in+Class+Potent+and+Selective+Inhibitor+of+Ataxia+Telangiectasia+Mutated+%28ATM%29+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DCadogan%26aufirst%3DE.%2BD.%26atitle%3DDiscovery%2520and%2520Preclinical%2520Pharmacology%2520of%2520AZD0156%253A%2520a%2520First%2520in%2520Class%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520Ataxia%2520Telangiectasia%2520Mutated%2520%2528ATM%2529%2520Kinase%26jtitle%3DAbstracts%2520of%2520Papers%252C%2520Annual%2520Meeting%2520of%2520the%2520American%2520Association%2520of%2520Cancer%2520Research%252C%2520New%2520Orleans%252C%2520LA%252C%25202016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riches, L. C.</span>; <span class="NLM_string-name">Hughes, G.</span>; <span class="NLM_string-name">Jones, G. N.</span>; <span class="NLM_string-name">Garcia-Trinidad, A.</span>; <span class="NLM_string-name">Thomason, A. G.</span>; <span class="NLM_string-name">Gavine, P.</span>; <span class="NLM_string-name">Cui, A.</span>; <span class="NLM_string-name">O’Connor, M.</span>; <span class="NLM_string-name">Ling, S.</span>; <span class="NLM_string-name">Stott, J.</span>; <span class="NLM_string-name">Clark, R.</span>; <span class="NLM_string-name">Peel, S.</span>; <span class="NLM_string-name">Gill, P.</span>; <span class="NLM_string-name">Goodwin, L.</span>; <span class="NLM_string-name">Pike, K. G.</span>; <span class="NLM_string-name">Pass, M.</span>; <span class="NLM_string-name">Barlaam, B.</span>; <span class="NLM_string-name">Smith, G.</span>; <span class="NLM_string-name">Cadogan, E. B.</span></span> unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Riches%2C+L.+C.%3B+Hughes%2C+G.%3B+Jones%2C+G.+N.%3B+Garcia-Trinidad%2C+A.%3B+Thomason%2C+A.+G.%3B+Gavine%2C+P.%3B+Cui%2C+A.%3B+O%E2%80%99Connor%2C+M.%3B+Ling%2C+S.%3B+Stott%2C+J.%3B+Clark%2C+R.%3B+Peel%2C+S.%3B+Gill%2C+P.%3B+Goodwin%2C+L.%3B+Pike%2C+K.+G.%3B+Pass%2C+M.%3B+Barlaam%2C+B.%3B+Smith%2C+G.%3B+Cadogan%2C+E.+B.+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DRiches%26aufirst%3DL.%2BC." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barlaam, B. C.</span>; <span class="NLM_string-name">Pike, K. G.</span></span> <span> </span><span class="NLM_article-title">Imidazo[4,5-<i>c</i>]quinolin-2-one Compounds and Their Use in Treating Cancer</span>. WO patent <span class="NLM_patent">WO 2015170081</span>, Nov 12, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=B.+C.+Barlaam&author=K.+G.+Pike&title=Imidazo%5B4%2C5-c%5Dquinolin-2-one+Compounds+and+Their+Use+in+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarlaam%26aufirst%3DB.%2BC.%26atitle%3DImidazo%255B4%252C5-c%255Dquinolin-2-one%2520Compounds%2520and%2520Their%2520Use%2520in%2520Treating%2520Cancer%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellison, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahdesmaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhaskar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J.</span></span> <span> </span><span class="NLM_article-title">A reliable method for the delection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilizing multiplex PCR-based targeted next generation sequencing</span>. <i>BMC Clin. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">5</span>, <span class="refDoi"> DOI: 10.1186/s12907-015-0004-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1186%2Fs12907-015-0004-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=25859162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=1%3ACAS%3A280%3ADC%252BC2MjivVejuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=5&author=G.+Ellisonauthor=S.+Huangauthor=H.+Carrauthor=A.+Wallaceauthor=M.+Ahdesmakiauthor=S.+Bhaskarauthor=J.+Mills&title=A+reliable+method+for+the+delection+of+BRCA1+and+BRCA2+mutations+in+fixed+tumour+tissue+utilizing+multiplex+PCR-based+targeted+next+generation+sequencing&doi=10.1186%2Fs12907-015-0004-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing</span></div><div class="casAuthors">Ellison Gillian; Mills John; Huang Shuwen; Wallace Andrew; Bhaskar Sanjeev; Carr Hedley; Ahdesmaki Miika</div><div class="citationInfo"><span class="NLM_cas:title">BMC clinical pathology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5</span>
        ISSN:<span class="NLM_cas:issn">1472-6890</span>.
    </div><div class="casAbstract">BACKGROUND:  Germline mutations in BRCA1 or BRCA2 lead to a high lifetime probability of developing ovarian or breast cancer.  These genes can also be involved in the development of non-hereditary tumours as somatic BRCA1/2 pathogenic variants are found in some of these cancers.  Since patients with somatic BRCA pathogenic variants may benefit from treatment with poly ADP ribose polymerase inhibitors, it is important to be able to test for somatic changes in routinely available tumour samples.  Such samples are typically formalin-fixed paraffin-embedded (FFPE) tissue, where the extracted DNA tends to be highly fragmented and of limited quantity, making analysis of large genes such as BRCA1 and BRCA2 challenging.  This is made more difficult as somatic changes may be evident in only part of the sample, due to the presence of normal tissue.  METHODS:  We examined the feasibility of analysing DNA extracted from FFPE ovarian and breast tumour tissue to identify significant DNA variants in BRCA1/ BRCA2 using next generation sequencing methods that were sensitive enough to detect low level mutations, multiplexed to reduce the amount of DNA required and had short amplicon design.  The utility of two GeneRead DNAseq Targeted Exon Enrichment Panels with different designs targeting only BRCA1/2 exons, and the Ion AmpliSeq BRCA community panel, followed by library preparation and adaptor ligation using the TruSeq DNA PCR-Free HT Sample Preparation Kit and NGS analysis on the MiSeq were investigated.  RESULTS:  Using the GeneRead method, we successfully analysed over 76% of samples, with >95% coverage of BRCA1/2 coding regions and a mean average read depth of >1000-fold.  All mutations identified were confirmed where possible by Sanger sequencing or replication to eliminate the risk of false positive results due to artefacts within FFPE material.  Admixture experiments demonstrated that BRCA1/2 variants could be detected if present in >10% of the sample.  A sample subset was evaluated using the Ion AmpliSeq BRCA panel, achieving >99% coverage and sufficient read depth for a proportion of the samples.  CONCLUSIONS:  Detection of BRCA1/2 variants in fixed tissue is feasible, and could be performed prospectively to facilitate optimum treatment decisions for ovarian or breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1SMGX3K8vvcKL0FlyGHDofW6udTcc2eY21vNFcv_tUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjivVejuw%253D%253D&md5=feb29e3176074b6ffb0ee903e86d7ed7</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1186%2Fs12907-015-0004-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12907-015-0004-6%26sid%3Dliteratum%253Aachs%26aulast%3DEllison%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DCarr%26aufirst%3DH.%26aulast%3DWallace%26aufirst%3DA.%26aulast%3DAhdesmaki%26aufirst%3DM.%26aulast%3DBhaskar%26aufirst%3DS.%26aulast%3DMills%26aufirst%3DJ.%26atitle%3DA%2520reliable%2520method%2520for%2520the%2520delection%2520of%2520BRCA1%2520and%2520BRCA2%2520mutations%2520in%2520fixed%2520tumour%2520tissue%2520utilizing%2520multiplex%2520PCR-based%2520targeted%2520next%2520generation%2520sequencing%26jtitle%3DBMC%2520Clin.%2520Pathol.%26date%3D2015%26volume%3D15%26spage%3D5%26doi%3D10.1186%2Fs12907-015-0004-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kowalski, K.</span>; <span class="NLM_string-name">Hansen, P.</span>; <span class="NLM_string-name">Dayton, B.</span>; <span class="NLM_string-name">Oladipupo, O.</span>; <span class="NLM_string-name">Thomas, E.</span>; <span class="NLM_string-name">Li, Y.</span>; <span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Overcoming Matrix-Based Interferences Using Multi-Extraction Techniques for LC-MS Analysis of AZD0156 and its Metabolite in Human Plasma</span>.  <i>65th American Society for Mass Spectrometry Annual Conference (ASMS 2017), Indianapolis, IN, 2017</i>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=K.+Kowalski&author=P.+Hansen&author=B.+Dayton&author=O.+Oladipupo&author=E.+Thomas&author=Y.+Li&author=Y.+Chen&title=Overcoming+Matrix-Based+Interferences+Using+Multi-Extraction+Techniques+for+LC-MS+Analysis+of+AZD0156+and+its+Metabolite+in+Human+Plasma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DKowalski%26aufirst%3DK.%26atitle%3DOvercoming%2520Matrix-Based%2520Interferences%2520Using%2520Multi-Extraction%2520Techniques%2520for%2520LC-MS%2520Analysis%2520of%2520AZD0156%2520and%2520its%2520Metabolite%2520in%2520Human%2520Plasma%26jtitle%3D65th%2520American%2520Society%2520for%2520Mass%2520Spectrometry%2520Annual%2520Conference%2520%2528ASMS%25202017%2529%252C%2520Indianapolis%252C%2520IN%252C%25202017%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <i>Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis</i>, <span class="NLM_edition">2nd</span> ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2000</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;key=10.1002%2F0471220639" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=R.+A.+Copeland&title=Enzymes%3A+A+Practical+Introduction+to+Structure%2C+Mechanism%2C+and+Data+Analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2F0471220639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471220639%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEnzymes%253A%2520A%2520Practical%2520Introduction%2520to%2520Structure%252C%2520Mechanism%252C%2520and%2520Data%2520Analysis%26pub%3DWiley%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JSX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JSX','PDB','4JSX'); return false;">PDB: 4JSX</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i26"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01896">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_63088"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01896">10.1021/acs.jmedchem.7b01896</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures for the key biological assays, the synthesis and analytical data of final compounds and key intermediates, experimental procedure and data for the NMR structural, and conformational elucidation of <b>64</b>, the purity assessment of <b>64</b>, and the kinome selectivity data for <b>64</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01896/suppl_file/jm7b01896_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Coordinates for the homology model (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01896/suppl_file/jm7b01896_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Molecular formular strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01896/suppl_file/jm7b01896_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01896/suppl_file/jm7b01896_si_001.pdf">jm7b01896_si_001.pdf (1.0 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01896/suppl_file/jm7b01896_si_002.pdb">jm7b01896_si_002.pdb (1.54 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01896/suppl_file/jm7b01896_si_003.csv">jm7b01896_si_003.csv (2.59 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01896&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-9%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01896%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01896" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995f7fafe33bf8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
